CN115772544A - 抗vegf-a和ang-2的aav载体 - Google Patents
抗vegf-a和ang-2的aav载体 Download PDFInfo
- Publication number
- CN115772544A CN115772544A CN202111048202.XA CN202111048202A CN115772544A CN 115772544 A CN115772544 A CN 115772544A CN 202111048202 A CN202111048202 A CN 202111048202A CN 115772544 A CN115772544 A CN 115772544A
- Authority
- CN
- China
- Prior art keywords
- gly
- ser
- thr
- ala
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010048036 Angiopoietin-2 Proteins 0.000 title claims abstract description 12
- 102100034608 Angiopoietin-2 Human genes 0.000 title claims abstract description 11
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 title description 12
- 239000013607 AAV vector Substances 0.000 title description 4
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 title description 4
- 241000702421 Dependoparvovirus Species 0.000 claims abstract description 46
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 18
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims abstract description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims abstract description 3
- 201000011190 diabetic macular edema Diseases 0.000 claims abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 53
- 239000013603 viral vector Substances 0.000 claims description 25
- 238000002347 injection Methods 0.000 claims description 18
- 239000007924 injection Substances 0.000 claims description 18
- 206010064930 age-related macular degeneration Diseases 0.000 claims description 10
- 208000002780 macular degeneration Diseases 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 8
- 230000003612 virological effect Effects 0.000 claims description 8
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 claims description 7
- 108090000565 Capsid Proteins Proteins 0.000 claims description 4
- 102100023321 Ceruloplasmin Human genes 0.000 claims description 4
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 4
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 241001655883 Adeno-associated virus - 1 Species 0.000 claims description 2
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 2
- 241000580270 Adeno-associated virus - 4 Species 0.000 claims description 2
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims description 2
- 241000972680 Adeno-associated virus - 6 Species 0.000 claims description 2
- 241001164823 Adeno-associated virus - 7 Species 0.000 claims description 2
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 206010038934 Retinopathy proliferative Diseases 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 12
- 150000007523 nucleic acids Chemical class 0.000 abstract description 2
- 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 abstract 1
- 210000000234 capsid Anatomy 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 78
- 241000880493 Leptailurus serval Species 0.000 description 66
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 61
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 55
- 108010089804 glycyl-threonine Proteins 0.000 description 44
- 108010003137 tyrosyltyrosine Proteins 0.000 description 41
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 40
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 39
- 108020004414 DNA Proteins 0.000 description 38
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 37
- 108010078144 glutaminyl-glycine Proteins 0.000 description 37
- 108010016616 cysteinylglycine Proteins 0.000 description 36
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 34
- 108010004073 cysteinylcysteine Proteins 0.000 description 34
- 108010065920 Insulin Lispro Proteins 0.000 description 31
- 108010079364 N-glycylalanine Proteins 0.000 description 31
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 30
- 108010061238 threonyl-glycine Proteins 0.000 description 30
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 29
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 29
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 28
- OYTPNWYZORARHL-XHNCKOQMSA-N Gln-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N OYTPNWYZORARHL-XHNCKOQMSA-N 0.000 description 28
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 28
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 28
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 28
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 27
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 26
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 26
- LJFNNUBZSZCZFN-WHFBIAKZSA-N Ala-Gly-Cys Chemical compound N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O LJFNNUBZSZCZFN-WHFBIAKZSA-N 0.000 description 25
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 25
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 25
- JMVQDLDPDBXAAX-YUMQZZPRSA-N Pro-Gly-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 JMVQDLDPDBXAAX-YUMQZZPRSA-N 0.000 description 24
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 24
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 24
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 24
- 108010070643 prolylglutamic acid Proteins 0.000 description 24
- 108010026333 seryl-proline Proteins 0.000 description 24
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 23
- AEJSNWMRPXAKCW-WHFBIAKZSA-N Cys-Ala-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AEJSNWMRPXAKCW-WHFBIAKZSA-N 0.000 description 22
- IDOGEHIWMJMAHT-BYPYZUCNSA-N Gly-Gly-Cys Chemical compound NCC(=O)NCC(=O)N[C@@H](CS)C(O)=O IDOGEHIWMJMAHT-BYPYZUCNSA-N 0.000 description 22
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 22
- YRNBANYVJJBGDI-VZFHVOOUSA-N Thr-Ala-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)N)O YRNBANYVJJBGDI-VZFHVOOUSA-N 0.000 description 22
- 239000013612 plasmid Substances 0.000 description 22
- 108010044292 tryptophyltyrosine Proteins 0.000 description 22
- OWFGFHQMSBTKLX-UFYCRDLUSA-N Val-Tyr-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N OWFGFHQMSBTKLX-UFYCRDLUSA-N 0.000 description 21
- 108010047495 alanylglycine Proteins 0.000 description 21
- 239000002773 nucleotide Substances 0.000 description 21
- 125000003729 nucleotide group Chemical group 0.000 description 21
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 20
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 20
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 20
- MBLJBGZWLHTJBH-SZMVWBNQSA-N Trp-Val-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 MBLJBGZWLHTJBH-SZMVWBNQSA-N 0.000 description 20
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 20
- ANHVRCNNGJMJNG-BZSNNMDCSA-N Tyr-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)O)N)O ANHVRCNNGJMJNG-BZSNNMDCSA-N 0.000 description 20
- 108010008355 arginyl-glutamine Proteins 0.000 description 20
- 108010049041 glutamylalanine Proteins 0.000 description 20
- 108010010147 glycylglutamine Proteins 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 108010073969 valyllysine Proteins 0.000 description 20
- HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 19
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 19
- RKQAYOWLSFLJEE-SVSWQMSJSA-N Ile-Thr-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O)N RKQAYOWLSFLJEE-SVSWQMSJSA-N 0.000 description 19
- IHCXPSYCHXFXKT-DCAQKATOSA-N Pro-Arg-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O IHCXPSYCHXFXKT-DCAQKATOSA-N 0.000 description 19
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 19
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 19
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 19
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 19
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 19
- 108010015792 glycyllysine Proteins 0.000 description 19
- 108010017391 lysylvaline Proteins 0.000 description 19
- 108010051242 phenylalanylserine Proteins 0.000 description 19
- 108010031719 prolyl-serine Proteins 0.000 description 19
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 18
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 18
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 18
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 18
- 108010084264 glycyl-glycyl-cysteine Proteins 0.000 description 18
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 18
- OHLLDUNVMPPUMD-DCAQKATOSA-N Cys-Leu-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N OHLLDUNVMPPUMD-DCAQKATOSA-N 0.000 description 17
- NMROINAYXCACKF-WHFBIAKZSA-N Gly-Cys-Cys Chemical compound NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(O)=O NMROINAYXCACKF-WHFBIAKZSA-N 0.000 description 17
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 17
- MVJRBCJCRYGCKV-GVXVVHGQSA-N Leu-Val-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MVJRBCJCRYGCKV-GVXVVHGQSA-N 0.000 description 17
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 17
- RMRFSFXLFWWAJZ-HJOGWXRNSA-N Tyr-Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 RMRFSFXLFWWAJZ-HJOGWXRNSA-N 0.000 description 17
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 17
- 108010077245 asparaginyl-proline Proteins 0.000 description 17
- 108010050848 glycylleucine Proteins 0.000 description 17
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 16
- ALNKNYKSZPSLBD-ZDLURKLDSA-N Cys-Thr-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ALNKNYKSZPSLBD-ZDLURKLDSA-N 0.000 description 16
- OSCLNNWLKKIQJM-WDSKDSINSA-N Gln-Ser-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O OSCLNNWLKKIQJM-WDSKDSINSA-N 0.000 description 16
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 16
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 16
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 16
- 108010087924 alanylproline Proteins 0.000 description 16
- 108010064235 lysylglycine Proteins 0.000 description 16
- 108010077112 prolyl-proline Proteins 0.000 description 16
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 16
- 108010072644 valyl-alanyl-prolyl-glycine Proteins 0.000 description 16
- DECCMEWNXSNSDO-ZLUOBGJFSA-N Ala-Cys-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O DECCMEWNXSNSDO-ZLUOBGJFSA-N 0.000 description 15
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 15
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 15
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 15
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 15
- FFJQHWKSGAWSTJ-BFHQHQDPSA-N Gly-Thr-Ala Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O FFJQHWKSGAWSTJ-BFHQHQDPSA-N 0.000 description 15
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 15
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 15
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 15
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 15
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 15
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 15
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 15
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 15
- 108010092854 aspartyllysine Proteins 0.000 description 15
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 15
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 15
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 15
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 14
- TVYMKYUSZSVOAG-ZLUOBGJFSA-N Cys-Ala-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O TVYMKYUSZSVOAG-ZLUOBGJFSA-N 0.000 description 14
- MADFVRSKEIEZHZ-DCAQKATOSA-N Gln-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N MADFVRSKEIEZHZ-DCAQKATOSA-N 0.000 description 14
- ZFBBMCKQSNJZSN-AUTRQRHGSA-N Gln-Val-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZFBBMCKQSNJZSN-AUTRQRHGSA-N 0.000 description 14
- GQGAFTPXAPKSCF-WHFBIAKZSA-N Gly-Ala-Cys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O GQGAFTPXAPKSCF-WHFBIAKZSA-N 0.000 description 14
- WTUSRDZLLWGYAT-KCTSRDHCSA-N Gly-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN WTUSRDZLLWGYAT-KCTSRDHCSA-N 0.000 description 14
- MAABHGXCIBEYQR-XVYDVKMFSA-N His-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MAABHGXCIBEYQR-XVYDVKMFSA-N 0.000 description 14
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 14
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 14
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 14
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 14
- QOIKZODVIPOPDD-AVGNSLFASA-N Tyr-Cys-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O QOIKZODVIPOPDD-AVGNSLFASA-N 0.000 description 14
- 108010081404 acein-2 Proteins 0.000 description 14
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 14
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 14
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 14
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 14
- 108010052774 valyl-lysyl-glycyl-phenylalanyl-tyrosine Proteins 0.000 description 14
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 13
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 13
- RCQRKPUXJAGEEC-ZLUOBGJFSA-N Ala-Cys-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(O)=O RCQRKPUXJAGEEC-ZLUOBGJFSA-N 0.000 description 13
- JWQWPRCDYWNVNM-ACZMJKKPSA-N Asn-Ser-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N JWQWPRCDYWNVNM-ACZMJKKPSA-N 0.000 description 13
- VNXQRBXEQXLERQ-CIUDSAMLSA-N Asp-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N VNXQRBXEQXLERQ-CIUDSAMLSA-N 0.000 description 13
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 13
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 13
- BIRKKBCSAIHDDF-WDSKDSINSA-N Gly-Glu-Cys Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(O)=O BIRKKBCSAIHDDF-WDSKDSINSA-N 0.000 description 13
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 13
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 13
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 13
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 13
- HXSUFWQYLPKEHF-IHRRRGAJSA-N Phe-Asn-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HXSUFWQYLPKEHF-IHRRRGAJSA-N 0.000 description 13
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 13
- CKDXFSPMIDSMGV-GUBZILKMSA-N Ser-Pro-Val Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O CKDXFSPMIDSMGV-GUBZILKMSA-N 0.000 description 13
- MQCPGOZXFSYJPS-KZVJFYERSA-N Thr-Ala-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MQCPGOZXFSYJPS-KZVJFYERSA-N 0.000 description 13
- GKWNLDNXMMLRMC-GLLZPBPUSA-N Thr-Glu-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O GKWNLDNXMMLRMC-GLLZPBPUSA-N 0.000 description 13
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 13
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 13
- XYNFFTNEQDWZNY-ULQDDVLXSA-N Tyr-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N XYNFFTNEQDWZNY-ULQDDVLXSA-N 0.000 description 13
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 13
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 13
- 108010024654 phenylalanyl-prolyl-alanine Proteins 0.000 description 13
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 12
- NVWJMQNYLYWVNQ-BYULHYEWSA-N Asn-Ile-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O NVWJMQNYLYWVNQ-BYULHYEWSA-N 0.000 description 12
- DBWYWXNMZZYIRY-LPEHRKFASA-N Asp-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O DBWYWXNMZZYIRY-LPEHRKFASA-N 0.000 description 12
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 12
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 12
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 12
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 12
- NGBGZCUWFVVJKC-IRXDYDNUSA-N Gly-Tyr-Tyr Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 NGBGZCUWFVVJKC-IRXDYDNUSA-N 0.000 description 12
- TTYKEFZRLKQTHH-MELADBBJSA-N His-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O TTYKEFZRLKQTHH-MELADBBJSA-N 0.000 description 12
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 12
- QARPMYDMYVLFMW-KKUMJFAQSA-N Phe-Pro-Glu Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 QARPMYDMYVLFMW-KKUMJFAQSA-N 0.000 description 12
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 12
- YDTUEBLEAVANFH-RCWTZXSCSA-N Pro-Val-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 YDTUEBLEAVANFH-RCWTZXSCSA-N 0.000 description 12
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 12
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 12
- UZJDBCHMIQXLOQ-HEIBUPTGSA-N Thr-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O UZJDBCHMIQXLOQ-HEIBUPTGSA-N 0.000 description 12
- XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 12
- SDHZOOIGIUEPDY-JYJNAYRXSA-N Val-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 SDHZOOIGIUEPDY-JYJNAYRXSA-N 0.000 description 12
- YKZVPMUGEJXEOR-JYJNAYRXSA-N Val-Val-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N YKZVPMUGEJXEOR-JYJNAYRXSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 12
- 108010005942 methionylglycine Proteins 0.000 description 12
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 11
- JTXVXGXTRXMOFJ-FXQIFTODSA-N Asn-Pro-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O JTXVXGXTRXMOFJ-FXQIFTODSA-N 0.000 description 11
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 11
- LGCVSPFCFXWUEY-IHPCNDPISA-N Asn-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N LGCVSPFCFXWUEY-IHPCNDPISA-N 0.000 description 11
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 11
- HYKFOHGZGLOCAY-ZLUOBGJFSA-N Cys-Cys-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O HYKFOHGZGLOCAY-ZLUOBGJFSA-N 0.000 description 11
- KOHBWQDSVCARMI-BWBBJGPYSA-N Cys-Cys-Thr Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KOHBWQDSVCARMI-BWBBJGPYSA-N 0.000 description 11
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 11
- CEXINUGNTZFNRY-BYPYZUCNSA-N Gly-Cys-Gly Chemical compound [NH3+]CC(=O)N[C@@H](CS)C(=O)NCC([O-])=O CEXINUGNTZFNRY-BYPYZUCNSA-N 0.000 description 11
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 11
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 11
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 11
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 11
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 11
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 11
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 11
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 11
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 11
- IUVYJBMTHARMIP-PCBIJLKTSA-N Phe-Asp-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IUVYJBMTHARMIP-PCBIJLKTSA-N 0.000 description 11
- SJRQWEDYTKYHHL-SLFFLAALSA-N Phe-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O SJRQWEDYTKYHHL-SLFFLAALSA-N 0.000 description 11
- TXPUNZXZDVJUJQ-LPEHRKFASA-N Pro-Asn-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N2CCC[C@@H]2C(=O)O TXPUNZXZDVJUJQ-LPEHRKFASA-N 0.000 description 11
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 11
- UGJRQLURDVGULT-LKXGYXEUSA-N Ser-Asn-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UGJRQLURDVGULT-LKXGYXEUSA-N 0.000 description 11
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 11
- YOPQYBJJNSIQGZ-JNPHEJMOSA-N Thr-Tyr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 YOPQYBJJNSIQGZ-JNPHEJMOSA-N 0.000 description 11
- BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 description 11
- JQTYTBPCSOAZHI-FXQIFTODSA-N Val-Ser-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N JQTYTBPCSOAZHI-FXQIFTODSA-N 0.000 description 11
- USXYVSTVPHELAF-RCWTZXSCSA-N Val-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N)O USXYVSTVPHELAF-RCWTZXSCSA-N 0.000 description 11
- SUGRIIAOLCDLBD-ZOBUZTSGSA-N Val-Trp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SUGRIIAOLCDLBD-ZOBUZTSGSA-N 0.000 description 11
- 108010037850 glycylvaline Proteins 0.000 description 11
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 11
- 108010000761 leucylarginine Proteins 0.000 description 11
- 108010038745 tryptophylglycine Proteins 0.000 description 11
- IESDGNYHXIOKRW-YXMSTPNBSA-N (2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-YXMSTPNBSA-N 0.000 description 10
- DIBLBAURNYJYBF-XLXZRNDBSA-N (2s)-2-[[(2s)-2-[[2-[[(2s)-6-amino-2-[[(2s)-2-amino-3-methylbutanoyl]amino]hexanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 DIBLBAURNYJYBF-XLXZRNDBSA-N 0.000 description 10
- KUDREHRZRIVKHS-UWJYBYFXSA-N Ala-Asp-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KUDREHRZRIVKHS-UWJYBYFXSA-N 0.000 description 10
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 10
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 10
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 10
- JPPLRQVZMZFOSX-UWJYBYFXSA-N Asn-Tyr-Ala Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 JPPLRQVZMZFOSX-UWJYBYFXSA-N 0.000 description 10
- MJIJBEYEHBKTIM-BYULHYEWSA-N Asn-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N MJIJBEYEHBKTIM-BYULHYEWSA-N 0.000 description 10
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 10
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 10
- OOXKFYNWRVGYFM-XIRDDKMYSA-N Asp-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CC(=O)O)N OOXKFYNWRVGYFM-XIRDDKMYSA-N 0.000 description 10
- HTSSXFASOUSJQG-IHPCNDPISA-N Asp-Tyr-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O HTSSXFASOUSJQG-IHPCNDPISA-N 0.000 description 10
- DZLQXIFVQFTFJY-BYPYZUCNSA-N Cys-Gly-Gly Chemical compound SC[C@H](N)C(=O)NCC(=O)NCC(O)=O DZLQXIFVQFTFJY-BYPYZUCNSA-N 0.000 description 10
- ZXCAQANTQWBICD-DCAQKATOSA-N Cys-Lys-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N ZXCAQANTQWBICD-DCAQKATOSA-N 0.000 description 10
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 10
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 10
- QQLBPVKLJBAXBS-FXQIFTODSA-N Glu-Glu-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QQLBPVKLJBAXBS-FXQIFTODSA-N 0.000 description 10
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 10
- MFYLRRCYBBJYPI-JYJNAYRXSA-N Glu-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O MFYLRRCYBBJYPI-JYJNAYRXSA-N 0.000 description 10
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 10
- GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 10
- PABFFPWEJMEVEC-JGVFFNPUSA-N Gly-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)O PABFFPWEJMEVEC-JGVFFNPUSA-N 0.000 description 10
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 10
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 10
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 10
- QQFSKBMCAKWHLG-UHFFFAOYSA-N Ile-Phe-Pro-Pro Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(NC(=O)C(N)C(C)CC)CC1=CC=CC=C1 QQFSKBMCAKWHLG-UHFFFAOYSA-N 0.000 description 10
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 10
- AXZGZMGRBDQTEY-SRVKXCTJSA-N Leu-Gln-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O AXZGZMGRBDQTEY-SRVKXCTJSA-N 0.000 description 10
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 10
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 10
- XNKDCYABMBBEKN-IUCAKERBSA-N Lys-Gly-Gln Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O XNKDCYABMBBEKN-IUCAKERBSA-N 0.000 description 10
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 10
- SPSSJSICDYYTQN-HJGDQZAQSA-N Met-Thr-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O SPSSJSICDYYTQN-HJGDQZAQSA-N 0.000 description 10
- YYKZDTVQHTUKDW-RYUDHWBXSA-N Phe-Gly-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N YYKZDTVQHTUKDW-RYUDHWBXSA-N 0.000 description 10
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 10
- WWPAHTZOWURIMR-ULQDDVLXSA-N Phe-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 WWPAHTZOWURIMR-ULQDDVLXSA-N 0.000 description 10
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 10
- TUYWCHPXKQTISF-LPEHRKFASA-N Pro-Cys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N2CCC[C@@H]2C(=O)O TUYWCHPXKQTISF-LPEHRKFASA-N 0.000 description 10
- PCWLNNZTBJTZRN-AVGNSLFASA-N Pro-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 PCWLNNZTBJTZRN-AVGNSLFASA-N 0.000 description 10
- VGNYHOBZJKWRGI-CIUDSAMLSA-N Ser-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO VGNYHOBZJKWRGI-CIUDSAMLSA-N 0.000 description 10
- UQFYNFTYDHUIMI-WHFBIAKZSA-N Ser-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CO UQFYNFTYDHUIMI-WHFBIAKZSA-N 0.000 description 10
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 10
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 10
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 10
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 10
- KWQBJOUOSNJDRR-XAVMHZPKSA-N Thr-Cys-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N)O KWQBJOUOSNJDRR-XAVMHZPKSA-N 0.000 description 10
- DSLHSTIUAPKERR-XGEHTFHBSA-N Thr-Cys-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O DSLHSTIUAPKERR-XGEHTFHBSA-N 0.000 description 10
- LIXBDERDAGNVAV-XKBZYTNZSA-N Thr-Gln-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O LIXBDERDAGNVAV-XKBZYTNZSA-N 0.000 description 10
- DQDXHYIEITXNJY-BPUTZDHNSA-N Trp-Gln-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N DQDXHYIEITXNJY-BPUTZDHNSA-N 0.000 description 10
- SVGAWGVHFIYAEE-JSGCOSHPSA-N Trp-Gly-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 SVGAWGVHFIYAEE-JSGCOSHPSA-N 0.000 description 10
- RIVVDNTUSRVTQT-IRIUXVKKSA-N Tyr-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O RIVVDNTUSRVTQT-IRIUXVKKSA-N 0.000 description 10
- JIODCDXKCJRMEH-NHCYSSNCSA-N Val-Arg-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N JIODCDXKCJRMEH-NHCYSSNCSA-N 0.000 description 10
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 10
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 10
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 10
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 10
- 108010041407 alanylaspartic acid Proteins 0.000 description 10
- 108010011559 alanylphenylalanine Proteins 0.000 description 10
- 238000003776 cleavage reaction Methods 0.000 description 10
- 108010034529 leucyl-lysine Proteins 0.000 description 10
- 230000007017 scission Effects 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 9
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 9
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 9
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 9
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 9
- QKHWNPQNOHEFST-VZFHVOOUSA-N Ala-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C)N)O QKHWNPQNOHEFST-VZFHVOOUSA-N 0.000 description 9
- FEZJJKXNPSEYEV-CIUDSAMLSA-N Arg-Gln-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FEZJJKXNPSEYEV-CIUDSAMLSA-N 0.000 description 9
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 9
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 9
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 9
- YUELDQUPTAYEGM-XIRDDKMYSA-N Asp-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)O)N YUELDQUPTAYEGM-XIRDDKMYSA-N 0.000 description 9
- XMKXONRMGJXCJV-LAEOZQHASA-N Asp-Val-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XMKXONRMGJXCJV-LAEOZQHASA-N 0.000 description 9
- VIRYODQIWJNWNU-NRPADANISA-N Cys-Glu-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N VIRYODQIWJNWNU-NRPADANISA-N 0.000 description 9
- BFEZQZKEPRKKHV-SRVKXCTJSA-N Glu-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O BFEZQZKEPRKKHV-SRVKXCTJSA-N 0.000 description 9
- BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 9
- VNBNZUAPOYGRDB-ZDLURKLDSA-N Gly-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)CN)O VNBNZUAPOYGRDB-ZDLURKLDSA-N 0.000 description 9
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 9
- ALPXXNRQBMRCPZ-MEYUZBJRSA-N His-Thr-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ALPXXNRQBMRCPZ-MEYUZBJRSA-N 0.000 description 9
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 9
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 9
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 9
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 9
- QQPSCXKFDSORFT-IHRRRGAJSA-N Lys-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN QQPSCXKFDSORFT-IHRRRGAJSA-N 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 9
- JDMKQHSHKJHAHR-UHFFFAOYSA-N Phe-Phe-Leu-Tyr Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)CC1=CC=CC=C1 JDMKQHSHKJHAHR-UHFFFAOYSA-N 0.000 description 9
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 9
- UAYHMOIGIQZLFR-NHCYSSNCSA-N Pro-Gln-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UAYHMOIGIQZLFR-NHCYSSNCSA-N 0.000 description 9
- GMJDSFYVTAMIBF-FXQIFTODSA-N Pro-Ser-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GMJDSFYVTAMIBF-FXQIFTODSA-N 0.000 description 9
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 9
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 9
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 9
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 9
- KGKWKSSSQGGYAU-SUSMZKCASA-N Thr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KGKWKSSSQGGYAU-SUSMZKCASA-N 0.000 description 9
- CYVQBKQYQGEELV-NKIYYHGXSA-N Thr-His-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O CYVQBKQYQGEELV-NKIYYHGXSA-N 0.000 description 9
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 9
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 9
- JJNXZIPLIXIGBX-HJPIBITLSA-N Tyr-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N JJNXZIPLIXIGBX-HJPIBITLSA-N 0.000 description 9
- HZWPGKAKGYJWCI-ULQDDVLXSA-N Tyr-Val-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O HZWPGKAKGYJWCI-ULQDDVLXSA-N 0.000 description 9
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 9
- OXVPMZVGCAPFIG-BQFCYCMXSA-N Val-Gln-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N OXVPMZVGCAPFIG-BQFCYCMXSA-N 0.000 description 9
- KRAHMIJVUPUOTQ-DCAQKATOSA-N Val-Ser-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KRAHMIJVUPUOTQ-DCAQKATOSA-N 0.000 description 9
- 108010038320 lysylphenylalanine Proteins 0.000 description 9
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 8
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 8
- ADPACBMPYWJJCE-FXQIFTODSA-N Arg-Ser-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O ADPACBMPYWJJCE-FXQIFTODSA-N 0.000 description 8
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 8
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 8
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 8
- ALMIMUZAWTUNIO-BZSNNMDCSA-N Asp-Tyr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ALMIMUZAWTUNIO-BZSNNMDCSA-N 0.000 description 8
- CVOZXIPULQQFNY-ZLUOBGJFSA-N Cys-Ala-Cys Chemical compound C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(O)=O CVOZXIPULQQFNY-ZLUOBGJFSA-N 0.000 description 8
- SMYXEYRYCLIPIL-ZLUOBGJFSA-N Cys-Cys-Cys Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(O)=O SMYXEYRYCLIPIL-ZLUOBGJFSA-N 0.000 description 8
- FTTZLFIEUQHLHH-BWBBJGPYSA-N Cys-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N)O FTTZLFIEUQHLHH-BWBBJGPYSA-N 0.000 description 8
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 8
- KRRMJKMGWWXWDW-STQMWFEESA-N Gly-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KRRMJKMGWWXWDW-STQMWFEESA-N 0.000 description 8
- GVVKYKCOFMMTKZ-WHFBIAKZSA-N Gly-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CN GVVKYKCOFMMTKZ-WHFBIAKZSA-N 0.000 description 8
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 8
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 8
- BXDLTKLPPKBVEL-FJXKBIBVSA-N Gly-Thr-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O BXDLTKLPPKBVEL-FJXKBIBVSA-N 0.000 description 8
- FOCSWPCHUDVNLP-PMVMPFDFSA-N His-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC4=CN=CN4)N FOCSWPCHUDVNLP-PMVMPFDFSA-N 0.000 description 8
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 8
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 8
- UGCIQUYEJIEHKX-GVXVVHGQSA-N Lys-Val-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O UGCIQUYEJIEHKX-GVXVVHGQSA-N 0.000 description 8
- 108700026244 Open Reading Frames Proteins 0.000 description 8
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 8
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 8
- HAYADTTXNZFUDM-IHRRRGAJSA-N Ser-Tyr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O HAYADTTXNZFUDM-IHRRRGAJSA-N 0.000 description 8
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 8
- GLQFKOVWXPPFTP-VEVYYDQMSA-N Thr-Arg-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GLQFKOVWXPPFTP-VEVYYDQMSA-N 0.000 description 8
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 8
- DIPIPFHFLPTCLK-LOKLDPHHSA-N Thr-Gln-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O DIPIPFHFLPTCLK-LOKLDPHHSA-N 0.000 description 8
- WYKJENSCCRJLRC-ZDLURKLDSA-N Thr-Gly-Cys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N)O WYKJENSCCRJLRC-ZDLURKLDSA-N 0.000 description 8
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 8
- SPVHQURZJCUDQC-VOAKCMCISA-N Thr-Lys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O SPVHQURZJCUDQC-VOAKCMCISA-N 0.000 description 8
- NQQMWWVVGIXUOX-SVSWQMSJSA-N Thr-Ser-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NQQMWWVVGIXUOX-SVSWQMSJSA-N 0.000 description 8
- VJOWWOGRNXRQMF-UVBJJODRSA-N Val-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 VJOWWOGRNXRQMF-UVBJJODRSA-N 0.000 description 8
- AGKDVLSDNSTLFA-UMNHJUIQSA-N Val-Gln-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N AGKDVLSDNSTLFA-UMNHJUIQSA-N 0.000 description 8
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 8
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 8
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 8
- 108010039538 alanyl-glycyl-aspartyl-valine Proteins 0.000 description 8
- 108010044940 alanylglutamine Proteins 0.000 description 8
- 108010047857 aspartylglycine Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 210000001508 eye Anatomy 0.000 description 8
- 108010009962 valyltyrosine Proteins 0.000 description 8
- 108010027345 wheylin-1 peptide Proteins 0.000 description 8
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 7
- WCBVQNZTOKJWJS-ACZMJKKPSA-N Ala-Cys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O WCBVQNZTOKJWJS-ACZMJKKPSA-N 0.000 description 7
- IORKCNUBHNIMKY-CIUDSAMLSA-N Ala-Pro-Glu Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O IORKCNUBHNIMKY-CIUDSAMLSA-N 0.000 description 7
- QDGMZAOSMNGBLP-MRFFXTKBSA-N Ala-Trp-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N QDGMZAOSMNGBLP-MRFFXTKBSA-N 0.000 description 7
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 7
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 7
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 7
- HSWYMWGDMPLTTH-FXQIFTODSA-N Asp-Glu-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HSWYMWGDMPLTTH-FXQIFTODSA-N 0.000 description 7
- UZNSWMFLKVKJLI-VHWLVUOQSA-N Asp-Ile-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O UZNSWMFLKVKJLI-VHWLVUOQSA-N 0.000 description 7
- MSHXWFKYXJTLEZ-CIUDSAMLSA-N Gln-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N MSHXWFKYXJTLEZ-CIUDSAMLSA-N 0.000 description 7
- LTUVYLVIZHJCOQ-KKUMJFAQSA-N Glu-Arg-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LTUVYLVIZHJCOQ-KKUMJFAQSA-N 0.000 description 7
- CKOFNWCLWRYUHK-XHNCKOQMSA-N Glu-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CKOFNWCLWRYUHK-XHNCKOQMSA-N 0.000 description 7
- YGLCLCMAYUYZSG-AVGNSLFASA-N Glu-Lys-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 YGLCLCMAYUYZSG-AVGNSLFASA-N 0.000 description 7
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 7
- QSTLUOIOYLYLLF-WDSKDSINSA-N Gly-Asp-Glu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QSTLUOIOYLYLLF-WDSKDSINSA-N 0.000 description 7
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 7
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 7
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 7
- NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 7
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 7
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 7
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 description 7
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 7
- QUCDKEKDPYISNX-HJGDQZAQSA-N Lys-Asn-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QUCDKEKDPYISNX-HJGDQZAQSA-N 0.000 description 7
- IOQWIOPSKJOEKI-SRVKXCTJSA-N Lys-Ser-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IOQWIOPSKJOEKI-SRVKXCTJSA-N 0.000 description 7
- XABXVVSWUVCZST-GVXVVHGQSA-N Lys-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN XABXVVSWUVCZST-GVXVVHGQSA-N 0.000 description 7
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 7
- AXIOGMQCDYVTNY-ACRUOGEOSA-N Phe-Phe-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 AXIOGMQCDYVTNY-ACRUOGEOSA-N 0.000 description 7
- IIEOLPMQYRBZCN-SRVKXCTJSA-N Phe-Ser-Cys Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O IIEOLPMQYRBZCN-SRVKXCTJSA-N 0.000 description 7
- PULPZRAHVFBVTO-DCAQKATOSA-N Pro-Glu-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PULPZRAHVFBVTO-DCAQKATOSA-N 0.000 description 7
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 7
- QDDJNKWPTJHROJ-UFYCRDLUSA-N Pro-Tyr-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 QDDJNKWPTJHROJ-UFYCRDLUSA-N 0.000 description 7
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 7
- ULVMNZOKDBHKKI-ACZMJKKPSA-N Ser-Gln-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ULVMNZOKDBHKKI-ACZMJKKPSA-N 0.000 description 7
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 7
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 7
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 7
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 7
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 7
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 7
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 7
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 7
- NLWCSMOXNKBRLC-WDSOQIARSA-N Trp-Lys-Val Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O NLWCSMOXNKBRLC-WDSOQIARSA-N 0.000 description 7
- IEESWNWYUOETOT-BVSLBCMMSA-N Trp-Val-Phe Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(O)=O IEESWNWYUOETOT-BVSLBCMMSA-N 0.000 description 7
- SCCKSNREWHMKOJ-SRVKXCTJSA-N Tyr-Asn-Ser Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O SCCKSNREWHMKOJ-SRVKXCTJSA-N 0.000 description 7
- SINRIKQYQJRGDQ-MEYUZBJRSA-N Tyr-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SINRIKQYQJRGDQ-MEYUZBJRSA-N 0.000 description 7
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 7
- OQWNEUXPKHIEJO-NRPADANISA-N Val-Glu-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N OQWNEUXPKHIEJO-NRPADANISA-N 0.000 description 7
- MJXNDRCLGDSBBE-FHWLQOOXSA-N Val-His-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N MJXNDRCLGDSBBE-FHWLQOOXSA-N 0.000 description 7
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 7
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 7
- TVGWMCTYUFBXAP-QTKMDUPCSA-N Val-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N)O TVGWMCTYUFBXAP-QTKMDUPCSA-N 0.000 description 7
- ZHWZDZFWBXWPDW-GUBZILKMSA-N Val-Val-Cys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O ZHWZDZFWBXWPDW-GUBZILKMSA-N 0.000 description 7
- 108010038633 aspartylglutamate Proteins 0.000 description 7
- 108010073093 leucyl-glycyl-glycyl-glycine Proteins 0.000 description 7
- 108010012058 leucyltyrosine Proteins 0.000 description 7
- 108010079202 tyrosyl-alanyl-cysteine Proteins 0.000 description 7
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 6
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 6
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 6
- VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 description 6
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 6
- WQLDNOCHHRISMS-NAKRPEOUSA-N Ala-Pro-Ile Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WQLDNOCHHRISMS-NAKRPEOUSA-N 0.000 description 6
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 6
- AUFACLFHBAGZEN-ZLUOBGJFSA-N Ala-Ser-Cys Chemical compound N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O AUFACLFHBAGZEN-ZLUOBGJFSA-N 0.000 description 6
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 6
- FMYQECOAIFGQGU-CYDGBPFRSA-N Arg-Val-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMYQECOAIFGQGU-CYDGBPFRSA-N 0.000 description 6
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 6
- NVGWESORMHFISY-SRVKXCTJSA-N Asn-Asn-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NVGWESORMHFISY-SRVKXCTJSA-N 0.000 description 6
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 6
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 6
- SZQCDCKIGWQAQN-FXQIFTODSA-N Cys-Arg-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O SZQCDCKIGWQAQN-FXQIFTODSA-N 0.000 description 6
- YMBAVNPKBWHDAW-CIUDSAMLSA-N Cys-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N YMBAVNPKBWHDAW-CIUDSAMLSA-N 0.000 description 6
- ZJBWJHQDOIMVLM-WHFBIAKZSA-N Cys-Cys-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O ZJBWJHQDOIMVLM-WHFBIAKZSA-N 0.000 description 6
- SFRQEQGPRTVDPO-NRPADANISA-N Cys-Gln-Val Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O SFRQEQGPRTVDPO-NRPADANISA-N 0.000 description 6
- URDUGPGPLNXXES-WHFBIAKZSA-N Cys-Gly-Cys Chemical compound SC[C@H](N)C(=O)NCC(=O)N[C@@H](CS)C(O)=O URDUGPGPLNXXES-WHFBIAKZSA-N 0.000 description 6
- WVLZTXGTNGHPBO-SRVKXCTJSA-N Cys-Leu-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O WVLZTXGTNGHPBO-SRVKXCTJSA-N 0.000 description 6
- YXQCLIVLWCKCRS-RYUDHWBXSA-N Gln-Gly-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N)O YXQCLIVLWCKCRS-RYUDHWBXSA-N 0.000 description 6
- ILKYYKRAULNYMS-JYJNAYRXSA-N Gln-Lys-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ILKYYKRAULNYMS-JYJNAYRXSA-N 0.000 description 6
- XQDGOJPVMSWZSO-SRVKXCTJSA-N Gln-Pro-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N XQDGOJPVMSWZSO-SRVKXCTJSA-N 0.000 description 6
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 6
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 6
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 6
- HUFCEIHAFNVSNR-IHRRRGAJSA-N Glu-Gln-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HUFCEIHAFNVSNR-IHRRRGAJSA-N 0.000 description 6
- ALMBZBOCGSVSAI-ACZMJKKPSA-N Glu-Ser-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ALMBZBOCGSVSAI-ACZMJKKPSA-N 0.000 description 6
- ZSIDREAPEPAPKL-XIRDDKMYSA-N Glu-Trp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N ZSIDREAPEPAPKL-XIRDDKMYSA-N 0.000 description 6
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 6
- BUEFQXUHTUZXHR-LURJTMIESA-N Gly-Gly-Pro zwitterion Chemical compound NCC(=O)NCC(=O)N1CCC[C@H]1C(O)=O BUEFQXUHTUZXHR-LURJTMIESA-N 0.000 description 6
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 6
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 6
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 6
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 6
- JJGBXTYGTKWGAT-YUMQZZPRSA-N Gly-Pro-Glu Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O JJGBXTYGTKWGAT-YUMQZZPRSA-N 0.000 description 6
- WNQKUUQIVDDAFA-ZPFDUUQYSA-N Ile-Gln-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N WNQKUUQIVDDAFA-ZPFDUUQYSA-N 0.000 description 6
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 6
- GTSAALPQZASLPW-KJYZGMDISA-N Ile-His-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N GTSAALPQZASLPW-KJYZGMDISA-N 0.000 description 6
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 6
- WKSHBPRUIRGWRZ-KCTSRDHCSA-N Ile-Trp-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N WKSHBPRUIRGWRZ-KCTSRDHCSA-N 0.000 description 6
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 6
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 6
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 6
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 6
- SWWCDAGDQHTKIE-RHYQMDGZSA-N Lys-Arg-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWWCDAGDQHTKIE-RHYQMDGZSA-N 0.000 description 6
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 6
- FGMHXLULNHTPID-KKUMJFAQSA-N Lys-His-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 FGMHXLULNHTPID-KKUMJFAQSA-N 0.000 description 6
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 6
- IEVXCWPVBYCJRZ-IXOXFDKPSA-N Lys-Thr-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IEVXCWPVBYCJRZ-IXOXFDKPSA-N 0.000 description 6
- DLCAXBGXGOVUCD-PPCPHDFISA-N Lys-Thr-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DLCAXBGXGOVUCD-PPCPHDFISA-N 0.000 description 6
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 6
- RKIIYGUHIQJCBW-SRVKXCTJSA-N Met-His-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RKIIYGUHIQJCBW-SRVKXCTJSA-N 0.000 description 6
- USBFEVBHEQBWDD-AVGNSLFASA-N Met-Leu-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O USBFEVBHEQBWDD-AVGNSLFASA-N 0.000 description 6
- FNYBIOGBMWFQRJ-SRVKXCTJSA-N Met-Pro-Met Chemical compound CSCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N FNYBIOGBMWFQRJ-SRVKXCTJSA-N 0.000 description 6
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 6
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 6
- 108010066427 N-valyltryptophan Proteins 0.000 description 6
- HWLKHNDRXWTFTN-GUBZILKMSA-N Pro-Pro-Cys Chemical compound C1C[C@H](NC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CS)C(=O)O HWLKHNDRXWTFTN-GUBZILKMSA-N 0.000 description 6
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 6
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 6
- DKKGAAJTDKHWOD-BIIVOSGPSA-N Ser-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)C(=O)O DKKGAAJTDKHWOD-BIIVOSGPSA-N 0.000 description 6
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 6
- GVIGVIOEYBOTCB-XIRDDKMYSA-N Ser-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC(C)C)C(O)=O)=CNC2=C1 GVIGVIOEYBOTCB-XIRDDKMYSA-N 0.000 description 6
- UPLYXVPQLJVWMM-KKUMJFAQSA-N Ser-Phe-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UPLYXVPQLJVWMM-KKUMJFAQSA-N 0.000 description 6
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 6
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 6
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 6
- RCOUFINCYASMDN-GUBZILKMSA-N Ser-Val-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O RCOUFINCYASMDN-GUBZILKMSA-N 0.000 description 6
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 6
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 6
- JBHMLZSKIXMVFS-XVSYOHENSA-N Thr-Asn-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JBHMLZSKIXMVFS-XVSYOHENSA-N 0.000 description 6
- SLUWOCTZVGMURC-BFHQHQDPSA-N Thr-Gly-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O SLUWOCTZVGMURC-BFHQHQDPSA-N 0.000 description 6
- JQAWYCUUFIMTHE-WLTAIBSBSA-N Thr-Gly-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JQAWYCUUFIMTHE-WLTAIBSBSA-N 0.000 description 6
- FIFDDJFLNVAVMS-RHYQMDGZSA-N Thr-Leu-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O FIFDDJFLNVAVMS-RHYQMDGZSA-N 0.000 description 6
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 6
- DXPURPNJDFCKKO-RHYQMDGZSA-N Thr-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DXPURPNJDFCKKO-RHYQMDGZSA-N 0.000 description 6
- WTMPKZWHRCMMMT-KZVJFYERSA-N Thr-Pro-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WTMPKZWHRCMMMT-KZVJFYERSA-N 0.000 description 6
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 6
- TZQWJCGVCIJDMU-HEIBUPTGSA-N Thr-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O)N)O TZQWJCGVCIJDMU-HEIBUPTGSA-N 0.000 description 6
- BEZTUFWTPVOROW-KJEVXHAQSA-N Thr-Tyr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O BEZTUFWTPVOROW-KJEVXHAQSA-N 0.000 description 6
- LTLBNCDNXQCOLB-UBHSHLNASA-N Trp-Asp-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 LTLBNCDNXQCOLB-UBHSHLNASA-N 0.000 description 6
- MKDXQPMIQPTTAW-SIXJUCDHSA-N Trp-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N MKDXQPMIQPTTAW-SIXJUCDHSA-N 0.000 description 6
- UGFOSENEZHEQKX-PJODQICGSA-N Trp-Val-Ala Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(O)=O UGFOSENEZHEQKX-PJODQICGSA-N 0.000 description 6
- SMLCYZYQFRTLCO-UWJYBYFXSA-N Tyr-Cys-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O SMLCYZYQFRTLCO-UWJYBYFXSA-N 0.000 description 6
- KHCSOLAHNLOXJR-BZSNNMDCSA-N Tyr-Leu-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHCSOLAHNLOXJR-BZSNNMDCSA-N 0.000 description 6
- AUZADXNWQMBZOO-JYJNAYRXSA-N Tyr-Pro-Arg Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 AUZADXNWQMBZOO-JYJNAYRXSA-N 0.000 description 6
- VYQQQIRHIFALGE-UWJYBYFXSA-N Tyr-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VYQQQIRHIFALGE-UWJYBYFXSA-N 0.000 description 6
- ZPFLBLFITJCBTP-QWRGUYRKSA-N Tyr-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O ZPFLBLFITJCBTP-QWRGUYRKSA-N 0.000 description 6
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 6
- OACSGBOREVRSME-NHCYSSNCSA-N Val-His-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(O)=O OACSGBOREVRSME-NHCYSSNCSA-N 0.000 description 6
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 6
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 6
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 6
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 6
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 6
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 6
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 6
- 108010068265 aspartyltyrosine Proteins 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 6
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 6
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 6
- WOJJIRYPFAZEPF-YFKPBYRVSA-N 2-[[(2s)-2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]propanoyl]amino]acetate Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)CN WOJJIRYPFAZEPF-YFKPBYRVSA-N 0.000 description 5
- UQJUGHFKNKGHFQ-VZFHVOOUSA-N Ala-Cys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UQJUGHFKNKGHFQ-VZFHVOOUSA-N 0.000 description 5
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 5
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 5
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 5
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 5
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 5
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 5
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 5
- ZDILXFDENZVOTL-BPNCWPANSA-N Ala-Val-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDILXFDENZVOTL-BPNCWPANSA-N 0.000 description 5
- YSUVMPICYVWRBX-VEVYYDQMSA-N Arg-Asp-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YSUVMPICYVWRBX-VEVYYDQMSA-N 0.000 description 5
- HJDNZFIYILEIKR-OSUNSFLBSA-N Arg-Ile-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HJDNZFIYILEIKR-OSUNSFLBSA-N 0.000 description 5
- ATABBWFGOHKROJ-GUBZILKMSA-N Arg-Pro-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O ATABBWFGOHKROJ-GUBZILKMSA-N 0.000 description 5
- ZJBUILVYSXQNSW-YTWAJWBKSA-N Arg-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ZJBUILVYSXQNSW-YTWAJWBKSA-N 0.000 description 5
- IOTKDTZEEBZNCM-UGYAYLCHSA-N Asn-Asn-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOTKDTZEEBZNCM-UGYAYLCHSA-N 0.000 description 5
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 5
- BFOYULZBKYOKAN-OLHMAJIHSA-N Asp-Asp-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFOYULZBKYOKAN-OLHMAJIHSA-N 0.000 description 5
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 5
- GYWQGGUCMDCUJE-DLOVCJGASA-N Asp-Phe-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O GYWQGGUCMDCUJE-DLOVCJGASA-N 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- NRVQLLDIJJEIIZ-VZFHVOOUSA-N Cys-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CS)N)O NRVQLLDIJJEIIZ-VZFHVOOUSA-N 0.000 description 5
- COYGBRTZEVWZBW-XKBZYTNZSA-N Gln-Cys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O COYGBRTZEVWZBW-XKBZYTNZSA-N 0.000 description 5
- NVEASDQHBRZPSU-BQBZGAKWSA-N Gln-Gln-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O NVEASDQHBRZPSU-BQBZGAKWSA-N 0.000 description 5
- XZLLTYBONVKGLO-SDDRHHMPSA-N Gln-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XZLLTYBONVKGLO-SDDRHHMPSA-N 0.000 description 5
- PAOHIZNRJNIXQY-XQXXSGGOSA-N Gln-Thr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PAOHIZNRJNIXQY-XQXXSGGOSA-N 0.000 description 5
- PAQUJCSYVIBPLC-AVGNSLFASA-N Glu-Asp-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PAQUJCSYVIBPLC-AVGNSLFASA-N 0.000 description 5
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 5
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 5
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 5
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 5
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 5
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 5
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 5
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 5
- YKIRNDPUWONXQN-GUBZILKMSA-N Lys-Asn-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKIRNDPUWONXQN-GUBZILKMSA-N 0.000 description 5
- KWUKZRFFKPLUPE-HJGDQZAQSA-N Lys-Asp-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWUKZRFFKPLUPE-HJGDQZAQSA-N 0.000 description 5
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 5
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 5
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 5
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 5
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 5
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 5
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 5
- HZWAHWQZPSXNCB-BPUTZDHNSA-N Ser-Arg-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O HZWAHWQZPSXNCB-BPUTZDHNSA-N 0.000 description 5
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 5
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 5
- FTVRVZNYIYWJGB-ACZMJKKPSA-N Ser-Asp-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FTVRVZNYIYWJGB-ACZMJKKPSA-N 0.000 description 5
- MOVJSUIKUNCVMG-ZLUOBGJFSA-N Ser-Cys-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N)O MOVJSUIKUNCVMG-ZLUOBGJFSA-N 0.000 description 5
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 5
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 5
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 5
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 5
- SXAGUVRFGJSFKC-ZEILLAHLSA-N Thr-His-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SXAGUVRFGJSFKC-ZEILLAHLSA-N 0.000 description 5
- GUHLYMZJVXUIPO-RCWTZXSCSA-N Thr-Met-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O GUHLYMZJVXUIPO-RCWTZXSCSA-N 0.000 description 5
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 5
- AZBIIKDSDLVJAK-VHWLVUOQSA-N Trp-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N AZBIIKDSDLVJAK-VHWLVUOQSA-N 0.000 description 5
- PKZIWSHDJYIPRH-JBACZVJFSA-N Trp-Tyr-Gln Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKZIWSHDJYIPRH-JBACZVJFSA-N 0.000 description 5
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 5
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 5
- GZUIDWDVMWZSMI-KKUMJFAQSA-N Tyr-Lys-Cys Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CS)C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GZUIDWDVMWZSMI-KKUMJFAQSA-N 0.000 description 5
- LDKDSFQSEUOCOO-RPTUDFQQSA-N Tyr-Thr-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LDKDSFQSEUOCOO-RPTUDFQQSA-N 0.000 description 5
- OJCISMMNNUNNJA-BZSNNMDCSA-N Tyr-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 OJCISMMNNUNNJA-BZSNNMDCSA-N 0.000 description 5
- BUPRFDPUIJNOLS-UFYCRDLUSA-N Tyr-Tyr-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(O)=O BUPRFDPUIJNOLS-UFYCRDLUSA-N 0.000 description 5
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 5
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 5
- YMTOEGGOCHVGEH-IHRRRGAJSA-N Val-Lys-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O YMTOEGGOCHVGEH-IHRRRGAJSA-N 0.000 description 5
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 5
- 108010087823 glycyltyrosine Proteins 0.000 description 5
- 108010073101 phenylalanylleucine Proteins 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- AXFMEGAFCUULFV-BLFANLJRSA-N (2s)-2-[[(2s)-1-[(2s,3r)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid Chemical compound CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AXFMEGAFCUULFV-BLFANLJRSA-N 0.000 description 4
- PPINMSZPTPRQQB-NHCYSSNCSA-N 2-[[(2s)-1-[(2s)-2-[[(2s)-2-amino-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acid Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PPINMSZPTPRQQB-NHCYSSNCSA-N 0.000 description 4
- UWQJHXKARZWDIJ-ZLUOBGJFSA-N Ala-Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O UWQJHXKARZWDIJ-ZLUOBGJFSA-N 0.000 description 4
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 4
- VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 4
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 4
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 4
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 4
- SUIJFTJDTJKSRK-IHRRRGAJSA-N Asn-Pro-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SUIJFTJDTJKSRK-IHRRRGAJSA-N 0.000 description 4
- HBUJSDCLZCXXCW-YDHLFZDLSA-N Asn-Val-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HBUJSDCLZCXXCW-YDHLFZDLSA-N 0.000 description 4
- JOCQXVJCTCEFAZ-CIUDSAMLSA-N Asp-His-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O JOCQXVJCTCEFAZ-CIUDSAMLSA-N 0.000 description 4
- NVFSJIXJZCDICF-SRVKXCTJSA-N Asp-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N NVFSJIXJZCDICF-SRVKXCTJSA-N 0.000 description 4
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 4
- DONWIPDSZZJHHK-HJGDQZAQSA-N Asp-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N)O DONWIPDSZZJHHK-HJGDQZAQSA-N 0.000 description 4
- USNJAPJZSGTTPX-XVSYOHENSA-N Asp-Phe-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O USNJAPJZSGTTPX-XVSYOHENSA-N 0.000 description 4
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 4
- SQIARYGNVQWOSB-BZSNNMDCSA-N Asp-Tyr-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SQIARYGNVQWOSB-BZSNNMDCSA-N 0.000 description 4
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 4
- NDNZRWUDUMTITL-FXQIFTODSA-N Cys-Ser-Val Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NDNZRWUDUMTITL-FXQIFTODSA-N 0.000 description 4
- SAEVTQWAYDPXMU-KATARQTJSA-N Cys-Thr-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O SAEVTQWAYDPXMU-KATARQTJSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- SHERTACNJPYHAR-ACZMJKKPSA-N Gln-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O SHERTACNJPYHAR-ACZMJKKPSA-N 0.000 description 4
- XKPACHRGOWQHFH-IRIUXVKKSA-N Gln-Thr-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XKPACHRGOWQHFH-IRIUXVKKSA-N 0.000 description 4
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 4
- WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 4
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 4
- ZCOJVESMNGBGLF-GRLWGSQLSA-N Glu-Ile-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZCOJVESMNGBGLF-GRLWGSQLSA-N 0.000 description 4
- INGJLBQKTRJLFO-UKJIMTQDSA-N Glu-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 4
- QDMVXRNLOPTPIE-WDCWCFNPSA-N Glu-Lys-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QDMVXRNLOPTPIE-WDCWCFNPSA-N 0.000 description 4
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 4
- ZALGPUWUVHOGAE-GVXVVHGQSA-N Glu-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZALGPUWUVHOGAE-GVXVVHGQSA-N 0.000 description 4
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 4
- QXPRJQPCFXMCIY-NKWVEPMBSA-N Gly-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN QXPRJQPCFXMCIY-NKWVEPMBSA-N 0.000 description 4
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 4
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 4
- ZKJZBRHRWKLVSJ-ZDLURKLDSA-N Gly-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN)O ZKJZBRHRWKLVSJ-ZDLURKLDSA-N 0.000 description 4
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 4
- HIAHVKLTHNOENC-HGNGGELXSA-N His-Glu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HIAHVKLTHNOENC-HGNGGELXSA-N 0.000 description 4
- RXKFKJVJVHLRIE-XIRDDKMYSA-N His-Ser-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CN=CN3)N RXKFKJVJVHLRIE-XIRDDKMYSA-N 0.000 description 4
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 4
- NPROWIBAWYMPAZ-GUDRVLHUSA-N Ile-Asp-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N NPROWIBAWYMPAZ-GUDRVLHUSA-N 0.000 description 4
- QJUWBDPGGYVRHY-YUMQZZPRSA-N Leu-Gly-Cys Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N QJUWBDPGGYVRHY-YUMQZZPRSA-N 0.000 description 4
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 4
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 4
- CPONGMJGVIAWEH-DCAQKATOSA-N Leu-Met-Ala Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O CPONGMJGVIAWEH-DCAQKATOSA-N 0.000 description 4
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 4
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 4
- LINKCQUOMUDLKN-KATARQTJSA-N Leu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N)O LINKCQUOMUDLKN-KATARQTJSA-N 0.000 description 4
- RFQATBGBLDAKGI-VHSXEESVSA-N Lys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCCN)N)C(=O)O RFQATBGBLDAKGI-VHSXEESVSA-N 0.000 description 4
- SBQDRNOLGSYHQA-YUMQZZPRSA-N Lys-Ser-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SBQDRNOLGSYHQA-YUMQZZPRSA-N 0.000 description 4
- BWTKUQPNOMMKMA-FIRPJDEBSA-N Phe-Ile-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BWTKUQPNOMMKMA-FIRPJDEBSA-N 0.000 description 4
- KNYPNEYICHHLQL-ACRUOGEOSA-N Phe-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 KNYPNEYICHHLQL-ACRUOGEOSA-N 0.000 description 4
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 4
- KIZQGKLMXKGDIV-BQBZGAKWSA-N Pro-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 KIZQGKLMXKGDIV-BQBZGAKWSA-N 0.000 description 4
- FUVBEZJCRMHWEM-FXQIFTODSA-N Pro-Asn-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FUVBEZJCRMHWEM-FXQIFTODSA-N 0.000 description 4
- KWMUAKQOVYCQJQ-ZPFDUUQYSA-N Pro-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]1CCCN1 KWMUAKQOVYCQJQ-ZPFDUUQYSA-N 0.000 description 4
- MHHQQZIFLWFZGR-DCAQKATOSA-N Pro-Lys-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O MHHQQZIFLWFZGR-DCAQKATOSA-N 0.000 description 4
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 4
- OWQXAJQZLWHPBH-FXQIFTODSA-N Pro-Ser-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O OWQXAJQZLWHPBH-FXQIFTODSA-N 0.000 description 4
- KMWFXJCGRXBQAC-CIUDSAMLSA-N Ser-Cys-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N KMWFXJCGRXBQAC-CIUDSAMLSA-N 0.000 description 4
- HVKMTOIAYDOJPL-NRPADANISA-N Ser-Gln-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVKMTOIAYDOJPL-NRPADANISA-N 0.000 description 4
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 4
- HMRAQFJFTOLDKW-GUBZILKMSA-N Ser-His-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMRAQFJFTOLDKW-GUBZILKMSA-N 0.000 description 4
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 4
- SYCFMSYTIFXWAJ-DCAQKATOSA-N Ser-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N SYCFMSYTIFXWAJ-DCAQKATOSA-N 0.000 description 4
- DGOJNGCGEYOBKN-BWBBJGPYSA-N Thr-Cys-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N)O DGOJNGCGEYOBKN-BWBBJGPYSA-N 0.000 description 4
- KPNSNVTUVKSBFL-ZJDVBMNYSA-N Thr-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KPNSNVTUVKSBFL-ZJDVBMNYSA-N 0.000 description 4
- JMBRNXUOLJFURW-BEAPCOKYSA-N Thr-Phe-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N)O JMBRNXUOLJFURW-BEAPCOKYSA-N 0.000 description 4
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 4
- JNKAYADBODLPMQ-HSHDSVGOSA-N Thr-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)=CNC2=C1 JNKAYADBODLPMQ-HSHDSVGOSA-N 0.000 description 4
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 4
- QNXZCKMXHPULME-ZNSHCXBVSA-N Thr-Val-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O QNXZCKMXHPULME-ZNSHCXBVSA-N 0.000 description 4
- UKINEYBQXPMOJO-UBHSHLNASA-N Trp-Asn-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N UKINEYBQXPMOJO-UBHSHLNASA-N 0.000 description 4
- XGFGVFMXDXALEV-XIRDDKMYSA-N Trp-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N XGFGVFMXDXALEV-XIRDDKMYSA-N 0.000 description 4
- XQMGDVVKFRLQKH-BBRMVZONSA-N Trp-Val-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O)=CNC2=C1 XQMGDVVKFRLQKH-BBRMVZONSA-N 0.000 description 4
- BURPTJBFWIOHEY-UWJYBYFXSA-N Tyr-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BURPTJBFWIOHEY-UWJYBYFXSA-N 0.000 description 4
- CDRYEAWHKJSGAF-BPNCWPANSA-N Tyr-Ala-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O CDRYEAWHKJSGAF-BPNCWPANSA-N 0.000 description 4
- GAKBTSMAPGLQFA-JNPHEJMOSA-N Tyr-Thr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 GAKBTSMAPGLQFA-JNPHEJMOSA-N 0.000 description 4
- RKIGNDAHUOOIMJ-BQFCYCMXSA-N Val-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 RKIGNDAHUOOIMJ-BQFCYCMXSA-N 0.000 description 4
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 4
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 4
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 108010093581 aspartyl-proline Proteins 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 108010060199 cysteinylproline Proteins 0.000 description 4
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 4
- 102000058223 human VEGFA Human genes 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 108010091871 leucylmethionine Proteins 0.000 description 4
- 108010057821 leucylproline Proteins 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 108010029020 prolylglycine Proteins 0.000 description 4
- 230000002207 retinal effect Effects 0.000 description 4
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 4
- 108010020532 tyrosyl-proline Proteins 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- QMOQBVOBWVNSNO-UHFFFAOYSA-N 2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(O)=O QMOQBVOBWVNSNO-UHFFFAOYSA-N 0.000 description 3
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 3
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 3
- NKJBKNVQHBZUIX-ACZMJKKPSA-N Ala-Gln-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKJBKNVQHBZUIX-ACZMJKKPSA-N 0.000 description 3
- FBHOPGDGELNWRH-DRZSPHRISA-N Ala-Glu-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FBHOPGDGELNWRH-DRZSPHRISA-N 0.000 description 3
- LTTLSZVJTDSACD-OWLDWWDNSA-N Ala-Thr-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O LTTLSZVJTDSACD-OWLDWWDNSA-N 0.000 description 3
- XKXAZPSREVUCRT-BPNCWPANSA-N Ala-Tyr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=C(O)C=C1 XKXAZPSREVUCRT-BPNCWPANSA-N 0.000 description 3
- JPOQZCHGOTWRTM-FQPOAREZSA-N Ala-Tyr-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPOQZCHGOTWRTM-FQPOAREZSA-N 0.000 description 3
- OZNSCVPYWZRQPY-CIUDSAMLSA-N Arg-Asp-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OZNSCVPYWZRQPY-CIUDSAMLSA-N 0.000 description 3
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 3
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 3
- PRLPSDIHSRITSF-UNQGMJICSA-N Arg-Phe-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PRLPSDIHSRITSF-UNQGMJICSA-N 0.000 description 3
- ICRHGPYYXMWHIE-LPEHRKFASA-N Arg-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ICRHGPYYXMWHIE-LPEHRKFASA-N 0.000 description 3
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 3
- AKEBUSZTMQLNIX-UWJYBYFXSA-N Asn-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N AKEBUSZTMQLNIX-UWJYBYFXSA-N 0.000 description 3
- GXMSVVBIAMWMKO-BQBZGAKWSA-N Asn-Arg-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCN=C(N)N GXMSVVBIAMWMKO-BQBZGAKWSA-N 0.000 description 3
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 3
- CTQIOCMSIJATNX-WHFBIAKZSA-N Asn-Gly-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O CTQIOCMSIJATNX-WHFBIAKZSA-N 0.000 description 3
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 3
- PPCORQFLAZWUNO-QWRGUYRKSA-N Asn-Phe-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N PPCORQFLAZWUNO-QWRGUYRKSA-N 0.000 description 3
- RBOBTTLFPRSXKZ-BZSNNMDCSA-N Asn-Phe-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RBOBTTLFPRSXKZ-BZSNNMDCSA-N 0.000 description 3
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 3
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 3
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 3
- KBQOUDLMWYWXNP-YDHLFZDLSA-N Asn-Val-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)N KBQOUDLMWYWXNP-YDHLFZDLSA-N 0.000 description 3
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 3
- SVFOIXMRMLROHO-SRVKXCTJSA-N Asp-Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SVFOIXMRMLROHO-SRVKXCTJSA-N 0.000 description 3
- KTTCQQNRRLCIBC-GHCJXIJMSA-N Asp-Ile-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O KTTCQQNRRLCIBC-GHCJXIJMSA-N 0.000 description 3
- 108700010070 Codon Usage Proteins 0.000 description 3
- GMXSSZUVDNPRMA-FXQIFTODSA-N Cys-Arg-Asp Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GMXSSZUVDNPRMA-FXQIFTODSA-N 0.000 description 3
- NDUSUIGBMZCOIL-ZKWXMUAHSA-N Cys-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N NDUSUIGBMZCOIL-ZKWXMUAHSA-N 0.000 description 3
- OXOQBEVULIBOSH-ZDLURKLDSA-N Cys-Gly-Thr Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O OXOQBEVULIBOSH-ZDLURKLDSA-N 0.000 description 3
- OZHXXYOHPLLLMI-CIUDSAMLSA-N Cys-Lys-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OZHXXYOHPLLLMI-CIUDSAMLSA-N 0.000 description 3
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 3
- KSMSFCBQBQPFAD-GUBZILKMSA-N Cys-Pro-Pro Chemical compound SC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 KSMSFCBQBQPFAD-GUBZILKMSA-N 0.000 description 3
- ALTQTAKGRFLRLR-GUBZILKMSA-N Cys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N ALTQTAKGRFLRLR-GUBZILKMSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- HHWQMFIGMMOVFK-WDSKDSINSA-N Gln-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O HHWQMFIGMMOVFK-WDSKDSINSA-N 0.000 description 3
- XKBASPWPBXNVLQ-WDSKDSINSA-N Gln-Gly-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XKBASPWPBXNVLQ-WDSKDSINSA-N 0.000 description 3
- IULKWYSYZSURJK-AVGNSLFASA-N Gln-Leu-Lys Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O IULKWYSYZSURJK-AVGNSLFASA-N 0.000 description 3
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 3
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 3
- HMIXCETWRYDVMO-GUBZILKMSA-N Gln-Pro-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O HMIXCETWRYDVMO-GUBZILKMSA-N 0.000 description 3
- KHHDJQRWIFHXHS-NRPADANISA-N Gln-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)N)N KHHDJQRWIFHXHS-NRPADANISA-N 0.000 description 3
- LXAUHIRMWXQRKI-XHNCKOQMSA-N Glu-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O LXAUHIRMWXQRKI-XHNCKOQMSA-N 0.000 description 3
- OBIHEDRRSMRKLU-ACZMJKKPSA-N Glu-Cys-Asp Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OBIHEDRRSMRKLU-ACZMJKKPSA-N 0.000 description 3
- CLROYXHHUZELFX-FXQIFTODSA-N Glu-Gln-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O CLROYXHHUZELFX-FXQIFTODSA-N 0.000 description 3
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 3
- NJCALAAIGREHDR-WDCWCFNPSA-N Glu-Leu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NJCALAAIGREHDR-WDCWCFNPSA-N 0.000 description 3
- AAJHGGDRKHYSDH-GUBZILKMSA-N Glu-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O AAJHGGDRKHYSDH-GUBZILKMSA-N 0.000 description 3
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 3
- BRFJMRSRMOMIMU-WHFBIAKZSA-N Gly-Ala-Asn Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O BRFJMRSRMOMIMU-WHFBIAKZSA-N 0.000 description 3
- MZZSCEANQDPJER-ONGXEEELSA-N Gly-Ala-Phe Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MZZSCEANQDPJER-ONGXEEELSA-N 0.000 description 3
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 3
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 3
- XRTDOIOIBMAXCT-NKWVEPMBSA-N Gly-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)CN)C(=O)O XRTDOIOIBMAXCT-NKWVEPMBSA-N 0.000 description 3
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 3
- IWAXHBCACVWNHT-BQBZGAKWSA-N Gly-Asp-Arg Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IWAXHBCACVWNHT-BQBZGAKWSA-N 0.000 description 3
- YTSVAIMKVLZUDU-YUMQZZPRSA-N Gly-Leu-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YTSVAIMKVLZUDU-YUMQZZPRSA-N 0.000 description 3
- GGAPHLIUUTVYMX-QWRGUYRKSA-N Gly-Phe-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)C[NH3+])CC1=CC=CC=C1 GGAPHLIUUTVYMX-QWRGUYRKSA-N 0.000 description 3
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 3
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 3
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 3
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 3
- TVMNTHXFRSXZGR-IHRRRGAJSA-N His-Lys-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O TVMNTHXFRSXZGR-IHRRRGAJSA-N 0.000 description 3
- ZNTSGDNUITWTRA-WDSOQIARSA-N His-Trp-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(O)=O ZNTSGDNUITWTRA-WDSOQIARSA-N 0.000 description 3
- FADXGVVLSPPEQY-GHCJXIJMSA-N Ile-Cys-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FADXGVVLSPPEQY-GHCJXIJMSA-N 0.000 description 3
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 3
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 3
- ZSESFIFAYQEKRD-CYDGBPFRSA-N Ile-Val-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N ZSESFIFAYQEKRD-CYDGBPFRSA-N 0.000 description 3
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 3
- HXWALXSAVBLTPK-NUTKFTJISA-N Leu-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N HXWALXSAVBLTPK-NUTKFTJISA-N 0.000 description 3
- UCOCBWDBHCUPQP-DCAQKATOSA-N Leu-Arg-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O UCOCBWDBHCUPQP-DCAQKATOSA-N 0.000 description 3
- DBVWMYGBVFCRBE-CIUDSAMLSA-N Leu-Asn-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DBVWMYGBVFCRBE-CIUDSAMLSA-N 0.000 description 3
- CQGSYZCULZMEDE-SRVKXCTJSA-N Leu-Gln-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O CQGSYZCULZMEDE-SRVKXCTJSA-N 0.000 description 3
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 3
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 3
- UHNQRAFSEBGZFZ-YESZJQIVSA-N Leu-Phe-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N UHNQRAFSEBGZFZ-YESZJQIVSA-N 0.000 description 3
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 3
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 3
- ICYRCNICGBJLGM-HJGDQZAQSA-N Leu-Thr-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 3
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 3
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 3
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 3
- 101500021084 Locusta migratoria 5 kDa peptide Proteins 0.000 description 3
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 3
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 3
- AFAFFVKJJYBBTC-UHFFFAOYSA-N Lys-Gln-Ala-Gly-Asp-Val Chemical compound CC(C)C(C(O)=O)NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)C(N)CCCCN AFAFFVKJJYBBTC-UHFFFAOYSA-N 0.000 description 3
- YXPJCVNIDDKGOE-MELADBBJSA-N Lys-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N)C(=O)O YXPJCVNIDDKGOE-MELADBBJSA-N 0.000 description 3
- ODTZHNZPINULEU-KKUMJFAQSA-N Lys-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N ODTZHNZPINULEU-KKUMJFAQSA-N 0.000 description 3
- PIXVFCBYEGPZPA-JYJNAYRXSA-N Lys-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N PIXVFCBYEGPZPA-JYJNAYRXSA-N 0.000 description 3
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 3
- ABHVWYPPHDYFNY-WDSOQIARSA-N Met-His-Trp Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CN=CN1 ABHVWYPPHDYFNY-WDSOQIARSA-N 0.000 description 3
- KSIPKXNIQOWMIC-RCWTZXSCSA-N Met-Thr-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KSIPKXNIQOWMIC-RCWTZXSCSA-N 0.000 description 3
- IIHMNTBFPMRJCN-RCWTZXSCSA-N Met-Val-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IIHMNTBFPMRJCN-RCWTZXSCSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 3
- JOXIIFVCSATTDH-IHPCNDPISA-N Phe-Asn-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N JOXIIFVCSATTDH-IHPCNDPISA-N 0.000 description 3
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 3
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 3
- AIZVVCMAFRREQS-GUBZILKMSA-N Pro-Cys-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AIZVVCMAFRREQS-GUBZILKMSA-N 0.000 description 3
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 3
- LGSANCBHSMDFDY-GARJFASQSA-N Pro-Glu-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O LGSANCBHSMDFDY-GARJFASQSA-N 0.000 description 3
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 3
- VBZXFFYOBDLLFE-HSHDSVGOSA-N Pro-Trp-Thr Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H]([C@H](O)C)C(O)=O)C(=O)[C@@H]1CCCN1 VBZXFFYOBDLLFE-HSHDSVGOSA-N 0.000 description 3
- UEJYSALTSUZXFV-SRVKXCTJSA-N Rigin Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O UEJYSALTSUZXFV-SRVKXCTJSA-N 0.000 description 3
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 3
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 3
- KCFKKAQKRZBWJB-ZLUOBGJFSA-N Ser-Cys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O KCFKKAQKRZBWJB-ZLUOBGJFSA-N 0.000 description 3
- CXBFHZLODKPIJY-AAEUAGOBSA-N Ser-Gly-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N CXBFHZLODKPIJY-AAEUAGOBSA-N 0.000 description 3
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 3
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 3
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 3
- RRVFEDGUXSYWOW-BZSNNMDCSA-N Ser-Phe-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RRVFEDGUXSYWOW-BZSNNMDCSA-N 0.000 description 3
- OZPDGESCTGGNAD-CIUDSAMLSA-N Ser-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO OZPDGESCTGGNAD-CIUDSAMLSA-N 0.000 description 3
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 3
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 3
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 3
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 3
- LAFLAXHTDVNVEL-WDCWCFNPSA-N Thr-Gln-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O LAFLAXHTDVNVEL-WDCWCFNPSA-N 0.000 description 3
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 3
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 3
- RPECVQBNONKZAT-WZLNRYEVSA-N Thr-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H]([C@@H](C)O)N RPECVQBNONKZAT-WZLNRYEVSA-N 0.000 description 3
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 3
- BSSJIVIFAJKLEK-XIRDDKMYSA-N Trp-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BSSJIVIFAJKLEK-XIRDDKMYSA-N 0.000 description 3
- RERRMBXDSFMBQE-ZFWWWQNUSA-N Trp-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N RERRMBXDSFMBQE-ZFWWWQNUSA-N 0.000 description 3
- SSSDKJMQMZTMJP-BVSLBCMMSA-N Trp-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CC=C(O)C=C1 SSSDKJMQMZTMJP-BVSLBCMMSA-N 0.000 description 3
- XLMDWQNAOKLKCP-XDTLVQLUSA-N Tyr-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N XLMDWQNAOKLKCP-XDTLVQLUSA-N 0.000 description 3
- NOXKHHXSHQFSGJ-FQPOAREZSA-N Tyr-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NOXKHHXSHQFSGJ-FQPOAREZSA-N 0.000 description 3
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 3
- SLCSPPCQWUHPPO-JYJNAYRXSA-N Tyr-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SLCSPPCQWUHPPO-JYJNAYRXSA-N 0.000 description 3
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 3
- PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 3
- MWUYSCVVPVITMW-IGNZVWTISA-N Tyr-Tyr-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 MWUYSCVVPVITMW-IGNZVWTISA-N 0.000 description 3
- KHPLUFDSWGDRHD-SLFFLAALSA-N Tyr-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C(=O)O KHPLUFDSWGDRHD-SLFFLAALSA-N 0.000 description 3
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 3
- LHADRQBREKTRLR-DCAQKATOSA-N Val-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N LHADRQBREKTRLR-DCAQKATOSA-N 0.000 description 3
- WDIGUPHXPBMODF-UMNHJUIQSA-N Val-Glu-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N WDIGUPHXPBMODF-UMNHJUIQSA-N 0.000 description 3
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 3
- MDYSKHBSPXUOPV-JSGCOSHPSA-N Val-Gly-Phe Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MDYSKHBSPXUOPV-JSGCOSHPSA-N 0.000 description 3
- ZIGZPYJXIWLQFC-QTKMDUPCSA-N Val-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C(C)C)N)O ZIGZPYJXIWLQFC-QTKMDUPCSA-N 0.000 description 3
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 3
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 3
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 3
- BZDGLJPROOOUOZ-XGEHTFHBSA-N Val-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N)O BZDGLJPROOOUOZ-XGEHTFHBSA-N 0.000 description 3
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 3
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000010609 cell counting kit-8 assay Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 3
- 108010084389 glycyltryptophan Proteins 0.000 description 3
- 108010018006 histidylserine Proteins 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 108010027338 isoleucylcysteine Proteins 0.000 description 3
- 108010003700 lysyl aspartic acid Proteins 0.000 description 3
- 108010082117 matrigel Proteins 0.000 description 3
- 108010056582 methionylglutamic acid Proteins 0.000 description 3
- 210000004925 microvascular endothelial cell Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000649 photocoagulation Effects 0.000 description 3
- 108010053725 prolylvaline Proteins 0.000 description 3
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 3
- 108010051110 tyrosyl-lysine Proteins 0.000 description 3
- 210000003556 vascular endothelial cell Anatomy 0.000 description 3
- 230000004393 visual impairment Effects 0.000 description 3
- XWTNPSHCJMZAHQ-QMMMGPOBSA-N 2-[[2-[[2-[[(2s)-2-amino-4-methylpentanoyl]amino]acetyl]amino]acetyl]amino]acetic acid Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(=O)NCC(O)=O XWTNPSHCJMZAHQ-QMMMGPOBSA-N 0.000 description 2
- DKJPOZOEBONHFS-ZLUOBGJFSA-N Ala-Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O DKJPOZOEBONHFS-ZLUOBGJFSA-N 0.000 description 2
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 2
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 2
- BFMIRJBURUXDRG-DLOVCJGASA-N Ala-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 BFMIRJBURUXDRG-DLOVCJGASA-N 0.000 description 2
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 2
- PEEYDECOOVQKRZ-DLOVCJGASA-N Ala-Ser-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PEEYDECOOVQKRZ-DLOVCJGASA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- PQWTZSNVWSOFFK-FXQIFTODSA-N Arg-Asp-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)CN=C(N)N PQWTZSNVWSOFFK-FXQIFTODSA-N 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- QUAWOKPCAKCHQL-SRVKXCTJSA-N Asn-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N QUAWOKPCAKCHQL-SRVKXCTJSA-N 0.000 description 2
- KNMRXHIAVXHCLW-ZLUOBGJFSA-N Asp-Asn-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)C(=O)O KNMRXHIAVXHCLW-ZLUOBGJFSA-N 0.000 description 2
- LKIYSIYBKYLKPU-BIIVOSGPSA-N Asp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O LKIYSIYBKYLKPU-BIIVOSGPSA-N 0.000 description 2
- KESWRFKUZRUTAH-FXQIFTODSA-N Asp-Pro-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O KESWRFKUZRUTAH-FXQIFTODSA-N 0.000 description 2
- GGRSYTUJHAZTFN-IHRRRGAJSA-N Asp-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O GGRSYTUJHAZTFN-IHRRRGAJSA-N 0.000 description 2
- GYNUXDMCDILYIQ-QRTARXTBSA-N Asp-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N GYNUXDMCDILYIQ-QRTARXTBSA-N 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- AMRLSQGGERHDHJ-FXQIFTODSA-N Cys-Ala-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMRLSQGGERHDHJ-FXQIFTODSA-N 0.000 description 2
- YFXFOZPXVFPBDH-VZFHVOOUSA-N Cys-Ala-Thr Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(O)=O YFXFOZPXVFPBDH-VZFHVOOUSA-N 0.000 description 2
- GUKYYUFHWYRMEU-WHFBIAKZSA-N Cys-Gly-Asp Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O GUKYYUFHWYRMEU-WHFBIAKZSA-N 0.000 description 2
- NAPULYCVEVVFRB-HEIBUPTGSA-N Cys-Thr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CS NAPULYCVEVVFRB-HEIBUPTGSA-N 0.000 description 2
- LMPBBFWHCRURJD-LAEOZQHASA-N Gln-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N LMPBBFWHCRURJD-LAEOZQHASA-N 0.000 description 2
- CRRFJBGUGNNOCS-PEFMBERDSA-N Gln-Asp-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CRRFJBGUGNNOCS-PEFMBERDSA-N 0.000 description 2
- IXFVOPOHSRKJNG-LAEOZQHASA-N Gln-Asp-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IXFVOPOHSRKJNG-LAEOZQHASA-N 0.000 description 2
- DOQUICBEISTQHE-CIUDSAMLSA-N Gln-Pro-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O DOQUICBEISTQHE-CIUDSAMLSA-N 0.000 description 2
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 2
- UBRQJXFDVZNYJP-AVGNSLFASA-N Gln-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UBRQJXFDVZNYJP-AVGNSLFASA-N 0.000 description 2
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 2
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 2
- MIWJDJAMMKHUAR-ZVZYQTTQSA-N Glu-Trp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N MIWJDJAMMKHUAR-ZVZYQTTQSA-N 0.000 description 2
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 2
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 2
- IBYOLNARKHMLBG-WHOFXGATSA-N Gly-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IBYOLNARKHMLBG-WHOFXGATSA-N 0.000 description 2
- QAMMIGULQSIRCD-IRXDYDNUSA-N Gly-Phe-Tyr Chemical compound C([C@H](NC(=O)C[NH3+])C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C([O-])=O)C1=CC=CC=C1 QAMMIGULQSIRCD-IRXDYDNUSA-N 0.000 description 2
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 2
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 2
- PYFIQROSWQERAS-LBPRGKRZSA-N Gly-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(=O)NCC(O)=O)=CNC2=C1 PYFIQROSWQERAS-LBPRGKRZSA-N 0.000 description 2
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 2
- HRGGKHFHRSFSDE-CIUDSAMLSA-N His-Asn-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N HRGGKHFHRSFSDE-CIUDSAMLSA-N 0.000 description 2
- PZUZIHRPOVVHOT-KBPBESRZSA-N His-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CN=CN1 PZUZIHRPOVVHOT-KBPBESRZSA-N 0.000 description 2
- UKTUOMWSJPXODT-GUDRVLHUSA-N Ile-Asn-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N UKTUOMWSJPXODT-GUDRVLHUSA-N 0.000 description 2
- HUWYGQOISIJNMK-SIGLWIIPSA-N Ile-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HUWYGQOISIJNMK-SIGLWIIPSA-N 0.000 description 2
- YKZAMJXNJUWFIK-JBDRJPRFSA-N Ile-Ser-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)N YKZAMJXNJUWFIK-JBDRJPRFSA-N 0.000 description 2
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 2
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 2
- JGKHAFUAPZCCDU-BZSNNMDCSA-N Leu-Tyr-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=C(O)C=C1 JGKHAFUAPZCCDU-BZSNNMDCSA-N 0.000 description 2
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 2
- GAOJCVKPIGHTGO-UWVGGRQHSA-N Lys-Arg-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O GAOJCVKPIGHTGO-UWVGGRQHSA-N 0.000 description 2
- VSRXPEHZMHSFKU-IUCAKERBSA-N Lys-Gln-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VSRXPEHZMHSFKU-IUCAKERBSA-N 0.000 description 2
- CTJUSALVKAWFFU-CIUDSAMLSA-N Lys-Ser-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N CTJUSALVKAWFFU-CIUDSAMLSA-N 0.000 description 2
- MEQLGHAMAUPOSJ-DCAQKATOSA-N Lys-Ser-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O MEQLGHAMAUPOSJ-DCAQKATOSA-N 0.000 description 2
- QWTGQXGNNMIUCW-BPUTZDHNSA-N Met-Asn-Trp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O QWTGQXGNNMIUCW-BPUTZDHNSA-N 0.000 description 2
- MHQXIBRPDKXDGZ-ZFWWWQNUSA-N Met-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 MHQXIBRPDKXDGZ-ZFWWWQNUSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- LLGTYVHITPVGKR-RYUDHWBXSA-N Phe-Gln-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O LLGTYVHITPVGKR-RYUDHWBXSA-N 0.000 description 2
- OSBADCBXAMSPQD-YESZJQIVSA-N Phe-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N OSBADCBXAMSPQD-YESZJQIVSA-N 0.000 description 2
- JLLJTMHNXQTMCK-UBHSHLNASA-N Phe-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 JLLJTMHNXQTMCK-UBHSHLNASA-N 0.000 description 2
- BPIMVBKDLSBKIJ-FCLVOEFKSA-N Phe-Thr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BPIMVBKDLSBKIJ-FCLVOEFKSA-N 0.000 description 2
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 2
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 2
- SPLBRAKYXGOFSO-UNQGMJICSA-N Pro-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2)O SPLBRAKYXGOFSO-UNQGMJICSA-N 0.000 description 2
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 2
- SFZKGGOGCNQPJY-CIUDSAMLSA-N Ser-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N SFZKGGOGCNQPJY-CIUDSAMLSA-N 0.000 description 2
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 2
- SQHKXWODKJDZRC-LKXGYXEUSA-N Ser-Thr-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQHKXWODKJDZRC-LKXGYXEUSA-N 0.000 description 2
- FVFUOQIYDPAIJR-XIRDDKMYSA-N Ser-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N FVFUOQIYDPAIJR-XIRDDKMYSA-N 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 2
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 2
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 2
- QWMPARMKIDVBLV-VZFHVOOUSA-N Thr-Cys-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O QWMPARMKIDVBLV-VZFHVOOUSA-N 0.000 description 2
- NRUPKQSXTJNQGD-XGEHTFHBSA-N Thr-Cys-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NRUPKQSXTJNQGD-XGEHTFHBSA-N 0.000 description 2
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 2
- HYVLNORXQGKONN-NUTKFTJISA-N Trp-Ala-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 HYVLNORXQGKONN-NUTKFTJISA-N 0.000 description 2
- RPVDDQYNBOVWLR-HOCLYGCPSA-N Trp-Gly-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O RPVDDQYNBOVWLR-HOCLYGCPSA-N 0.000 description 2
- YXSSXUIBUJGHJY-SFJXLCSZSA-N Trp-Thr-Phe Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)[C@H](O)C)C(O)=O)C1=CC=CC=C1 YXSSXUIBUJGHJY-SFJXLCSZSA-N 0.000 description 2
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 2
- FFCRCJZJARTYCG-KKUMJFAQSA-N Tyr-Cys-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N)O FFCRCJZJARTYCG-KKUMJFAQSA-N 0.000 description 2
- CDHQEOXPWBDFPL-QWRGUYRKSA-N Tyr-Gly-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDHQEOXPWBDFPL-QWRGUYRKSA-N 0.000 description 2
- NKUGCYDFQKFVOJ-JYJNAYRXSA-N Tyr-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NKUGCYDFQKFVOJ-JYJNAYRXSA-N 0.000 description 2
- XDGPTBVOSHKDFT-KKUMJFAQSA-N Tyr-Met-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O XDGPTBVOSHKDFT-KKUMJFAQSA-N 0.000 description 2
- AVFGBGGRZOKSFS-KJEVXHAQSA-N Tyr-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O AVFGBGGRZOKSFS-KJEVXHAQSA-N 0.000 description 2
- VBFVQTPETKJCQW-RPTUDFQQSA-N Tyr-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VBFVQTPETKJCQW-RPTUDFQQSA-N 0.000 description 2
- SZEIFUXUTBBQFQ-STQMWFEESA-N Tyr-Pro-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SZEIFUXUTBBQFQ-STQMWFEESA-N 0.000 description 2
- GNWUWQAVVJQREM-NHCYSSNCSA-N Val-Asn-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N GNWUWQAVVJQREM-NHCYSSNCSA-N 0.000 description 2
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 2
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 108010070783 alanyltyrosine Proteins 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000013373 clone screening Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229940116862 faricimab Drugs 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 229940020947 fluorescein sodium Drugs 0.000 description 2
- 108010051307 glycyl-glycyl-proline Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- MXHCPCSDRGLRER-UHFFFAOYSA-N pentaglycine Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(O)=O MXHCPCSDRGLRER-UHFFFAOYSA-N 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 229960003876 ranibizumab Drugs 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 208000029257 vision disease Diseases 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- SBGXWWCLHIOABR-UHFFFAOYSA-N Ala Ala Gly Ala Chemical compound CC(N)C(=O)NC(C)C(=O)NCC(=O)NC(C)C(O)=O SBGXWWCLHIOABR-UHFFFAOYSA-N 0.000 description 1
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 1
- KQESEZXHYOUIIM-CQDKDKBSSA-N Ala-Lys-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KQESEZXHYOUIIM-CQDKDKBSSA-N 0.000 description 1
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 1
- YMIYZAOBQDRCPP-UHFFFAOYSA-N Ala-Thr-Cys-Cys Chemical compound CC(N)C(=O)NC(C(O)C)C(=O)NC(CS)C(=O)NC(CS)C(O)=O YMIYZAOBQDRCPP-UHFFFAOYSA-N 0.000 description 1
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 1
- ZUVMUOOHJYNJPP-XIRDDKMYSA-N Arg-Trp-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZUVMUOOHJYNJPP-XIRDDKMYSA-N 0.000 description 1
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 1
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 1
- SZNGQSBRHFMZLT-IHRRRGAJSA-N Asn-Pro-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SZNGQSBRHFMZLT-IHRRRGAJSA-N 0.000 description 1
- YWFLXGZHZXXINF-BPUTZDHNSA-N Asn-Pro-Trp Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 YWFLXGZHZXXINF-BPUTZDHNSA-N 0.000 description 1
- PUUPMDXIHCOPJU-HJGDQZAQSA-N Asn-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O PUUPMDXIHCOPJU-HJGDQZAQSA-N 0.000 description 1
- KZYSHAMXEBPJBD-JRQIVUDYSA-N Asn-Thr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KZYSHAMXEBPJBD-JRQIVUDYSA-N 0.000 description 1
- DATSKXOXPUAOLK-KKUMJFAQSA-N Asn-Tyr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O DATSKXOXPUAOLK-KKUMJFAQSA-N 0.000 description 1
- JUWISGAGWSDGDH-KKUMJFAQSA-N Asp-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=CC=C1 JUWISGAGWSDGDH-KKUMJFAQSA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
- DCJNIJAWIRPPBB-CIUDSAMLSA-N Cys-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N DCJNIJAWIRPPBB-CIUDSAMLSA-N 0.000 description 1
- QADHATDBZXHRCA-ACZMJKKPSA-N Cys-Gln-Asn Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CS)N QADHATDBZXHRCA-ACZMJKKPSA-N 0.000 description 1
- BPHKULHWEIUDOB-FXQIFTODSA-N Cys-Gln-Gln Chemical compound SC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O BPHKULHWEIUDOB-FXQIFTODSA-N 0.000 description 1
- CVLIHKBUPSFRQP-WHFBIAKZSA-N Cys-Gly-Ala Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(O)=O CVLIHKBUPSFRQP-WHFBIAKZSA-N 0.000 description 1
- GDNWBSFSHJVXKL-GUBZILKMSA-N Cys-Lys-Gln Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O GDNWBSFSHJVXKL-GUBZILKMSA-N 0.000 description 1
- CMYVIUWVYHOLRD-ZLUOBGJFSA-N Cys-Ser-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O CMYVIUWVYHOLRD-ZLUOBGJFSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KGNSGRRALVIRGR-QWRGUYRKSA-N Gln-Tyr Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KGNSGRRALVIRGR-QWRGUYRKSA-N 0.000 description 1
- FTMLQFPULNGION-ZVZYQTTQSA-N Gln-Val-Trp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O FTMLQFPULNGION-ZVZYQTTQSA-N 0.000 description 1
- CSMHMEATMDCQNY-DZKIICNBSA-N Gln-Val-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CSMHMEATMDCQNY-DZKIICNBSA-N 0.000 description 1
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 1
- ITVBKCZZLJUUHI-HTUGSXCWSA-N Glu-Phe-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ITVBKCZZLJUUHI-HTUGSXCWSA-N 0.000 description 1
- SWDNPSMMEWRNOH-HJGDQZAQSA-N Glu-Pro-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWDNPSMMEWRNOH-HJGDQZAQSA-N 0.000 description 1
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 1
- CIMULJZTTOBOPN-WHFBIAKZSA-N Gly-Asn-Asn Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CIMULJZTTOBOPN-WHFBIAKZSA-N 0.000 description 1
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 1
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 1
- CQZDZKRHFWJXDF-WDSKDSINSA-N Gly-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CN CQZDZKRHFWJXDF-WDSKDSINSA-N 0.000 description 1
- BEQGFMIBZFNROK-JGVFFNPUSA-N Gly-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)O BEQGFMIBZFNROK-JGVFFNPUSA-N 0.000 description 1
- ICUTTWWCDIIIEE-BQBZGAKWSA-N Gly-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN ICUTTWWCDIIIEE-BQBZGAKWSA-N 0.000 description 1
- WDXLKVQATNEAJQ-BQBZGAKWSA-N Gly-Pro-Asp Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WDXLKVQATNEAJQ-BQBZGAKWSA-N 0.000 description 1
- FFALDIDGPLUDKV-ZDLURKLDSA-N Gly-Thr-Ser Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O FFALDIDGPLUDKV-ZDLURKLDSA-N 0.000 description 1
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 1
- GNNJKUYDWFIBTK-QWRGUYRKSA-N Gly-Tyr-Asp Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O GNNJKUYDWFIBTK-QWRGUYRKSA-N 0.000 description 1
- HQSKKSLNLSTONK-JTQLQIEISA-N Gly-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 HQSKKSLNLSTONK-JTQLQIEISA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- ZHHLTWUOWXHVQJ-YUMQZZPRSA-N His-Ser-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZHHLTWUOWXHVQJ-YUMQZZPRSA-N 0.000 description 1
- HZWWOGWOBQBETJ-CUJWVEQBSA-N His-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O HZWWOGWOBQBETJ-CUJWVEQBSA-N 0.000 description 1
- KUHFPGIVBOCRMV-MNXVOIDGSA-N Ile-Gln-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N KUHFPGIVBOCRMV-MNXVOIDGSA-N 0.000 description 1
- LBRCLQMZAHRTLV-ZKWXMUAHSA-N Ile-Gly-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LBRCLQMZAHRTLV-ZKWXMUAHSA-N 0.000 description 1
- KEKTTYCXKGBAAL-VGDYDELISA-N Ile-His-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N KEKTTYCXKGBAAL-VGDYDELISA-N 0.000 description 1
- JODPUDMBQBIWCK-GHCJXIJMSA-N Ile-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O JODPUDMBQBIWCK-GHCJXIJMSA-N 0.000 description 1
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 1
- GVEODXUBBFDBPW-MGHWNKPDSA-N Ile-Tyr-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 GVEODXUBBFDBPW-MGHWNKPDSA-N 0.000 description 1
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 1
- BTNXKBVLWJBTNR-SRVKXCTJSA-N Leu-His-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O BTNXKBVLWJBTNR-SRVKXCTJSA-N 0.000 description 1
- ZGUMORRUBUCXEH-AVGNSLFASA-N Leu-Lys-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZGUMORRUBUCXEH-AVGNSLFASA-N 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- CLBGMWIYPYAZPR-AVGNSLFASA-N Lys-Arg-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O CLBGMWIYPYAZPR-AVGNSLFASA-N 0.000 description 1
- MWVUEPNEPWMFBD-SRVKXCTJSA-N Lys-Cys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCCN MWVUEPNEPWMFBD-SRVKXCTJSA-N 0.000 description 1
- YKBSXQFZWFXFIB-VOAKCMCISA-N Lys-Thr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O YKBSXQFZWFXFIB-VOAKCMCISA-N 0.000 description 1
- IEIHKHYMBIYQTH-YESZJQIVSA-N Lys-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCCN)N)C(=O)O IEIHKHYMBIYQTH-YESZJQIVSA-N 0.000 description 1
- DRRXXZBXDMLGFC-IHRRRGAJSA-N Lys-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN DRRXXZBXDMLGFC-IHRRRGAJSA-N 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- CAODKDAPYGUMLK-FXQIFTODSA-N Met-Asn-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CAODKDAPYGUMLK-FXQIFTODSA-N 0.000 description 1
- XLTSAUGGDYRFLS-UMPQAUOISA-N Met-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCSC)N)O XLTSAUGGDYRFLS-UMPQAUOISA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- GYEPCBNTTRORKW-PCBIJLKTSA-N Phe-Ile-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O GYEPCBNTTRORKW-PCBIJLKTSA-N 0.000 description 1
- DMEYUTSDVRCWRS-ULQDDVLXSA-N Phe-Lys-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 DMEYUTSDVRCWRS-ULQDDVLXSA-N 0.000 description 1
- CXMSESHALPOLRE-MEYUZBJRSA-N Phe-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)O CXMSESHALPOLRE-MEYUZBJRSA-N 0.000 description 1
- GNRMAQSIROFNMI-IXOXFDKPSA-N Phe-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GNRMAQSIROFNMI-IXOXFDKPSA-N 0.000 description 1
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 1
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 1
- KWMZPPWYBVZIER-XGEHTFHBSA-N Pro-Ser-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWMZPPWYBVZIER-XGEHTFHBSA-N 0.000 description 1
- VVAWNPIOYXAMAL-KJEVXHAQSA-N Pro-Thr-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VVAWNPIOYXAMAL-KJEVXHAQSA-N 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- HBOABDXGTMMDSE-GUBZILKMSA-N Ser-Arg-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O HBOABDXGTMMDSE-GUBZILKMSA-N 0.000 description 1
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 1
- ICHZYBVODUVUKN-SRVKXCTJSA-N Ser-Asn-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ICHZYBVODUVUKN-SRVKXCTJSA-N 0.000 description 1
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 1
- FFOKMZOAVHEWET-IMJSIDKUSA-N Ser-Cys Chemical compound OC[C@H](N)C(=O)N[C@@H](CS)C(O)=O FFOKMZOAVHEWET-IMJSIDKUSA-N 0.000 description 1
- KNCJWSPMTFFJII-ZLUOBGJFSA-N Ser-Cys-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O KNCJWSPMTFFJII-ZLUOBGJFSA-N 0.000 description 1
- BRGQQXQKPUCUJQ-KBIXCLLPSA-N Ser-Glu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRGQQXQKPUCUJQ-KBIXCLLPSA-N 0.000 description 1
- OHKFXGKHSJKKAL-NRPADANISA-N Ser-Glu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OHKFXGKHSJKKAL-NRPADANISA-N 0.000 description 1
- NBUKGEFVZJMSIS-XIRDDKMYSA-N Ser-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CO)N NBUKGEFVZJMSIS-XIRDDKMYSA-N 0.000 description 1
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 1
- IUXGJEIKJBYKOO-SRVKXCTJSA-N Ser-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N IUXGJEIKJBYKOO-SRVKXCTJSA-N 0.000 description 1
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 1
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- TZKPNGDGUVREEB-FOHZUACHSA-N Thr-Asn-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O TZKPNGDGUVREEB-FOHZUACHSA-N 0.000 description 1
- DCLBXIWHLVEPMQ-JRQIVUDYSA-N Thr-Asp-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DCLBXIWHLVEPMQ-JRQIVUDYSA-N 0.000 description 1
- UTCFSBBXPWKLTG-XKBZYTNZSA-N Thr-Cys-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O UTCFSBBXPWKLTG-XKBZYTNZSA-N 0.000 description 1
- LYGKYFKSZTUXGZ-ZDLURKLDSA-N Thr-Cys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(O)=O LYGKYFKSZTUXGZ-ZDLURKLDSA-N 0.000 description 1
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 1
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 1
- IJVNLNRVDUTWDD-MEYUZBJRSA-N Thr-Leu-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IJVNLNRVDUTWDD-MEYUZBJRSA-N 0.000 description 1
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 1
- BCYUHPXBHCUYBA-CUJWVEQBSA-N Thr-Ser-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BCYUHPXBHCUYBA-CUJWVEQBSA-N 0.000 description 1
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 1
- UQCNIMDPYICBTR-KYNKHSRBSA-N Thr-Thr-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UQCNIMDPYICBTR-KYNKHSRBSA-N 0.000 description 1
- FBQHKSPOIAFUEI-OWLDWWDNSA-N Thr-Trp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O FBQHKSPOIAFUEI-OWLDWWDNSA-N 0.000 description 1
- LXXCHJKHJYRMIY-FQPOAREZSA-N Thr-Tyr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O LXXCHJKHJYRMIY-FQPOAREZSA-N 0.000 description 1
- LVRFMARKDGGZMX-IZPVPAKOSA-N Thr-Tyr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=C(O)C=C1 LVRFMARKDGGZMX-IZPVPAKOSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- BGDKAVGWHJFAGW-UHFFFAOYSA-N Tropicamide Chemical compound C=1C=CC=CC=1C(CO)C(=O)N(CC)CC1=CC=NC=C1 BGDKAVGWHJFAGW-UHFFFAOYSA-N 0.000 description 1
- UDCHKDYNMRJYMI-QEJZJMRPSA-N Trp-Glu-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UDCHKDYNMRJYMI-QEJZJMRPSA-N 0.000 description 1
- CXPJPTFWKXNDKV-NUTKFTJISA-N Trp-Leu-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CXPJPTFWKXNDKV-NUTKFTJISA-N 0.000 description 1
- UIRVSEPRMWDVEW-RNXOBYDBSA-N Trp-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)N UIRVSEPRMWDVEW-RNXOBYDBSA-N 0.000 description 1
- QAYSODICXVZUIA-WLTAIBSBSA-N Tyr-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QAYSODICXVZUIA-WLTAIBSBSA-N 0.000 description 1
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 1
- VPEFOFYNHBWFNQ-UFYCRDLUSA-N Tyr-Pro-Tyr Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 VPEFOFYNHBWFNQ-UFYCRDLUSA-N 0.000 description 1
- ZZDYJFVIKVSUFA-WLTAIBSBSA-N Tyr-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ZZDYJFVIKVSUFA-WLTAIBSBSA-N 0.000 description 1
- WYOBRXPIZVKNMF-IRXDYDNUSA-N Tyr-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 WYOBRXPIZVKNMF-IRXDYDNUSA-N 0.000 description 1
- VHRLUTIMTDOVCG-PEDHHIEDSA-N Val-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](C(C)C)N VHRLUTIMTDOVCG-PEDHHIEDSA-N 0.000 description 1
- DAVNYIUELQBTAP-XUXIUFHCSA-N Val-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N DAVNYIUELQBTAP-XUXIUFHCSA-N 0.000 description 1
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 1
- VTIAEOKFUJJBTC-YDHLFZDLSA-N Val-Tyr-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VTIAEOKFUJJBTC-YDHLFZDLSA-N 0.000 description 1
- JXWGBRRVTRAZQA-ULQDDVLXSA-N Val-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N JXWGBRRVTRAZQA-ULQDDVLXSA-N 0.000 description 1
- 208000032594 Vascular Remodeling Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000038018 age-related macular disease Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 229960000397 bevacizumab Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001775 bruch membrane Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000024389 cytopenia Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- -1 e.g. Proteins 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000004220 fundus oculi Anatomy 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- KZNQNBZMBZJQJO-YFKPBYRVSA-N glyclproline Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 1
- 108010075431 glycyl-alanyl-phenylalanine Proteins 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 1
- 229960004359 iodixanol Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 238000013227 male C57BL/6J mice Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 210000002747 omentum Anatomy 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000003733 optic disk Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229960004791 tropicamide Drugs 0.000 description 1
- 108010080629 tryptophan-leucine Proteins 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Images
Abstract
本公开提供了用于治疗受试者的湿性年龄相关的黄斑变性或糖尿病性黄斑水肿的药物组合物和方法。提供了包含衣壳和包含核酸表达盒的重组AAV。表达盒包括编码启动子、可操作地连接至双特异性抗体的信号肽，其中所述双特异性抗体包含特异于VEGF‑A和ANG‑2的结合结构域。
Description
发明领域
本发明涉及免疫学和基因递送领域。更具体地，本申请涉及用于生产感兴趣的蛋白诸如抗体的组合物、系统和方法。
背景技术
年龄相关黄斑变性(age-related macular degeneration,AMD)是由各种因素诱导并与年龄相关的一组黄斑疾病，其共同特点是黄斑部视网膜及视网膜色素上皮和脉络膜发生病变，并导致患者视功能障碍和中心视力进行性下降。我国乃至世界AMD的患病率不断上升且随着年龄增加而升高，是50岁以上人群不可逆视力损伤的主要原因之一。随着人口的老龄化，预计到2040年AMD患者将达2.88亿人。AMD临床分型没有统一标准，国内外目前均倾向于先分期再分型，晚期分成2种类型，分别为干性型(萎缩型)和新生血管性型(渗出型、湿性型)，其中，新生血管性年龄相关性黄斑变性(neovascular age-related maculardegeneration,nAMD)也称湿性年龄相关性黄斑变性(wet age-related maculardegeneration,wAMD)，是导致视力丧失的主要临床类型，其主要特点是脉络膜新生血管(choroidal neovascularization,CNV)出现在黄斑区，从而导致黄斑区发生出血、渗出。糖尿病性视网膜病变(diabetic macular edema,DME)目前是西方发达国家重要致盲的原因之一，随着我国人民生活水平的提高，人口老龄化，DME的发病率已逐渐增高，严重影响患者的视功能和生存质量。
VEGF是wAMD和DME的发病机制中最重要的因素之一，它能特异地作用于血管内皮细胞，促使血管内皮细胞的增殖，诱导新生血管的生成以及血管渗漏的增加。目前研究发现，阻断VEGF的表达可诱导血管重塑的发生，同时促使尚未成熟的新生血管回退，因此VEGF是一个有前景的wAMD和DME的治疗靶点。自2006年以雷珠单抗(Ranibizumab)为代表的抗VEGF药物应用以来，抗VEGF药物已被广泛应用于治疗wAMD和DME。在近10年间，由于同时应用多种抗VEGF治疗方法，因wAMD和DME导致的不可逆盲已有大幅减少。
尽管靶向VEGF的药物在临床上取得了长足的进步和突破，它可以显著降低血管渗漏和水肿的程度，改善视力，并且未发现严重的并发症。但是，这些注射入体内的蛋白质药物会随着代谢而迅速清除，因此需要多次眼内注射以维持治疗效果。长期治疗增加了患者的经济负担，重复注射会增加患者的痛苦和发生不良反应的可能性，在从常规给药转变为低频给药时会出现一定程度的视力下降，一些患者在治疗后容易复发。针对wAMD和DME现有疗法的局限性，在本领域上出现了对更加经济且持续时间更长、效果更优的治疗策略的需求。
本发明旨在提供一种抗VEGF-A和抗ANG-2基因疗法。
发明内容
本发明提供了一种AAV病毒载体，包括编码目的基因核酸序列的表达盒，所述目的基因为双特异性抗体构建体，其中所述双特异性抗体构建体包含特异于VEGF-A和ANG-2的结合结构域，其优选为单链抗体串联分子(tandem scFv，ta-scFv)，所述双特异性抗体构建体中重链可变区(VH)和轻链可变区(VL)从N-末端到C-末端按照如下顺序排列：
1)VH抗VEGF-A-VL抗VEGF-A-VH抗ANG-2-VL抗ANG-2；
2)VL抗ANG-2-VH抗VEGF-A-VL抗VEGF-A-VH抗ANG-2；或
3)VL抗VEGF-A-VH抗ANG-2-VL抗ANG-2-VH抗VEGF-A。
在一个实施例中，重链可变区(VH)和轻链可变区(VL)之间可操作性地由(G4S)n链接，其中n为大于1的整数，优选为1至4间任意整数，例如G4S、(G4S)2、(G4S)3或(G4S)4，例如，
1)VH抗VEGF-A-(G4S)m+X-VL抗VEGF-A-(G4S)m-VH抗ANG-2-(G4S)3-VL抗ANG-2；其中m≥1，X≥2，优选为VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2；
2)VL抗ANG-2-(G4S)m-VH抗VEGF-A-(G4S)m+X-VL抗VEGF-A-(G4S)m-VH抗ANG-2，其中m≥1，X≥2，优选为VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2；或
3)VL抗VEGF-A-(G4S)m-VH抗ANG-2-(G4S)m+X-VL抗ANG-2-(G4S)m-VH抗VEGF-A，其中m≥1，X≥2，优选为VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S-VH抗VEGF-A。
在一个实施例中，所述双特异性抗体构建体的N-末端包含信号肽序列或标签序列，优选所述信号肽序列为CD5-sp信号肽，其包含如SEQ ID NO：21所示的序列，优选标签序列选自HA标签、Myc、His、Flag、GST、或GFP等荧光标签。
在一个实施例中，AAV病毒载体进一步包括：5’ITR和3’ITR、启动子和polyA序列。
在一个具体实施例中，所述VH抗VEGF-A包含如SEQ ID NO:1所示的氨基酸序列，编码其核苷酸序列包含如SEQ ID NO:2所示的核苷酸序列，所述VL抗VEGF-A包含如SEQ ID NO:3所示的氨基酸序列，编码其核苷酸序列包含如SEQ ID NO:4所示的核苷酸序列；所述VH抗ANG-2包含如SEQ ID NO:5所示的氨基酸序列，编码其核苷酸序列包含如SEQ ID NO:6所示的核苷酸序列，所述VL抗ANG-2包含如SEQ ID NO:7所示的氨基酸序列，编码其核苷酸序列包含如SEQ IDNO:8所示的核苷酸序列。
在一个具体实施例中，所述双特异性抗体构建体的结构选自
VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:9所示；
VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2，如SEQ ID NO:13所示；
VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S-VH抗VEGF-A；如SEQ ID NO:17所示；
CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:11所示；
CD5-sp-VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2，如SEQ ID NO:15所示；或
CD5-sp-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S-VH抗VEGF-A；如SEQ ID NO:19所示。
在一个具体实施例中，CD5-sp信号肽的序列如SEQ ID NO:21所示。
在一个实施例中，所述VH抗VEGF-A包含如SEQ ID NO:23所示的氨基酸序列，所述VL抗VEGF-A包含如SEQ ID NO:25所示的氨基酸序列；所述VH抗ANG-2包含如SEQ ID NO:5所示的氨基酸序列，所述VL抗ANG-2包含如SEQ ID NO:7所示的氨基酸序列。优选，其中所述双特异性抗体构建体的结构选自
VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:27所示；或
CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:29所示。
在一个实施例中，所述VH抗VEGF-A包含如SEQ ID NO:31所示的氨基酸序列，所述VL抗VEGF-A包含如SEQ ID NO:33所示的氨基酸序列；所述VH抗ANG-2包含如SEQ ID NO:5所示的氨基酸序列，所述VL抗ANG-2包含如SEQ ID NO:7所示的氨基酸序列。优选，其中所述双特异性抗体构建体的结构选自
VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:35所示；或
CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:37所示。
另一方面，本发明提供了一种AAV病毒载体，包括编码双特异性抗体构建体的序列，其中所述双特异性抗体构建体包含特异于VEGF-A和ANG-2的结合结构域，所述双特异性抗体构建体结构按照如下顺序排列：
抗ANG-2重链Fab段-P2A-抗VEGF-A重链Fab段-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链、
抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链、
HA-抗ANG-2重链Fab段-P2A-抗VEGF-A重链Fab段-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链、或
HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链，
其中抗ANG-2重链中恒定区CH1被CL替换，抗ANG-2轻链中CL被恒定区CH1替换。
在一个实施例中，其中所述抗ANG-2重链Fab段包含SEQ ID NO:39,所述抗ANG-2轻链包含SEQ ID NO:45，所述抗VEGF-A重链Fab段包含SEQ ID NO:41、51或59，所述抗VEGF-A轻链包含SEQ ID NO:43、53或61。其中，在一个具体实施例中，所述双特异性抗体构建体的序列包含选自SEQ ID NO:47、49、55、57、63、或65。
在一个具体实施例中，所述双特异性抗体构建体的N-末端包含信号肽序列或标签序列，优选所述信号肽序列为如SEQ ID NO：21所示的CD5-sp信号肽，优选标签序列为HA标签。
本发明所述的AAV病毒载体进一步包括：5’ITR和3’ITR、启动子、polyA序列。
又一方面，本发明提供了一种AAV病毒颗粒，包括如前任意的AAV病毒载体和衣壳蛋白，优选其中所述衣壳蛋白的血清型为AAV1、AAV2、AAV4、AAV5、AAV6、AAV7、AAV8、或AAV9。
本发明提供了一种药物组合物，包括如前任一项所述的AAV病毒载体或如前所述的AAV病毒颗粒，以及药学上可接受的载体。
本发明提供如前任一项所述的AAV病毒载体、如前所述的AAV病毒颗粒、或如前所述的药物组合物在制备用于治疗或预防癌症、眼内新生血管综合征、类风湿性关节炎、银屑病、增殖性视网膜病变、年龄相关的黄斑变性或糖尿病性黄斑水肿的药物中的用途。
在一个实施例中，所述年龄相关的黄斑变性为湿性年龄相关黄斑变性。
在一个具体实施例中，所述药物通过玻璃体腔或视网膜下腔注射施用。
附图说明
图1示出了XMVA01和XMFAR01的结构示意图和载体信息。图1A示出了XMVA01和XMFAR01的结构示意图，图1B示出XMVA01的载体信息，图1C示出XMFAR01的载体信息。
图2示出了XMVA01、XMFAR01载体转染细胞后表达VEGF165中和蛋白的含量。
图3示出了使用Immobilon Western Chemiluminescent HRP Substrate试剂盒(Millipore)进行曝光分析抗体的特异性。
图4示出了在细胞中表达XMVA01、XMFAR01对人视网膜微血管内皮细胞(HRMEC)在ECGS刺激下增殖的影响。
图5示出了在细胞中表达XMVA01、XMFAR01对HRMECs管腔形成的影响。
图6示出了在细胞中表达XMVA01、XMFAR01对HRMECs迁移的影响。
图7示出了单次视网膜下腔注射XMVA01、XMFAR01后对光斑的荧光渗漏程度影响的免疫荧光图。
图8示出了单次视网膜下腔注射XMVA01、XMFAR01后对光斑的荧光渗漏程度影响的定量图。
图9示出了单次视网膜下腔注射XMVA01、XMFAR01后光斑处主要病变汇总。
图10示出了XMVA02的结构示意图。
图11示出了XMVA03的结构示意图。
图12示出了XMVA04的结构示意图。
图13示出了XMVA05的结构示意图。
图14示出了XMFAR02的结构示意图。
图15示出了XMFAR03的结构示意图。
发明详述
以下根据实施例，并且结合附图，详细描述本发明。从下文的详细描述中，本发明的上述方面和本发明的其他方面将是明显的。本发明的范围不局限于下列实施例。
本发明中的抗体可以以多种形式存在，包括多克隆、单克隆、单特异性的、多特异性的、非特异性的、人源化的、单链的、嵌合的、合成的、重组的、杂合的、突变的、以及嫁接的抗体；本发明中的抗体形式还包括全长抗体、抗体片段，例如Fab、Fab’、F(ab’)2、Fv、scFv、di-scFv、tri-scFv、Fd和其它保留抗原结合功能的抗体片段；还可以是二聚体结构Diabody或三聚体结构Triabody。在具体实施例中，本发明的抗体为抗体轻链可变区(VL)和抗体重链可变区(VH)拼接而成的scFv或者完整的抗体，该抗体可以结合两种不同的抗原，例如VEGF和ANG-2。
抗体轻链可变区(VL)和抗体重链可变区(VH)，VH和VL区可以进一步细分成：称为互补决定区(CDR)的高变区，以及穿插分布的称为框架区(FWR)的更保守区域。本发明公开的抗体和抗原结合片段的CDR由Kabat编号所定义或识别。在一个实施方案中，每个VH和VL一般包括从氨基端到羧基端按以下顺序排列的3个CDR和4个FWR：FWR1、CDR1、FWR2、CDR2、FWR3、CDR3、FWR4。
本文使用的“载体”是指包括重组多核苷酸的载体，所述重组多核苷酸包括可操作地连接至待表达的核苷酸序列的表达控制序列。
下述实施例中的实验方法，如无特殊说明，均为常规方法。
实施例
实例1：质粒载体的构建
表达anti-VEGF-A/ANG-2基因的AAV载体质粒的构建
抗VEGF的VH氨基酸序列(SEQ ID NO:1)和VL氨基酸序列(SEQ ID NO:3)、抗ANG-2的VH氨基酸序列(SEQ ID NO:5)和和VL氨基酸序列(SEQ ID NO:7)，在N端加上分泌信号肽CD5-sp核苷酸序列(SEQ ID NO:21),分别用(G4S)3、G4S、(G4S)3肽接头连接，组成了结构为CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2的开放阅读框(SEQ ID NO:11)，根据人密码子偏好设计核苷酸序列(SEQ ID NO:12)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMVA01；
氨基酸序列A chain(抗ANG-2重链，SEQ ID NO:39)、B chain(抗VEGF-A重链，SEQID NO:41)、C chain(抗VEGF-A轻链，SEQ ID NO:43)、D chain(抗ANG-2轻链，SEQ ID NO:47)，在组合物的N端加上HA标签，各链之间分别用P2A/T2A/E2A连接，组成了结构为HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链的开放阅读框(SEQID NO:49)，根据人密码子偏好设计核苷酸序列(SEQ ID NO:50)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMFAR01，由南京金斯瑞生物科技公司合成全基因。
用BamH I/EcoR V双酶切XMVA01/XMFAR01和pAAV9neo-CAG质粒，通过连接、转化及克隆筛选鉴定等常规分子生物学操作构建了XMVA01、XMFAR01载体，其结构示意图见图1。用无内毒素的质粒提取试剂盒(MN)获得高质量的质粒DNA备用。
实例2：XMVA01、XMFAR01在细胞中的表达测定
将XMVA01、XMFAR01质粒分别转染HEK293T细胞，收集上清，用ELISA和Westernbolt方法检测上清中蛋白的表达。具体操作如下：用含10％胎牛血清的DMEM的完全培养基重悬293T细胞后，接种至培养皿中，37℃、5％CO2培养箱培养至细胞的汇合度达到70％-90％时，采用Lipofectamine 2000(Invitrogen)促转试剂，按照其说明书转染质粒。继续培养72h后，收集上清液，-80℃备用。
ELISA具体检测方法如下：以0.1μg/mL VEGF165(proteintech)蛋白包被酶标板(Thermo)，每孔100μL，4℃过夜孵育，用含有0.05％Tween(Sangon)的PBS洗涤酶标板3次，每次3分钟。用含有2％BSA(麦客生物)的PBS 200μL/孔室温封闭1h，再次洗涤3次。在酶标板中分别加入康柏西普(10mg/mL)标准品和XMVA01、XMFAR01质粒转染HEK293T细胞后收集的细胞上清，标准品从第一孔以39ng/mL浓度开始连续8个稀释度进行倍比稀释，待测上清以1:10或1:50进行倍比稀释，数据取平均值，以未转染质粒的细胞上清液作为对照组(Control组)，37℃孵育1小时，洗涤3次。每孔加入1：5000稀释的辣根过氧化氢酶标记的羊抗人IgG抗体(JacksonImmunoResearch)，37℃孵育1小时，再洗涤3次。每孔加入TMB显色液(Beyotime)100μL/孔，室温避光反应8分钟，向上述孔中加入100μL/孔终止液(Beyotime)终止反应。用酶标仪在450nm处测定OD值，计算待测样品的含量，结果见图2。XMVA01、XMFAR01载体转染细胞后能有效表达VEGF165中和蛋白，和对照组相比，具有显著差异。
Western bolt具体检测方法如下：通过还原SDS-PAGE分析XMFAR01蛋白表达。将2μg VEGF165蛋白(proteintech)或2μg Ang-2蛋白(Sino Biological)与15μL PBS(pH 7.2)混合，再加入5μL含DTT还原剂(Sangon)的SDS-PAGE加样缓冲液，在70℃下加热30分钟，10000rpm离心取上清并进行4％-12％SDS-PAGE凝胶上样。110V电泳1.5小时，转印PVDF(Millipore)1.5小时，将PVDF膜在含有5％的脱脂奶粉的TBST中室温封闭1小时，以XMFAR01质粒转染HEK293T细胞后收集的细胞上清作为一抗，4℃过夜孵育后，TBST洗涤5次，每次5分钟。用1:1000稀释的辣根过氧化氢酶标记的羊抗人IgG(JacksonImmunoResearch)作为二抗室温孵育1小时，并重复洗涤。使用Immobilon Western Chemiluminescent HRP Substrate试剂盒(Millipore)进行曝光分析抗体的特异性，结果见图3。
实例3：在细胞中表达XMVA01、XMFAR01对人视网膜微血管内皮细胞(HRMEC)增殖的
影响
具体实验如下：用含1％ECGS的ECM的完全培养基(Science Cell)调整HRMECs的细胞密度为4×104/mL，100μL/孔接种于平底96孔板中，将XMVA01、XMFAR01质粒转染HEK293T细胞后收集的细胞上清以100μL/孔加入孔内，以未转染质粒的细胞上清液作为对照组(Control组)。37℃、5％CO2的培养箱中培养72小时，按照Cell Counting Kit-8(CCK-8，Biosharp)说明书分别在实验组和对照组中加入20μL/孔的CCK-8的溶液，孵育4小时后，用酶标仪测定在450nm处的吸光值，结果见图4，XMVA01、XMFAR01载体所表达的蛋白均能有效抑制ECGS刺激下的HRMECs的增殖。
实例4：在细胞中表达XMVA01、XMFAR01对HRMECs管腔形成的影响
将解冻后的Matrigel(Corning)基质胶均一地铺在平底96孔板中，50μL/孔，37℃培养箱孵育1小时；以XMVA01、XMFAR01质粒转染HEK293T细胞后收集的细胞上清处理HRMECs，以未转染质粒的细胞上清液作为对照组(Control组)，培养48小时后用不含生长因子和血清的ECM的基础培养基重悬，并调整细胞密度为2×105/mL，100μL/孔接种在含基质胶的96孔板内；于37℃，5％CO2中培养箱中培养，每间隔2小时观察一次，4-8小时后，在显微镜下观察、拍照，记录经待测上清处理后对HRMECs管腔的形成能力的影响，结果见图5。XMVA01、XMFAR01载体所表达的蛋白均能有效抑制HRMECs管腔的形成。
实例5：在细胞中表达XMVA01、XMFAR01对HRMEC迁移的影响
在细胞培养板上，用ECM完全培养基重悬HRMEC后，按照1-2×105/孔，进行接种；24小时后，进行划痕并拍照；将XMVA01、XMFAR01质粒转染HEK293T细胞后收集的细胞上清和含30mmol/L高糖的ECM完全培养基继续共孵育，以未转染质粒的细胞上清液作为对照组(Control组)，24小时后，对划痕结果进行显微拍照，结果见图6，XMVA01、XMFAR01载体所表达的蛋白均能显著高效抑制高糖诱导的HRMECs的迁移。
实例6：重组AAV病毒的制备和鉴定
使用三质粒包装系统和纯化重组AAV病毒，辅助质粒(phelper)、AAV的Cap和Rep蛋白表达质粒(AAV2/5)、表达载体目的质粒(XMVA01或XMFAR01)按照2:1:1的质量比，和PEI促转剂形成转染复合物，转染HEK293T细胞，进行含目的基因的AAV病毒的包装。分别于转染后第3天和第7天，进行两次上清的收集，即获得含有目的基因的AAV病毒颗粒。采用不同梯度的碘克沙醇(15％、25％、40％和60％)进行密度梯度离心(Beckman的超速离心机)，获得纯化的AAV病毒。对获得的纯化的AAV病毒，通过透射电子显微电镜进行AAV质量的鉴定和qPCR进行AAV病毒滴度的定量。
实例7：XMVA01、XMFAR01对小鼠CNV的抑制作用
目前建立CNV动物模型主要是通过高能量激光光凝视网膜，这是目前国内外普遍使用的脉络膜新生血管动物模型。选择性破坏光感受器外节盘膜、Bruch膜、视网膜色素上皮以及部分前脉络膜毛细血管网，随后发生损伤修复反应，包括成纤维细胞、视网膜色素上皮细胞和血管内皮细胞侵入生长，最终在光凝区内形成新生血管。
SPF级7～9周雄性C57BL/6J小鼠34只(购自上海吉辉实验动物饲养有限公司)，体重19-23g，注射前进行一般眼科检查、眼底照相(FP)和眼底血管荧光造影(FFA)检测。对筛选合格的动物进行注射，处理见下表：
表1.给药方案
注：*Control组为AAV-GFP，
为再生元公司阿柏西普
由于AAV注射后需要一定时间目的基因的表达才能达到稳定水平，第1、3、4组于第1天(D1)进行双眼视网膜下腔注射，第2组于第29天(D29)进行双眼玻璃体腔注射，在第22天(D22)和第57天(D57)，对注射成功动物进行双眼眼底激光光凝以诱导CNV模型。
小鼠CNV模型的建立：于D22、D57进行双眼眼底激光诱导CNV，双眼各滴复方托吡卡胺滴眼液1-2滴散瞳，肌肉注射舒泰50(50mg/kg，50mg/mL)实施麻醉。麻醉后，双眼滴卡波姆滴眼液，放置眼底激光镜，看距离视盘约1.5-2PD处围绕视乳头避开血管进行光凝。激光参数为：波长532nm，功率200mW，光斑直径50μm，曝光时间100ms，光凝后动物双眼涂氧氟沙星眼膏。
于第36天(D36)、第71天(D71)对小鼠进行FFA检测：静脉注射荧光素钠注射液(100mg/mL，0.02mL/只)，注入荧光素钠后早期(1.5分钟内)、晚期(3分钟后)双眼采集清晰图片若干张，对有效光斑的荧光渗漏程度进行评级，计算3级渗漏光斑的比率，结果见图7、图8。结果表明，单次玻璃体腔注射
后1周可显著抑制CNV形成，但效果无法持续至注射后6周。单次视网膜下腔注射XMVA01、XMFAR01后5周对CNV有显著抑制作用，效果可以持续至少10周。
有效光斑是指其附近无严重视网膜出血、在FFA中能完整显示且不被给药部位高荧光干扰的光斑。光斑荧光渗漏评级标准为：0级(无荧光渗漏)，1级(轻度荧光渗漏，渗漏面积为激光光斑大小的1～50％)，2级(中度荧光渗漏，渗漏面积为激光光斑大小的50～100％)，3级(重度荧光渗漏，渗漏面积大于激光光斑大小)。
各级光斑比率(％)＝对应级别光斑总数÷4种光斑总数×100％；
实例8：组织病理学评价
于D71采用舒泰50肌肉注射(50mg/kg，50mg/mL)对动物进行麻醉，颈动脉放血安乐死。采集各组动物眼球并放入Davidson’s固定液中固定保存，进行取材(经光斑处和注射位点处取材)、包埋、切片(每眼制作2张切片)、HE染色，在光镜下观察病灶处CNV和给药注射位点的视网膜损伤情况，按4级法(轻微，轻度，中度，重度)对病变进行分级，动物眼底激光光斑处显微镜观察主要病变汇总见图9。
各组动物眼底光斑处均可见轻微到中度脉络膜/巩膜纤维增生、轻微到中度CNV形成、轻微到重度视网膜外核层细胞减少以及轻微到中度视网膜结构异常。与Control组相比，XMVA01组中度CNV形成发生率降低较为明显，表明XMVA01(3×109vg/眼)能够在一定程度上抑制CNV形成，而
(40μg/眼)和XMFAR01(3×109vg/眼)对CNV无明显抑制作用(图9)。
统计分析
采用双尾分析，统计学水平设在5％或p≤0.05，计算各项分析指标的平均数和标准差(Mean±SD)。上述数据按下列过程分析：
用Levene's Test检验方差齐性；如果没有统计学意义(p>0.05)，用单因素方差分析(ANOVA)进行统计分析。如果ANOVA有统计学意义(p≤0.05)，则进行LSD多重比较。
如果方差不齐(p≤0.05)，则进行Kruskal-Wallis非参数检验。如果Kruskal-Wallis非参数检验结果显著(p≤0.05)，则进一步采用Mann-Whitney U检验进行两两比较。
实例9：其他质粒载体的构建
方案1
抗VEGF的VH氨基酸序列(SEQ ID NO:1)和VL氨基酸序列(SEQ ID NO:3)、抗ANG-2的VH氨基酸序列(SEQ ID NO:5)和和VL氨基酸序列(SEQ ID NO:7)，在N端加上分泌信号肽CD5-sp核苷酸序列(SEQ ID NO:21),分别用G4S、(G4S)3、G4S肽接头连接，组成了结构为CD5-sp-VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2的开放阅读框，氨基酸序列为SEQ IDNO:15，根据人密码子偏好设计核苷酸序列(SEQ ID NO:16)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMVA02(见图10)。
方案2
抗VEGF的VH氨基酸序列(SEQ ID NO:1)和VL氨基酸序列(SEQ ID NO:3)、抗ANG-2的VH氨基酸序列(SEQ ID NO:5)和VL氨基酸序列(SEQ ID NO:7)，在N端加上分泌信号肽CD5-sp核苷酸序列(SEQ ID NO:21),分别用G4S、(G4S)3、G4S肽接头连接，组成了结构为CD5-sp-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S-VH抗VEGF-A的开放阅读框，氨基酸序列为SEQ IDNO:19，根据人密码子偏好设计核苷酸序列(SEQ ID NO:20)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMVA03(见图11)。
方案3
将KEGG DRUG Database上公布的Bevacizumab(D06409)的scFv区进行改造，命名为G6-23和G6-31，其氨基酸序列分别为G6-23 VH(SEQ ID NO:23)、G6-23 VL(SEQ ID NO:25)、G6-31 VH(SEQ ID NO:31)、G6-31 VL(SEQ ID NO:33)。
将G6-23 VH(SEQ ID NO:23)、G6-23 VL(SEQ ID NO:25)与抗ANG-2的VH氨基酸序列(SEQ ID NO:5)和VL氨基酸序列(SEQ ID NO:7)组合，在N端加上分泌信号肽CD5-sp(SEQID NO:21)，分别用(G4S)3、G4S、(G4S)3肽接头连接，组成了结构为CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2的开放阅读框，氨基酸序列为SEQ ID NO:29，根据人密码子偏好设计核苷酸序列(SEQ ID NO:30)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMVA04(见图12)。
方案4
将G6-31 VH(SEQ ID NO:31)、G631 VL(SEQ ID NO:33)与抗ANG-2的VH氨基酸序列(SEQ ID NO:5)和VL氨基酸序列(SEQ ID NO:7)，在N端加上分泌信号肽CD5-sp(SEQ ID NO:21)，分别用(G4S)4、P2A、(G4S)4肽接头连接，组成了结构为CD5-sp-VH抗VEGF-A-(G4S)4-VL抗VEGF-A-P2A-VH抗ANG-2-(G4S)4-VL抗ANG-2的开放阅读框，氨基酸序列为SEQ ID NO:37，根据人密码子偏好设计核苷酸序列(SEQ ID NO:38)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMVA05(见图13)。
方案5
将Faricimab(D11516)中anti-VEGF的VH和VL替换为G6-23的VH(SEQ ID NO:23)和VL(SEQ ID NO:25)，在N端加上HA标签，各链之间分别用P2A/T2A/E2A连接，组成了结构为HA+A chain+P2A+B chain(G6-23)+T2A+C chain(G6-23)+E2A+D chain(HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链)的开放阅读框，氨基酸序列为SEQ IDNO:57，根据人密码子偏好设计核苷酸序列(SEQ ID NO:58)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMFAR02；(见图14)。
方案6
将Faricimab(D11516)中anti-VEGF的VH和VL替换为G6-31的VH(SEQ ID NO:31)和VL(SEQ ID NO:33)，在N端加上HA标签，各链之间分别用P2A/T2A/E2A连接，组成了结构为HA+A chain+P2A+B chain(G6-31)+T2A+C chain(G6-31)+E2A+D chain(HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链)的开放阅读框，氨基酸序列为SEQ IDNO:65，根据人密码子偏好设计核苷酸序列(SEQ ID NO:66)，并在5’端引入BamH I酶切位点，在3’端引入EcoR V酶切位点，命名为XMFAR03(见图15)。
通过连接、转化及克隆筛选鉴定等常规分子生物学操作构建了XMVA02、XMVA03、XMVA04、XMVA05、XMFAR02、XMFAR03载体，用无内毒素的质粒提取试剂盒(MN)获得高质量的质粒DNA备用。
按照实施例2中所述方法，将质粒分别转染HEK293T细胞，收集上清，用ELISA和Western bolt方法检测上清中蛋白的表达。按照实施例3中所述的方法，在细胞中表达上述载体对人视网膜微血管内皮细胞(HRMEC)增殖的影响。按照实施例4中所述的方法，在细胞中表达上述质粒对HRMECs管腔形成的影响。按照实施例5的中所述的方法，在细胞中表达上述质粒对HRMEC迁移的影响。按照实施例6中所述的方法，制备重组AAV病毒并鉴定。按照实施例7中所述方法，建立CNV动物模型，分析各组AAV(XMVA02、XMVA03、XMVA04、XMVA05、XMFAR02、XMFAR03对应的AAV病毒)对小鼠CNV的抑制作用。
表2.序列信息
SEQUENCE LISTING
<110> 合肥星眸生物科技有限公司
<120> 抗VEGF-A和ANG-2的AAV载体
<130> AJ8339PI2101
<160> 74
<170> PatentIn version 3.3
<210> 1
<211> 120
<212> PRT
<213> Artificial
<220>
<223> VH抗VEGF-A
<400> 1
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Ser Leu Thr Asp Tyr
20 25 30
Tyr Tyr Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Gly Phe Ile Asp Pro Asp Asp Asp Pro Tyr Tyr Ala Thr Trp Ala
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Gly Gly Asp His Asn Ser Gly Trp Gly Leu Asp Ile Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 2
<211> 360
<212> DNA
<213> Artificial
<220>
<223> VH抗VEGF-A
<400> 2
gaggtgcagc tggttgaatc tggcggagga ctggttcagc ctggcggatc tctgagactg 60
agctgtaccg ccagcggctt cagcctgacc gactactact acatgacctg ggtccgacag 120
gcccctggca aaggacttga gtgggtcgga ttcatcgacc ccgacgacga tccttactac 180
gccacatggg ccaagggcag attcaccatc agccgggaca acagcaagaa caccctgtac 240
ctgcagatga acagcctgag agccgaggac accgccgtgt actattgtgc cggcggagat 300
cacaatagcg gctggggcct tgatatttgg ggccagggaa cactggtcac cgtgtctagt 360
<210> 3
<211> 111
<212> PRT
<213> Artificial
<220>
<223> VL抗VEGF-A
<400> 3
Glu Ile Val Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Ile Ile Thr Cys Gln Ala Ser Glu Ile Ile His Ser Trp
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Leu Ala Ser Thr Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Asn Val Tyr Leu Ala Ser Thr
85 90 95
Asn Gly Ala Asn Phe Gly Gln Gly Thr Lys Leu Thr Val Leu Gly
100 105 110
<210> 4
<211> 333
<212> DNA
<213> Artificial
<220>
<223> VL抗VEGF-A
<400> 4
gagatcgtga tgacacagag ccccagcaca ctgtctgcca gcgtgggaga cagagtgatc 60
atcacatgcc aggccagcga gatcatccac agctggctgg cttggtatca gcagaagcct 120
ggcaaggccc ctaagctgct gatctacctg gcctctacac tggccagcgg agtgcctagc 180
agattttctg gctctggatc tggcgccgag ttcaccctga ccatcagtag cctgcagcct 240
gacgacttcg ccacctacta ctgccagaac gtgtacctgg ccagcaccaa cggcgccaat 300
tttggccagg gcaccaagct gacagtgctg gga 333
<210> 5
<211> 129
<212> PRT
<213> Artificial
<220>
<223> VH抗ANG-2
<400> 5
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr
100 105 110
Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
115 120 125
Ser
<210> 6
<211> 387
<212> DNA
<213> Artificial
<220>
<223> VH抗ANG-2
<400> 6
caggttcagc tggttcagtc tggcgccgaa gtgaagaaac ctggcgcctc tgtgaaggtg 60
tcctgcaagg ccagcggcta cacctttacc ggctactaca tgcactgggt ccgacaggct 120
ccaggacagg gacttgaatg gatgggctgg atcaacccca atagcggcgg caccaattac 180
gcccagaaat tccagggcag agtgaccatg accagagaca ccagcatcag caccgcctac 240
atggaactga gccggctgag atccgatgac accgccgtgt actactgcgc cagatctccc 300
aatccttact actacgacag cagcgggtac tactacccag gcgccttcga tatttggggc 360
cagggcacaa tggtcaccgt gtctagt 387
<210> 7
<211> 108
<212> PRT
<213> Artificial
<220>
<223> VL抗ANG-2
<400> 7
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
100 105
<210> 8
<211> 324
<212> DNA
<213> Artificial
<220>
<223> VL抗ANG-2
<400> 8
agctacgtgc tgacacagcc tccatccgtg tctgtggctc caggacagac cgccagaatc 60
acatgcggcg gcaacaacat cggcagcaag agcgtgcact ggtatcagca gaagcctgga 120
caggctcctg tgctggtggt gtacgacgac agcgatagac ctagcggcat ccccgagaga 180
ttcagcggca gcaattccgg caataccgcc acactgacca tcagcagagt ggaagctggc 240
gacgaggccg actactactg ccaagtgtgg gacagcagca gcgaccactg ggttttcggc 300
ggaggcacaa agctgacagt gctg 324
<210> 9
<211> 503
<212> PRT
<213> Artificial
<220>
<223> VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 9
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Ser Leu Thr Asp Tyr
20 25 30
Tyr Tyr Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
35 40 45
Val Gly Phe Ile Asp Pro Asp Asp Asp Pro Tyr Tyr Ala Thr Trp Ala
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Gly Gly Asp His Asn Ser Gly Trp Gly Leu Asp Ile Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Gly Gly Gly Gly Ser Glu Ile Val Met Thr Gln Ser Pro Ser
130 135 140
Thr Leu Ser Ala Ser Val Gly Asp Arg Val Ile Ile Thr Cys Gln Ala
145 150 155 160
Ser Glu Ile Ile His Ser Trp Leu Ala Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Lys Ala Pro Lys Leu Leu Ile Tyr Leu Ala Ser Thr Leu Ala Ser Gly
180 185 190
Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr Leu
195 200 205
Thr Ile Ser Ser Leu Gln Pro Asp Asp Phe Ala Thr Tyr Tyr Cys Gln
210 215 220
Asn Val Tyr Leu Ala Ser Thr Asn Gly Ala Asn Phe Gly Gln Gly Thr
225 230 235 240
Lys Leu Thr Val Leu Gly Gly Gly Gly Gly Ser Gln Val Gln Leu Val
245 250 255
Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser
260 265 270
Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp Val
275 280 285
Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn Pro
290 295 300
Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr
305 310 315 320
Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser Arg
325 330 335
Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro Asn
340 345 350
Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp
355 360 365
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly
370 375 380
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ser Tyr Val Leu Thr
385 390 395 400
Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr
405 410 415
Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln
420 425 430
Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg
435 440 445
Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr
450 455 460
Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr
465 470 475 480
Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His Trp Val Phe Gly Gly
485 490 495
Gly Thr Lys Leu Thr Val Leu
500
<210> 10
<211> 1509
<212> DNA
<213> Artificial
<220>
<223> VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 10
gaggtgcagc tggttgaatc tggcggagga ctggttcagc ctggcggatc tctgagactg 60
agctgtaccg ccagcggctt cagcctgacc gactactact acatgacctg ggtccgacag 120
gcccctggca aaggacttga gtgggtcgga ttcatcgacc ccgacgacga tccttactac 180
gccacatggg ccaagggcag attcaccatc agccgggaca acagcaagaa caccctgtac 240
ctgcagatga acagcctgag agccgaggac accgccgtgt actattgtgc cggcggagat 300
cacaatagcg gctggggcct tgatatttgg ggccagggaa cactggtcac cgtgtctagt 360
ggtggaggtg gctccggtgg cggtggcagc ggcggtggcg gctctgagat cgtgatgaca 420
cagagcccca gcacactgtc tgccagcgtg ggagacagag tgatcatcac atgccaggcc 480
agcgagatca tccacagctg gctggcttgg tatcagcaga agcctggcaa ggcccctaag 540
ctgctgatct acctggcctc tacactggcc agcggagtgc ctagcagatt ttctggctct 600
ggatctggcg ccgagttcac cctgaccatc agtagcctgc agcctgacga cttcgccacc 660
tactactgcc agaacgtgta cctggccagc accaacggcg ccaattttgg ccagggcacc 720
aagctgacag tgctgggagg cggagggggc tctcaggttc agctggttca gtctggcgcc 780
gaagtgaaga aacctggcgc ctctgtgaag gtgtcctgca aggccagcgg ctacaccttt 840
accggctact acatgcactg ggtccgacag gctccaggac agggacttga atggatgggc 900
tggatcaacc ccaatagcgg cggcaccaat tacgcccaga aattccaggg cagagtgacc 960
atgaccagag acaccagcat cagcaccgcc tacatggaac tgagccggct gagatccgat 1020
gacaccgccg tgtactactg cgccagatct cccaatcctt actactacga cagcagcggg 1080
tactactacc caggcgcctt cgatatttgg ggccagggca caatggtcac cgtgtctagt 1140
ggtggaggtg gctccggtgg cggtggcagc ggcggtggcg gctctagcta cgtgctgaca 1200
cagcctccat ccgtgtctgt ggctccagga cagaccgcca gaatcacatg cggcggcaac 1260
aacatcggca gcaagagcgt gcactggtat cagcagaagc ctggacaggc tcctgtgctg 1320
gtggtgtacg acgacagcga tagacctagc ggcatccccg agagattcag cggcagcaat 1380
tccggcaata ccgccacact gaccatcagc agagtggaag ctggcgacga ggccgactac 1440
tactgccaag tgtgggacag cagcagcgac cactgggttt tcggcggagg cacaaagctg 1500
acagtgctg 1509
<210> 11
<211> 527
<212> PRT
<213> Artificial
<220>
<223> CD5-sp-VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 11
Met Pro Met Gly Ser Leu Gln Pro Leu Ala Thr Leu Tyr Leu Leu Gly
1 5 10 15
Met Leu Val Ala Ser Cys Leu Gly Glu Val Gln Leu Val Glu Ser Gly
20 25 30
Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Thr Ala
35 40 45
Ser Gly Phe Ser Leu Thr Asp Tyr Tyr Tyr Met Thr Trp Val Arg Gln
50 55 60
Ala Pro Gly Lys Gly Leu Glu Trp Val Gly Phe Ile Asp Pro Asp Asp
65 70 75 80
Asp Pro Tyr Tyr Ala Thr Trp Ala Lys Gly Arg Phe Thr Ile Ser Arg
85 90 95
Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala
100 105 110
Glu Asp Thr Ala Val Tyr Tyr Cys Ala Gly Gly Asp His Asn Ser Gly
115 120 125
Trp Gly Leu Asp Ile Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
130 135 140
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Glu
145 150 155 160
Ile Val Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly Asp
165 170 175
Arg Val Ile Ile Thr Cys Gln Ala Ser Glu Ile Ile His Ser Trp Leu
180 185 190
Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
195 200 205
Leu Ala Ser Thr Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
210 215 220
Gly Ser Gly Ala Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Asp
225 230 235 240
Asp Phe Ala Thr Tyr Tyr Cys Gln Asn Val Tyr Leu Ala Ser Thr Asn
245 250 255
Gly Ala Asn Phe Gly Gln Gly Thr Lys Leu Thr Val Leu Gly Gly Gly
260 265 270
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys
275 280 285
Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe
290 295 300
Thr Gly Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu
305 310 315 320
Glu Trp Met Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala
325 330 335
Gln Lys Phe Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser
340 345 350
Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val
355 360 365
Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly
370 375 380
Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val
385 390 395 400
Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
405 410 415
Gly Gly Ser Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala
420 425 430
Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser
435 440 445
Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu
450 455 460
Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe
465 470 475 480
Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val
485 490 495
Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser
500 505 510
Ser Asp His Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
515 520 525
<210> 12
<211> 1581
<212> DNA
<213> Artificial
<220>
<223> CD5-sp-VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 12
atgccaatgg ggtccctaca acccctggca acactatatc tgctaggtat gctcgtggcc 60
tcctgtttag gagaggtgca gctggttgaa tctggcggag gactggttca gcctggcgga 120
tctctgagac tgagctgtac cgccagcggc ttcagcctga ccgactacta ctacatgacc 180
tgggtccgac aggcccctgg caaaggactt gagtgggtcg gattcatcga ccccgacgac 240
gatccttact acgccacatg ggccaagggc agattcacca tcagccggga caacagcaag 300
aacaccctgt acctgcagat gaacagcctg agagccgagg acaccgccgt gtactattgt 360
gccggcggag atcacaatag cggctggggc cttgatattt ggggccaggg aacactggtc 420
accgtgtcta gtggtggagg tggctccggt ggcggtggca gcggcggtgg cggctctgag 480
atcgtgatga cacagagccc cagcacactg tctgccagcg tgggagacag agtgatcatc 540
acatgccagg ccagcgagat catccacagc tggctggctt ggtatcagca gaagcctggc 600
aaggccccta agctgctgat ctacctggcc tctacactgg ccagcggagt gcctagcaga 660
ttttctggct ctggatctgg cgccgagttc accctgacca tcagtagcct gcagcctgac 720
gacttcgcca cctactactg ccagaacgtg tacctggcca gcaccaacgg cgccaatttt 780
ggccagggca ccaagctgac agtgctggga ggcggagggg gctctcaggt tcagctggtt 840
cagtctggcg ccgaagtgaa gaaacctggc gcctctgtga aggtgtcctg caaggccagc 900
ggctacacct ttaccggcta ctacatgcac tgggtccgac aggctccagg acagggactt 960
gaatggatgg gctggatcaa ccccaatagc ggcggcacca attacgccca gaaattccag 1020
ggcagagtga ccatgaccag agacaccagc atcagcaccg cctacatgga actgagccgg 1080
ctgagatccg atgacaccgc cgtgtactac tgcgccagat ctcccaatcc ttactactac 1140
gacagcagcg ggtactacta cccaggcgcc ttcgatattt ggggccaggg cacaatggtc 1200
accgtgtcta gtggtggagg tggctccggt ggcggtggca gcggcggtgg cggctctagc 1260
tacgtgctga cacagcctcc atccgtgtct gtggctccag gacagaccgc cagaatcaca 1320
tgcggcggca acaacatcgg cagcaagagc gtgcactggt atcagcagaa gcctggacag 1380
gctcctgtgc tggtggtgta cgacgacagc gatagaccta gcggcatccc cgagagattc 1440
agcggcagca attccggcaa taccgccaca ctgaccatca gcagagtgga agctggcgac 1500
gaggccgact actactgcca agtgtgggac agcagcagcg accactgggt tttcggcgga 1560
ggcacaaagc tgacagtgct g 1581
<210> 13
<211> 493
<212> PRT
<213> Artificial
<220>
<223> VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2
<400> 13
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Gly Gly Gly
100 105 110
Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly
115 120 125
Gly Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Ser Leu Thr Asp
130 135 140
Tyr Tyr Tyr Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu
145 150 155 160
Trp Val Gly Phe Ile Asp Pro Asp Asp Asp Pro Tyr Tyr Ala Thr Trp
165 170 175
Ala Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu
180 185 190
Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr
195 200 205
Cys Ala Gly Gly Asp His Asn Ser Gly Trp Gly Leu Asp Ile Trp Gly
210 215 220
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly
225 230 235 240
Gly Gly Ser Gly Gly Gly Gly Ser Glu Ile Val Met Thr Gln Ser Pro
245 250 255
Ser Thr Leu Ser Ala Ser Val Gly Asp Arg Val Ile Ile Thr Cys Gln
260 265 270
Ala Ser Glu Ile Ile His Ser Trp Leu Ala Trp Tyr Gln Gln Lys Pro
275 280 285
Gly Lys Ala Pro Lys Leu Leu Ile Tyr Leu Ala Ser Thr Leu Ala Ser
290 295 300
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr
305 310 315 320
Leu Thr Ile Ser Ser Leu Gln Pro Asp Asp Phe Ala Thr Tyr Tyr Cys
325 330 335
Gln Asn Val Tyr Leu Ala Ser Thr Asn Gly Ala Asn Phe Gly Gln Gly
340 345 350
Thr Lys Leu Thr Val Leu Gly Gly Gly Gly Gly Ser Gln Val Gln Leu
355 360 365
Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val
370 375 380
Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp
385 390 395 400
Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn
405 410 415
Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val
420 425 430
Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser
435 440 445
Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro
450 455 460
Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe
465 470 475 480
Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
485 490
<210> 14
<211> 1479
<212> DNA
<213> Artificial
<220>
<223> VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2
<400> 14
agctacgtgc tgacacagcc tccatccgtg tctgtggctc caggacagac cgccagaatc 60
acatgcggcg gcaacaacat cggcagcaag agcgtgcact ggtatcagca gaagcctgga 120
caggctcctg tgctggtggt gtacgacgac agcgatagac ctagcggcat ccccgagaga 180
ttcagcggca gcaattccgg caataccgcc acactgacca tcagcagagt ggaagctggc 240
gacgaggccg actactactg ccaagtgtgg gacagcagca gcgaccactg ggttttcggc 300
ggaggcacaa agctgacagt gctgggaggc ggaggatctg aggtgcagct ggttgaatct 360
ggcggaggac tggttcagcc tggcggatct ctgagactga gctgtaccgc cagcggcttc 420
agcctgaccg actactacta catgacctgg gtccgacagg cccctggcaa aggacttgag 480
tgggtcggat tcatcgaccc cgacgacgat ccttactacg ccacatgggc caagggcaga 540
ttcaccatca gccgggacaa cagcaagaac accctgtacc tgcagatgaa cagcctgaga 600
gccgaggaca ccgccgtgta ctattgtgcc ggcggagatc acaatagcgg ctggggcctt 660
gatatttggg gccagggaac actggtcacc gtgtctagtg gtggaggtgg ctccggtggc 720
ggtggcagcg gcggtggcgg ctctgagatc gtgatgacac agagccccag cacactgtct 780
gccagcgtgg gagacagagt gatcatcaca tgccaggcca gcgagatcat ccacagctgg 840
ctggcttggt atcagcagaa gcctggcaag gcccctaagc tgctgatcta cctggcctct 900
acactggcca gcggagtgcc tagcagattt tctggctctg gatctggcgc cgagttcacc 960
ctgaccatca gtagcctgca gcctgacgac ttcgccacct actactgcca gaacgtgtac 1020
ctggccagca ccaacggcgc caattttggc cagggcacca agctgacagt gctgggaggc 1080
ggagggggct ctcaggttca gctggttcag tctggcgccg aagtgaagaa acctggcgcc 1140
tctgtgaagg tgtcctgcaa ggccagcggc tacaccttta ccggctacta catgcactgg 1200
gtccgacagg ctccaggaca gggacttgaa tggatgggct ggatcaaccc caatagcggc 1260
ggcaccaatt acgcccagaa attccagggc agagtgacca tgaccagaga caccagcatc 1320
agcaccgcct acatggaact gagccggctg agatccgatg acaccgccgt gtactactgc 1380
gccagatctc ccaatcctta ctactacgac agcagcgggt actactaccc aggcgccttc 1440
gatatttggg gccagggcac aatggtcacc gtgtctagt 1479
<210> 15
<211> 517
<212> PRT
<213> Artificial
<220>
<223> CD5-sp-VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2
<400> 15
Met Pro Met Gly Ser Leu Gln Pro Leu Ala Thr Leu Tyr Leu Leu Gly
1 5 10 15
Met Leu Val Ala Ser Cys Leu Gly Ser Tyr Val Leu Thr Gln Pro Pro
20 25 30
Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
35 40 45
Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly
50 55 60
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly
65 70 75 80
Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu
85 90 95
Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
100 105 110
Val Trp Asp Ser Ser Ser Asp His Trp Val Phe Gly Gly Gly Thr Lys
115 120 125
Leu Thr Val Leu Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser
130 135 140
Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Thr
145 150 155 160
Ala Ser Gly Phe Ser Leu Thr Asp Tyr Tyr Tyr Met Thr Trp Val Arg
165 170 175
Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Gly Phe Ile Asp Pro Asp
180 185 190
Asp Asp Pro Tyr Tyr Ala Thr Trp Ala Lys Gly Arg Phe Thr Ile Ser
195 200 205
Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg
210 215 220
Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Gly Gly Asp His Asn Ser
225 230 235 240
Gly Trp Gly Leu Asp Ile Trp Gly Gln Gly Thr Leu Val Thr Val Ser
245 250 255
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
260 265 270
Glu Ile Val Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
275 280 285
Asp Arg Val Ile Ile Thr Cys Gln Ala Ser Glu Ile Ile His Ser Trp
290 295 300
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
305 310 315 320
Tyr Leu Ala Ser Thr Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly
325 330 335
Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
340 345 350
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Asn Val Tyr Leu Ala Ser Thr
355 360 365
Asn Gly Ala Asn Phe Gly Gln Gly Thr Lys Leu Thr Val Leu Gly Gly
370 375 380
Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys
385 390 395 400
Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr
405 410 415
Phe Thr Gly Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly
420 425 430
Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr
435 440 445
Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile
450 455 460
Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala
465 470 475 480
Val Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser
485 490 495
Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met
500 505 510
Val Thr Val Ser Ser
515
<210> 16
<211> 1551
<212> DNA
<213> Artificial
<220>
<223> CD5-sp-VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2
<400> 16
atgccaatgg ggtccctaca acccctggca acactatatc tgctaggtat gctcgtggcc 60
tcctgtttag gaagctacgt gctgacacag cctccatccg tgtctgtggc tccaggacag 120
accgccagaa tcacatgcgg cggcaacaac atcggcagca agagcgtgca ctggtatcag 180
cagaagcctg gacaggctcc tgtgctggtg gtgtacgacg acagcgatag acctagcggc 240
atccccgaga gattcagcgg cagcaattcc ggcaataccg ccacactgac catcagcaga 300
gtggaagctg gcgacgaggc cgactactac tgccaagtgt gggacagcag cagcgaccac 360
tgggttttcg gcggaggcac aaagctgaca gtgctgggag gcggaggatc tgaggtgcag 420
ctggttgaat ctggcggagg actggttcag cctggcggat ctctgagact gagctgtacc 480
gccagcggct tcagcctgac cgactactac tacatgacct gggtccgaca ggcccctggc 540
aaaggacttg agtgggtcgg attcatcgac cccgacgacg atccttacta cgccacatgg 600
gccaagggca gattcaccat cagccgggac aacagcaaga acaccctgta cctgcagatg 660
aacagcctga gagccgagga caccgccgtg tactattgtg ccggcggaga tcacaatagc 720
ggctggggcc ttgatatttg gggccaggga acactggtca ccgtgtctag tggtggaggt 780
ggctccggtg gcggtggcag cggcggtggc ggctctgaga tcgtgatgac acagagcccc 840
agcacactgt ctgccagcgt gggagacaga gtgatcatca catgccaggc cagcgagatc 900
atccacagct ggctggcttg gtatcagcag aagcctggca aggcccctaa gctgctgatc 960
tacctggcct ctacactggc cagcggagtg cctagcagat tttctggctc tggatctggc 1020
gccgagttca ccctgaccat cagtagcctg cagcctgacg acttcgccac ctactactgc 1080
cagaacgtgt acctggccag caccaacggc gccaattttg gccagggcac caagctgaca 1140
gtgctgggag gcggaggggg ctctcaggtt cagctggttc agtctggcgc cgaagtgaag 1200
aaacctggcg cctctgtgaa ggtgtcctgc aaggccagcg gctacacctt taccggctac 1260
tacatgcact gggtccgaca ggctccagga cagggacttg aatggatggg ctggatcaac 1320
cccaatagcg gcggcaccaa ttacgcccag aaattccagg gcagagtgac catgaccaga 1380
gacaccagca tcagcaccgc ctacatggaa ctgagccggc tgagatccga tgacaccgcc 1440
gtgtactact gcgccagatc tcccaatcct tactactacg acagcagcgg gtactactac 1500
ccaggcgcct tcgatatttg gggccagggc acaatggtca ccgtgtctag t 1551
<210> 17
<211> 493
<212> PRT
<213> Artificial
<220>
<223> VL抗VEGF-A-G4S -VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S -VH抗VEGF-A
<400> 17
Glu Ile Val Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Ile Ile Thr Cys Gln Ala Ser Glu Ile Ile His Ser Trp
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Leu Ala Ser Thr Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Ala Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Asn Val Tyr Leu Ala Ser Thr
85 90 95
Asn Gly Ala Asn Phe Gly Gln Gly Thr Lys Leu Thr Val Leu Gly Gly
100 105 110
Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys
115 120 125
Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr
130 135 140
Phe Thr Gly Tyr Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly
145 150 155 160
Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr
165 170 175
Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile
180 185 190
Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala
195 200 205
Val Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser
210 215 220
Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met
225 230 235 240
Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly
245 250 255
Gly Gly Gly Ser Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val
260 265 270
Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly
275 280 285
Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val
290 295 300
Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg
305 310 315 320
Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg
325 330 335
Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser
340 345 350
Ser Ser Asp His Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
355 360 365
Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu
370 375 380
Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe
385 390 395 400
Ser Leu Thr Asp Tyr Tyr Tyr Met Thr Trp Val Arg Gln Ala Pro Gly
405 410 415
Lys Gly Leu Glu Trp Val Gly Phe Ile Asp Pro Asp Asp Asp Pro Tyr
420 425 430
Tyr Ala Thr Trp Ala Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser
435 440 445
Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr
450 455 460
Ala Val Tyr Tyr Cys Ala Gly Gly Asp His Asn Ser Gly Trp Gly Leu
465 470 475 480
Asp Ile Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
485 490
<210> 18
<211> 1479
<212> DNA
<213> Artificial
<220>
<223> VL抗VEGF-A-G4S -VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S -VH抗VEGF-A
<400> 18
gagatcgtga tgacacagag ccccagcaca ctgtctgcca gcgtgggaga cagagtgatc 60
atcacatgcc aggccagcga gatcatccac agctggctgg cttggtatca gcagaagcct 120
ggcaaggccc ctaagctgct gatctacctg gcctctacac tggccagcgg agtgcctagc 180
agattttctg gctctggatc tggcgccgag ttcaccctga ccatcagtag cctgcagcct 240
gacgacttcg ccacctacta ctgccagaac gtgtacctgg ccagcaccaa cggcgccaat 300
tttggccagg gcaccaagct gacagtgctg ggaggcggag ggggctctca ggttcagctg 360
gttcagtctg gcgccgaagt gaagaaacct ggcgcctctg tgaaggtgtc ctgcaaggcc 420
agcggctaca cctttaccgg ctactacatg cactgggtcc gacaggctcc aggacaggga 480
cttgaatgga tgggctggat caaccccaat agcggcggca ccaattacgc ccagaaattc 540
cagggcagag tgaccatgac cagagacacc agcatcagca ccgcctacat ggaactgagc 600
cggctgagat ccgatgacac cgccgtgtac tactgcgcca gatctcccaa tccttactac 660
tacgacagca gcgggtacta ctacccaggc gccttcgata tttggggcca gggcacaatg 720
gtcaccgtgt ctagtggtgg aggtggctcc ggtggcggtg gcagcggcgg tggcggctct 780
agctacgtgc tgacacagcc tccatccgtg tctgtggctc caggacagac cgccagaatc 840
acatgcggcg gcaacaacat cggcagcaag agcgtgcact ggtatcagca gaagcctgga 900
caggctcctg tgctggtggt gtacgacgac agcgatagac ctagcggcat ccccgagaga 960
ttcagcggca gcaattccgg caataccgcc acactgacca tcagcagagt ggaagctggc 1020
gacgaggccg actactactg ccaagtgtgg gacagcagca gcgaccactg ggttttcggc 1080
ggaggcacaa agctgacagt gctgggcgga gggggctctg aggtgcagct ggttgaatct 1140
ggcggaggac tggttcagcc tggcggatct ctgagactga gctgtaccgc cagcggcttc 1200
agcctgaccg actactacta catgacctgg gtccgacagg cccctggcaa aggacttgag 1260
tgggtcggat tcatcgaccc cgacgacgat ccttactacg ccacatgggc caagggcaga 1320
ttcaccatca gccgggacaa cagcaagaac accctgtacc tgcagatgaa cagcctgaga 1380
gccgaggaca ccgccgtgta ctattgtgcc ggcggagatc acaatagcgg ctggggcctt 1440
gatatttggg gccagggaac actggtcacc gtgtctagt 1479
<210> 19
<211> 517
<212> PRT
<213> Artificial
<220>
<223> CD5-sp-VL抗VEGF-A-G4S -VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S
-VH抗VEGF-A
<400> 19
Met Pro Met Gly Ser Leu Gln Pro Leu Ala Thr Leu Tyr Leu Leu Gly
1 5 10 15
Met Leu Val Ala Ser Cys Leu Gly Glu Ile Val Met Thr Gln Ser Pro
20 25 30
Ser Thr Leu Ser Ala Ser Val Gly Asp Arg Val Ile Ile Thr Cys Gln
35 40 45
Ala Ser Glu Ile Ile His Ser Trp Leu Ala Trp Tyr Gln Gln Lys Pro
50 55 60
Gly Lys Ala Pro Lys Leu Leu Ile Tyr Leu Ala Ser Thr Leu Ala Ser
65 70 75 80
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Ala Glu Phe Thr
85 90 95
Leu Thr Ile Ser Ser Leu Gln Pro Asp Asp Phe Ala Thr Tyr Tyr Cys
100 105 110
Gln Asn Val Tyr Leu Ala Ser Thr Asn Gly Ala Asn Phe Gly Gln Gly
115 120 125
Thr Lys Leu Thr Val Leu Gly Gly Gly Gly Gly Ser Gln Val Gln Leu
130 135 140
Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val
145 150 155 160
Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp
165 170 175
Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn
180 185 190
Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val
195 200 205
Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser
210 215 220
Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro
225 230 235 240
Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe
245 250 255
Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly
260 265 270
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ser Tyr Val Leu
275 280 285
Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile
290 295 300
Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln
305 310 315 320
Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp
325 330 335
Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn
340 345 350
Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp
355 360 365
Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His Trp Val Phe Gly
370 375 380
Gly Gly Thr Lys Leu Thr Val Leu Gly Gly Gly Gly Ser Glu Val Gln
385 390 395 400
Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg
405 410 415
Leu Ser Cys Thr Ala Ser Gly Phe Ser Leu Thr Asp Tyr Tyr Tyr Met
420 425 430
Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Gly Phe
435 440 445
Ile Asp Pro Asp Asp Asp Pro Tyr Tyr Ala Thr Trp Ala Lys Gly Arg
450 455 460
Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln Met
465 470 475 480
Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Gly Gly
485 490 495
Asp His Asn Ser Gly Trp Gly Leu Asp Ile Trp Gly Gln Gly Thr Leu
500 505 510
Val Thr Val Ser Ser
515
<210> 20
<211> 1551
<212> DNA
<213> Artificial
<220>
<223> CD5-sp-VL抗VEGF-A-G4S -VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S
-VH抗VEGF-A
<400> 20
atgccaatgg ggtccctaca acccctggca acactatatc tgctaggtat gctcgtggcc 60
tcctgtttag gagagatcgt gatgacacag agccccagca cactgtctgc cagcgtggga 120
gacagagtga tcatcacatg ccaggccagc gagatcatcc acagctggct ggcttggtat 180
cagcagaagc ctggcaaggc ccctaagctg ctgatctacc tggcctctac actggccagc 240
ggagtgccta gcagattttc tggctctgga tctggcgccg agttcaccct gaccatcagt 300
agcctgcagc ctgacgactt cgccacctac tactgccaga acgtgtacct ggccagcacc 360
aacggcgcca attttggcca gggcaccaag ctgacagtgc tgggaggcgg agggggctct 420
caggttcagc tggttcagtc tggcgccgaa gtgaagaaac ctggcgcctc tgtgaaggtg 480
tcctgcaagg ccagcggcta cacctttacc ggctactaca tgcactgggt ccgacaggct 540
ccaggacagg gacttgaatg gatgggctgg atcaacccca atagcggcgg caccaattac 600
gcccagaaat tccagggcag agtgaccatg accagagaca ccagcatcag caccgcctac 660
atggaactga gccggctgag atccgatgac accgccgtgt actactgcgc cagatctccc 720
aatccttact actacgacag cagcgggtac tactacccag gcgccttcga tatttggggc 780
cagggcacaa tggtcaccgt gtctagtggt ggaggtggct ccggtggcgg tggcagcggc 840
ggtggcggct ctagctacgt gctgacacag cctccatccg tgtctgtggc tccaggacag 900
accgccagaa tcacatgcgg cggcaacaac atcggcagca agagcgtgca ctggtatcag 960
cagaagcctg gacaggctcc tgtgctggtg gtgtacgacg acagcgatag acctagcggc 1020
atccccgaga gattcagcgg cagcaattcc ggcaataccg ccacactgac catcagcaga 1080
gtggaagctg gcgacgaggc cgactactac tgccaagtgt gggacagcag cagcgaccac 1140
tgggttttcg gcggaggcac aaagctgaca gtgctgggcg gagggggctc tgaggtgcag 1200
ctggttgaat ctggcggagg actggttcag cctggcggat ctctgagact gagctgtacc 1260
gccagcggct tcagcctgac cgactactac tacatgacct gggtccgaca ggcccctggc 1320
aaaggacttg agtgggtcgg attcatcgac cccgacgacg atccttacta cgccacatgg 1380
gccaagggca gattcaccat cagccgggac aacagcaaga acaccctgta cctgcagatg 1440
aacagcctga gagccgagga caccgccgtg tactattgtg ccggcggaga tcacaatagc 1500
ggctggggcc ttgatatttg gggccaggga acactggtca ccgtgtctag t 1551
<210> 21
<211> 24
<212> PRT
<213> Artificial
<220>
<223> CD5-sp信号肽
<400> 21
Met Pro Met Gly Ser Leu Gln Pro Leu Ala Thr Leu Tyr Leu Leu Gly
1 5 10 15
Met Leu Val Ala Ser Cys Leu Gly
20
<210> 22
<211> 72
<212> DNA
<213> Artificial
<220>
<223> CD5-sp信号肽
<400> 22
atgccaatgg ggtccctaca acccctggca acactatatc tgctaggtat gctcgtggcc 60
tcctgtttag ga 72
<210> 23
<211> 120
<212> PRT
<213> Artificial
<220>
<223> VH抗VEGF-A（G6-23）
<400> 23
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 24
<211> 360
<212> DNA
<213> Artificial
<220>
<223> VH抗VEGF-A（G6-23）
<400> 24
gaggtgcagc tggtggagag cggaggagga ctggtgcagc caggaggctc cctgcggctg 60
tcttgcgccg ccagcggctt taccatctcc gactactgga ttcactgggt gagacaggca 120
cctggcaagg gactggagtg ggtggcagga atcaccccag caggaggcta cacatactat 180
gccgacagcg tgaagggccg gttcaccatc tccgccgata cctctaagaa cacagcctat 240
ctgcagatga actccctgcg ggccgaggac acagccgtgt actattgcgc cagattcgtg 300
ttcttcctgc catacgccat ggattattgg ggccagggca ccctggtgac agtgagctcc 360
<210> 25
<211> 108
<212> PRT
<213> Artificial
<220>
<223> VL抗VEGF-A（G6-23）
<400> 25
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Lys Gln Gly Tyr Ala Asn Pro Trp
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 26
<211> 324
<212> DNA
<213> Artificial
<220>
<223> VL抗VEGF-A（G6-23）
<400> 26
gatattcaga tgacacagtc cccatctagc ctgtctgcca gcgtgggcga cagggtgacc 60
atcacatgta gagcaagcca ggacgtgagc accgcagtgg catggtacca gcagaagcct 120
ggcaaggccc caaagctgct gatctactcc gcctctttcc tgtattctgg cgtgccaagc 180
aggtttagcg ggtccggatc tggaaccgac ttcaccctga caatctcctc tctgcagcct 240
gaggattttg ccacatacta ttgcaagcag ggctatgcca atccatggac cttcggccag 300
ggcacaaagg tggagatcaa gagg 324
<210> 27
<211> 500
<212> PRT
<213> Artificial
<220>
<223> VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2- (G4S)3-VL抗ANG-2
<400> 27
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
130 135 140
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
145 150 155 160
Ser Gln Asp Val Ser Thr Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly
180 185 190
Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu
195 200 205
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Lys
210 215 220
Gln Gly Tyr Ala Asn Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu
225 230 235 240
Ile Lys Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly
245 250 255
Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala
260 265 270
Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp Val Arg Gln Ala
275 280 285
Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser Gly
290 295 300
Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr Arg
305 310 315 320
Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg Ser
325 330 335
Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr Tyr
340 345 350
Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp Gly
355 360 365
Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly
370 375 380
Gly Gly Ser Gly Gly Gly Gly Ser Ser Tyr Val Leu Thr Gln Pro Pro
385 390 395 400
Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
405 410 415
Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly
420 425 430
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly
435 440 445
Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu
450 455 460
Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
465 470 475 480
Val Trp Asp Ser Ser Ser Asp His Trp Val Phe Gly Gly Gly Thr Lys
485 490 495
Leu Thr Val Leu
500
<210> 28
<211> 1500
<212> DNA
<213> Artificial
<220>
<223> VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2- (G4S)3-VL抗ANG-2
<400> 28
gaggtgcagc tggtggagag cggaggagga ctggtgcagc caggaggctc cctgcggctg 60
tcttgcgccg ccagcggctt taccatctcc gactactgga ttcactgggt gagacaggca 120
cctggcaagg gactggagtg ggtggcagga atcaccccag caggaggcta cacatactat 180
gccgacagcg tgaagggccg gttcaccatc tccgccgata cctctaagaa cacagcctat 240
ctgcagatga actccctgcg ggccgaggac acagccgtgt actattgcgc cagattcgtg 300
ttcttcctgc catacgccat ggattattgg ggccagggca ccctggtgac agtgagctcc 360
ggtggaggtg gctccggtgg cggtggcagc ggcggtggcg gctctgatat tcagatgaca 420
cagtccccat ctagcctgtc tgccagcgtg ggcgacaggg tgaccatcac atgtagagca 480
agccaggacg tgagcaccgc agtggcatgg taccagcaga agcctggcaa ggccccaaag 540
ctgctgatct actccgcctc tttcctgtat tctggcgtgc caagcaggtt tagcgggtcc 600
ggatctggaa ccgacttcac cctgacaatc tcctctctgc agcctgagga ttttgccaca 660
tactattgca agcagggcta tgccaatcca tggaccttcg gccagggcac aaaggtggag 720
atcaagaggg gcggaggggg ctctcaggtt cagctggttc agtctggcgc cgaagtgaag 780
aaacctggcg cctctgtgaa ggtgtcctgc aaggccagcg gctacacctt taccggctac 840
tacatgcact gggtccgaca ggctccagga cagggacttg aatggatggg ctggatcaac 900
cccaatagcg gcggcaccaa ttacgcccag aaattccagg gcagagtgac catgaccaga 960
gacaccagca tcagcaccgc ctacatggaa ctgagccggc tgagatccga tgacaccgcc 1020
gtgtactact gcgccagatc tcccaatcct tactactacg acagcagcgg gtactactac 1080
ccaggcgcct tcgatatttg gggccagggc acaatggtca ccgtgtctag tggtggaggt 1140
ggctccggtg gcggtggcag cggcggtggc ggctctagct acgtgctgac acagcctcca 1200
tccgtgtctg tggctccagg acagaccgcc agaatcacat gcggcggcaa caacatcggc 1260
agcaagagcg tgcactggta tcagcagaag cctggacagg ctcctgtgct ggtggtgtac 1320
gacgacagcg atagacctag cggcatcccc gagagattca gcggcagcaa ttccggcaat 1380
accgccacac tgaccatcag cagagtggaa gctggcgacg aggccgacta ctactgccaa 1440
gtgtgggaca gcagcagcga ccactgggtt ttcggcggag gcacaaagct gacagtgctg 1500
<210> 29
<211> 524
<212> PRT
<213> Artificial
<220>
<223> CD5-sp-VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 29
Met Pro Met Gly Ser Leu Gln Pro Leu Ala Thr Leu Tyr Leu Leu Gly
1 5 10 15
Met Leu Val Ala Ser Cys Leu Gly Glu Val Gln Leu Val Glu Ser Gly
20 25 30
Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala
35 40 45
Ser Gly Phe Thr Ile Ser Asp Tyr Trp Ile His Trp Val Arg Gln Ala
50 55 60
Pro Gly Lys Gly Leu Glu Trp Val Ala Gly Ile Thr Pro Ala Gly Gly
65 70 75 80
Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala
85 90 95
Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala
100 105 110
Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Phe Val Phe Phe Leu Pro
115 120 125
Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
130 135 140
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp
145 150 155 160
Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp
165 170 175
Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala Val
180 185 190
Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
195 200 205
Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
210 215 220
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu
225 230 235 240
Asp Phe Ala Thr Tyr Tyr Cys Lys Gln Gly Tyr Ala Asn Pro Trp Thr
245 250 255
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Gly Gly Gly Gly Ser
260 265 270
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
275 280 285
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
290 295 300
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
305 310 315 320
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
325 330 335
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
340 345 350
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
355 360 365
Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr
370 375 380
Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
385 390 395 400
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
405 410 415
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
420 425 430
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
435 440 445
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
450 455 460
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
465 470 475 480
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
485 490 495
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
500 505 510
Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
515 520
<210> 30
<211> 1572
<212> PRT
<213> Artificial
<220>
<223> CD5-sp-VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 30
Ala Thr Gly Cys Cys Ala Ala Thr Gly Gly Gly Gly Thr Cys Cys Cys
1 5 10 15
Thr Ala Cys Ala Ala Cys Cys Cys Cys Thr Gly Gly Cys Ala Ala Cys
20 25 30
Ala Cys Thr Ala Thr Ala Thr Cys Thr Gly Cys Thr Ala Gly Gly Thr
35 40 45
Ala Thr Gly Cys Thr Cys Gly Thr Gly Gly Cys Cys Thr Cys Cys Thr
50 55 60
Gly Thr Thr Thr Ala Gly Gly Ala Gly Ala Gly Gly Thr Gly Cys Ala
65 70 75 80
Gly Cys Thr Gly Gly Thr Gly Gly Ala Gly Ala Gly Cys Gly Gly Ala
85 90 95
Gly Gly Ala Gly Gly Ala Cys Thr Gly Gly Thr Gly Cys Ala Gly Cys
100 105 110
Cys Ala Gly Gly Ala Gly Gly Cys Thr Cys Cys Cys Thr Gly Cys Gly
115 120 125
Gly Cys Thr Gly Thr Cys Thr Thr Gly Cys Gly Cys Cys Gly Cys Cys
130 135 140
Ala Gly Cys Gly Gly Cys Thr Thr Thr Ala Cys Cys Ala Thr Cys Thr
145 150 155 160
Cys Cys Gly Ala Cys Thr Ala Cys Thr Gly Gly Ala Thr Thr Cys Ala
165 170 175
Cys Thr Gly Gly Gly Thr Gly Ala Gly Ala Cys Ala Gly Gly Cys Ala
180 185 190
Cys Cys Thr Gly Gly Cys Ala Ala Gly Gly Gly Ala Cys Thr Gly Gly
195 200 205
Ala Gly Thr Gly Gly Gly Thr Gly Gly Cys Ala Gly Gly Ala Ala Thr
210 215 220
Cys Ala Cys Cys Cys Cys Ala Gly Cys Ala Gly Gly Ala Gly Gly Cys
225 230 235 240
Thr Ala Cys Ala Cys Ala Thr Ala Cys Thr Ala Thr Gly Cys Cys Gly
245 250 255
Ala Cys Ala Gly Cys Gly Thr Gly Ala Ala Gly Gly Gly Cys Cys Gly
260 265 270
Gly Thr Thr Cys Ala Cys Cys Ala Thr Cys Thr Cys Cys Gly Cys Cys
275 280 285
Gly Ala Thr Ala Cys Cys Thr Cys Thr Ala Ala Gly Ala Ala Cys Ala
290 295 300
Cys Ala Gly Cys Cys Thr Ala Thr Cys Thr Gly Cys Ala Gly Ala Thr
305 310 315 320
Gly Ala Ala Cys Thr Cys Cys Cys Thr Gly Cys Gly Gly Gly Cys Cys
325 330 335
Gly Ala Gly Gly Ala Cys Ala Cys Ala Gly Cys Cys Gly Thr Gly Thr
340 345 350
Ala Cys Thr Ala Thr Thr Gly Cys Gly Cys Cys Ala Gly Ala Thr Thr
355 360 365
Cys Gly Thr Gly Thr Thr Cys Thr Thr Cys Cys Thr Gly Cys Cys Ala
370 375 380
Thr Ala Cys Gly Cys Cys Ala Thr Gly Gly Ala Thr Thr Ala Thr Thr
385 390 395 400
Gly Gly Gly Gly Cys Cys Ala Gly Gly Gly Cys Ala Cys Cys Cys Thr
405 410 415
Gly Gly Thr Gly Ala Cys Ala Gly Thr Gly Ala Gly Cys Thr Cys Cys
420 425 430
Gly Gly Thr Gly Gly Ala Gly Gly Thr Gly Gly Cys Thr Cys Cys Gly
435 440 445
Gly Thr Gly Gly Cys Gly Gly Thr Gly Gly Cys Ala Gly Cys Gly Gly
450 455 460
Cys Gly Gly Thr Gly Gly Cys Gly Gly Cys Thr Cys Thr Gly Ala Thr
465 470 475 480
Ala Thr Thr Cys Ala Gly Ala Thr Gly Ala Cys Ala Cys Ala Gly Thr
485 490 495
Cys Cys Cys Cys Ala Thr Cys Thr Ala Gly Cys Cys Thr Gly Thr Cys
500 505 510
Thr Gly Cys Cys Ala Gly Cys Gly Thr Gly Gly Gly Cys Gly Ala Cys
515 520 525
Ala Gly Gly Gly Thr Gly Ala Cys Cys Ala Thr Cys Ala Cys Ala Thr
530 535 540
Gly Thr Ala Gly Ala Gly Cys Ala Ala Gly Cys Cys Ala Gly Gly Ala
545 550 555 560
Cys Gly Thr Gly Ala Gly Cys Ala Cys Cys Gly Cys Ala Gly Thr Gly
565 570 575
Gly Cys Ala Thr Gly Gly Thr Ala Cys Cys Ala Gly Cys Ala Gly Ala
580 585 590
Ala Gly Cys Cys Thr Gly Gly Cys Ala Ala Gly Gly Cys Cys Cys Cys
595 600 605
Ala Ala Ala Gly Cys Thr Gly Cys Thr Gly Ala Thr Cys Thr Ala Cys
610 615 620
Thr Cys Cys Gly Cys Cys Thr Cys Thr Thr Thr Cys Cys Thr Gly Thr
625 630 635 640
Ala Thr Thr Cys Thr Gly Gly Cys Gly Thr Gly Cys Cys Ala Ala Gly
645 650 655
Cys Ala Gly Gly Thr Thr Thr Ala Gly Cys Gly Gly Gly Thr Cys Cys
660 665 670
Gly Gly Ala Thr Cys Thr Gly Gly Ala Ala Cys Cys Gly Ala Cys Thr
675 680 685
Thr Cys Ala Cys Cys Cys Thr Gly Ala Cys Ala Ala Thr Cys Thr Cys
690 695 700
Cys Thr Cys Thr Cys Thr Gly Cys Ala Gly Cys Cys Thr Gly Ala Gly
705 710 715 720
Gly Ala Thr Thr Thr Thr Gly Cys Cys Ala Cys Ala Thr Ala Cys Thr
725 730 735
Ala Thr Thr Gly Cys Ala Ala Gly Cys Ala Gly Gly Gly Cys Thr Ala
740 745 750
Thr Gly Cys Cys Ala Ala Thr Cys Cys Ala Thr Gly Gly Ala Cys Cys
755 760 765
Thr Thr Cys Gly Gly Cys Cys Ala Gly Gly Gly Cys Ala Cys Ala Ala
770 775 780
Ala Gly Gly Thr Gly Gly Ala Gly Ala Thr Cys Ala Ala Gly Ala Gly
785 790 795 800
Gly Gly Gly Cys Gly Gly Ala Gly Gly Gly Gly Gly Cys Thr Cys Thr
805 810 815
Cys Ala Gly Gly Thr Thr Cys Ala Gly Cys Thr Gly Gly Thr Thr Cys
820 825 830
Ala Gly Thr Cys Thr Gly Gly Cys Gly Cys Cys Gly Ala Ala Gly Thr
835 840 845
Gly Ala Ala Gly Ala Ala Ala Cys Cys Thr Gly Gly Cys Gly Cys Cys
850 855 860
Thr Cys Thr Gly Thr Gly Ala Ala Gly Gly Thr Gly Thr Cys Cys Thr
865 870 875 880
Gly Cys Ala Ala Gly Gly Cys Cys Ala Gly Cys Gly Gly Cys Thr Ala
885 890 895
Cys Ala Cys Cys Thr Thr Thr Ala Cys Cys Gly Gly Cys Thr Ala Cys
900 905 910
Thr Ala Cys Ala Thr Gly Cys Ala Cys Thr Gly Gly Gly Thr Cys Cys
915 920 925
Gly Ala Cys Ala Gly Gly Cys Thr Cys Cys Ala Gly Gly Ala Cys Ala
930 935 940
Gly Gly Gly Ala Cys Thr Thr Gly Ala Ala Thr Gly Gly Ala Thr Gly
945 950 955 960
Gly Gly Cys Thr Gly Gly Ala Thr Cys Ala Ala Cys Cys Cys Cys Ala
965 970 975
Ala Thr Ala Gly Cys Gly Gly Cys Gly Gly Cys Ala Cys Cys Ala Ala
980 985 990
Thr Thr Ala Cys Gly Cys Cys Cys Ala Gly Ala Ala Ala Thr Thr Cys
995 1000 1005
Cys Ala Gly Gly Gly Cys Ala Gly Ala Gly Thr Gly Ala Cys Cys
1010 1015 1020
Ala Thr Gly Ala Cys Cys Ala Gly Ala Gly Ala Cys Ala Cys Cys
1025 1030 1035
Ala Gly Cys Ala Thr Cys Ala Gly Cys Ala Cys Cys Gly Cys Cys
1040 1045 1050
Thr Ala Cys Ala Thr Gly Gly Ala Ala Cys Thr Gly Ala Gly Cys
1055 1060 1065
Cys Gly Gly Cys Thr Gly Ala Gly Ala Thr Cys Cys Gly Ala Thr
1070 1075 1080
Gly Ala Cys Ala Cys Cys Gly Cys Cys Gly Thr Gly Thr Ala Cys
1085 1090 1095
Thr Ala Cys Thr Gly Cys Gly Cys Cys Ala Gly Ala Thr Cys Thr
1100 1105 1110
Cys Cys Cys Ala Ala Thr Cys Cys Thr Thr Ala Cys Thr Ala Cys
1115 1120 1125
Thr Ala Cys Gly Ala Cys Ala Gly Cys Ala Gly Cys Gly Gly Gly
1130 1135 1140
Thr Ala Cys Thr Ala Cys Thr Ala Cys Cys Cys Ala Gly Gly Cys
1145 1150 1155
Gly Cys Cys Thr Thr Cys Gly Ala Thr Ala Thr Thr Thr Gly Gly
1160 1165 1170
Gly Gly Cys Cys Ala Gly Gly Gly Cys Ala Cys Ala Ala Thr Gly
1175 1180 1185
Gly Thr Cys Ala Cys Cys Gly Thr Gly Thr Cys Thr Ala Gly Thr
1190 1195 1200
Gly Gly Thr Gly Gly Ala Gly Gly Thr Gly Gly Cys Thr Cys Cys
1205 1210 1215
Gly Gly Thr Gly Gly Cys Gly Gly Thr Gly Gly Cys Ala Gly Cys
1220 1225 1230
Gly Gly Cys Gly Gly Thr Gly Gly Cys Gly Gly Cys Thr Cys Thr
1235 1240 1245
Ala Gly Cys Thr Ala Cys Gly Thr Gly Cys Thr Gly Ala Cys Ala
1250 1255 1260
Cys Ala Gly Cys Cys Thr Cys Cys Ala Thr Cys Cys Gly Thr Gly
1265 1270 1275
Thr Cys Thr Gly Thr Gly Gly Cys Thr Cys Cys Ala Gly Gly Ala
1280 1285 1290
Cys Ala Gly Ala Cys Cys Gly Cys Cys Ala Gly Ala Ala Thr Cys
1295 1300 1305
Ala Cys Ala Thr Gly Cys Gly Gly Cys Gly Gly Cys Ala Ala Cys
1310 1315 1320
Ala Ala Cys Ala Thr Cys Gly Gly Cys Ala Gly Cys Ala Ala Gly
1325 1330 1335
Ala Gly Cys Gly Thr Gly Cys Ala Cys Thr Gly Gly Thr Ala Thr
1340 1345 1350
Cys Ala Gly Cys Ala Gly Ala Ala Gly Cys Cys Thr Gly Gly Ala
1355 1360 1365
Cys Ala Gly Gly Cys Thr Cys Cys Thr Gly Thr Gly Cys Thr Gly
1370 1375 1380
Gly Thr Gly Gly Thr Gly Thr Ala Cys Gly Ala Cys Gly Ala Cys
1385 1390 1395
Ala Gly Cys Gly Ala Thr Ala Gly Ala Cys Cys Thr Ala Gly Cys
1400 1405 1410
Gly Gly Cys Ala Thr Cys Cys Cys Cys Gly Ala Gly Ala Gly Ala
1415 1420 1425
Thr Thr Cys Ala Gly Cys Gly Gly Cys Ala Gly Cys Ala Ala Thr
1430 1435 1440
Thr Cys Cys Gly Gly Cys Ala Ala Thr Ala Cys Cys Gly Cys Cys
1445 1450 1455
Ala Cys Ala Cys Thr Gly Ala Cys Cys Ala Thr Cys Ala Gly Cys
1460 1465 1470
Ala Gly Ala Gly Thr Gly Gly Ala Ala Gly Cys Thr Gly Gly Cys
1475 1480 1485
Gly Ala Cys Gly Ala Gly Gly Cys Cys Gly Ala Cys Thr Ala Cys
1490 1495 1500
Thr Ala Cys Thr Gly Cys Cys Ala Ala Gly Thr Gly Thr Gly Gly
1505 1510 1515
Gly Ala Cys Ala Gly Cys Ala Gly Cys Ala Gly Cys Gly Ala Cys
1520 1525 1530
Cys Ala Cys Thr Gly Gly Gly Thr Thr Thr Thr Cys Gly Gly Cys
1535 1540 1545
Gly Gly Ala Gly Gly Cys Ala Cys Ala Ala Ala Gly Cys Thr Gly
1550 1555 1560
Ala Cys Ala Gly Thr Gly Cys Thr Gly
1565 1570
<210> 31
<211> 120
<212> PRT
<213> Artificial
<220>
<223> VH抗VEGF-A（G6-31）
<400> 31
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser
115 120
<210> 32
<211> 360
<212> DNA
<213> Artificial
<220>
<223> VH抗VEGF-A（G6-31）
<400> 32
gaggtgcagc tggtggagag cggaggagga ctggtgcagc caggaggctc cctgcggctg 60
tcttgcgccg ccagcggctt taccatctcc gactactgga ttcactgggt gagacaggca 120
cctggcaagg gactggagtg ggtggcagga atcaccccag caggaggcta cacatactat 180
gccgacagcg tgaagggccg gttcaccatc tccgccgata cctctaagaa cacagcctat 240
ctgcagatga actccctgcg ggccgaggac acagccgtgt actattgcgc cagattcgtg 300
ttcttcctgc catacgccat ggattattgg ggccagggca ccctggtgac agtgagctcc 360
<210> 33
<211> 108
<212> PRT
<213> Artificial
<220>
<223> VL抗VEGF-A（G6-31）
<400> 33
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Gly Asn Pro Phe
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
100 105
<210> 34
<211> 324
<212> DNA
<213> Artificial
<220>
<223> VL抗VEGF-A（G6-31）
<400> 34
gatattcaga tgacacagtc cccatctagc ctgtctgcca gcgtgggcga cagggtgacc 60
atcacatgta gagcaagcca ggacgtgagc accgcagtgg catggtacca gcagaagcct 120
ggcaaggccc caaagctgct gatctactcc gcctctttcc tgtattctgg cgtgccaagc 180
aggtttagcg ggtccggatc tggaaccgac ttcaccctga caatctcctc tctgcagcct 240
gaggattttg ccacatacta ttgccagcag ggctatggca atccattcac ctttggccag 300
ggcacaaagg tggagatcaa gagg 324
<210> 35
<211> 500
<212> PRT
<213> Artificial
<220>
<223> VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2- (G4S)3-VL抗ANG-2
<400> 35
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
115 120 125
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
130 135 140
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala
145 150 155 160
Ser Gln Asp Val Ser Thr Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly
180 185 190
Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu
195 200 205
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln
210 215 220
Gln Gly Tyr Gly Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Val Glu
225 230 235 240
Ile Lys Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly
245 250 255
Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala
260 265 270
Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp Val Arg Gln Ala
275 280 285
Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser Gly
290 295 300
Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr Arg
305 310 315 320
Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg Ser
325 330 335
Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr Tyr
340 345 350
Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp Gly
355 360 365
Gln Gly Thr Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly
370 375 380
Gly Gly Ser Gly Gly Gly Gly Ser Ser Tyr Val Leu Thr Gln Pro Pro
385 390 395 400
Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
405 410 415
Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly
420 425 430
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly
435 440 445
Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu
450 455 460
Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
465 470 475 480
Val Trp Asp Ser Ser Ser Asp His Trp Val Phe Gly Gly Gly Thr Lys
485 490 495
Leu Thr Val Leu
500
<210> 36
<211> 1500
<212> DNA
<213> Artificial
<220>
<223> VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2- (G4S)3-VL抗ANG-2
<400> 36
gaggtgcagc tggtggagag cggaggagga ctggtgcagc caggaggctc cctgcggctg 60
tcttgcgccg ccagcggctt taccatctcc gactactgga ttcactgggt gagacaggca 120
cctggcaagg gactggagtg ggtggcagga atcaccccag caggaggcta cacatactat 180
gccgacagcg tgaagggccg gttcaccatc tccgccgata cctctaagaa cacagcctat 240
ctgcagatga actccctgcg ggccgaggac acagccgtgt actattgcgc cagattcgtg 300
ttcttcctgc catacgccat ggattattgg ggccagggca ccctggtgac agtgagctcc 360
ggtggaggtg gctccggtgg cggtggcagc ggcggtggcg gctctgatat tcagatgaca 420
cagtccccat ctagcctgtc tgccagcgtg ggcgacaggg tgaccatcac atgtagagca 480
agccaggacg tgagcaccgc agtggcatgg taccagcaga agcctggcaa ggccccaaag 540
ctgctgatct actccgcctc tttcctgtat tctggcgtgc caagcaggtt tagcgggtcc 600
ggatctggaa ccgacttcac cctgacaatc tcctctctgc agcctgagga ttttgccaca 660
tactattgcc agcagggcta tggcaatcca ttcacctttg gccagggcac aaaggtggag 720
atcaagaggg gcggaggggg ctctcaggtt cagctggttc agtctggcgc cgaagtgaag 780
aaacctggcg cctctgtgaa ggtgtcctgc aaggccagcg gctacacctt taccggctac 840
tacatgcact gggtccgaca ggctccagga cagggacttg aatggatggg ctggatcaac 900
cccaatagcg gcggcaccaa ttacgcccag aaattccagg gcagagtgac catgaccaga 960
gacaccagca tcagcaccgc ctacatggaa ctgagccggc tgagatccga tgacaccgcc 1020
gtgtactact gcgccagatc tcccaatcct tactactacg acagcagcgg gtactactac 1080
ccaggcgcct tcgatatttg gggccagggc acaatggtca ccgtgtctag tggtggaggt 1140
ggctccggtg gcggtggcag cggcggtggc ggctctagct acgtgctgac acagcctcca 1200
tccgtgtctg tggctccagg acagaccgcc agaatcacat gcggcggcaa caacatcggc 1260
agcaagagcg tgcactggta tcagcagaag cctggacagg ctcctgtgct ggtggtgtac 1320
gacgacagcg atagacctag cggcatcccc gagagattca gcggcagcaa ttccggcaat 1380
accgccacac tgaccatcag cagagtggaa gctggcgacg aggccgacta ctactgccaa 1440
gtgtgggaca gcagcagcga ccactgggtt ttcggcggag gcacaaagct gacagtgctg 1500
<210> 37
<211> 524
<212> PRT
<213> Artificial
<220>
<223> CD5-sp-VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 37
Met Pro Met Gly Ser Leu Gln Pro Leu Ala Thr Leu Tyr Leu Leu Gly
1 5 10 15
Met Leu Val Ala Ser Cys Leu Gly Glu Val Gln Leu Val Glu Ser Gly
20 25 30
Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala
35 40 45
Ser Gly Phe Thr Ile Ser Asp Tyr Trp Ile His Trp Val Arg Gln Ala
50 55 60
Pro Gly Lys Gly Leu Glu Trp Val Ala Gly Ile Thr Pro Ala Gly Gly
65 70 75 80
Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Ala
85 90 95
Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala
100 105 110
Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Phe Val Phe Phe Leu Pro
115 120 125
Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser
130 135 140
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp
145 150 155 160
Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp
165 170 175
Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala Val
180 185 190
Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
195 200 205
Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
210 215 220
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu
225 230 235 240
Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Gly Asn Pro Phe Thr
245 250 255
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Gly Gly Gly Gly Ser
260 265 270
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
275 280 285
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
290 295 300
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
305 310 315 320
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
325 330 335
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
340 345 350
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
355 360 365
Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr
370 375 380
Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
385 390 395 400
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
405 410 415
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
420 425 430
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
435 440 445
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
450 455 460
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
465 470 475 480
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
485 490 495
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
500 505 510
Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
515 520
<210> 38
<211> 1572
<212> DNA
<213> Artificial
<220>
<223> CD5-sp-VH抗VEGF-A- (G4S)3-VL抗VEGF-A- G4S-VH抗ANG-2-
(G4S)3-VL抗ANG-2
<400> 38
atgccaatgg ggtccctaca acccctggca acactatatc tgctaggtat gctcgtggcc 60
tcctgtttag gagaggtgca gctggtggag agcggaggag gactggtgca gccaggaggc 120
tccctgcggc tgtcttgcgc cgccagcggc tttaccatct ccgactactg gattcactgg 180
gtgagacagg cacctggcaa gggactggag tgggtggcag gaatcacccc agcaggaggc 240
tacacatact atgccgacag cgtgaagggc cggttcacca tctccgccga tacctctaag 300
aacacagcct atctgcagat gaactccctg cgggccgagg acacagccgt gtactattgc 360
gccagattcg tgttcttcct gccatacgcc atggattatt ggggccaggg caccctggtg 420
acagtgagct ccggtggagg tggctccggt ggcggtggca gcggcggtgg cggctctgat 480
attcagatga cacagtcccc atctagcctg tctgccagcg tgggcgacag ggtgaccatc 540
acatgtagag caagccagga cgtgagcacc gcagtggcat ggtaccagca gaagcctggc 600
aaggccccaa agctgctgat ctactccgcc tctttcctgt attctggcgt gccaagcagg 660
tttagcgggt ccggatctgg aaccgacttc accctgacaa tctcctctct gcagcctgag 720
gattttgcca catactattg ccagcagggc tatggcaatc cattcacctt tggccagggc 780
acaaaggtgg agatcaagag gggcggaggg ggctctcagg ttcagctggt tcagtctggc 840
gccgaagtga agaaacctgg cgcctctgtg aaggtgtcct gcaaggccag cggctacacc 900
tttaccggct actacatgca ctgggtccga caggctccag gacagggact tgaatggatg 960
ggctggatca accccaatag cggcggcacc aattacgccc agaaattcca gggcagagtg 1020
accatgacca gagacaccag catcagcacc gcctacatgg aactgagccg gctgagatcc 1080
gatgacaccg ccgtgtacta ctgcgccaga tctcccaatc cttactacta cgacagcagc 1140
gggtactact acccaggcgc cttcgatatt tggggccagg gcacaatggt caccgtgtct 1200
agtggtggag gtggctccgg tggcggtggc agcggcggtg gcggctctag ctacgtgctg 1260
acacagcctc catccgtgtc tgtggctcca ggacagaccg ccagaatcac atgcggcggc 1320
aacaacatcg gcagcaagag cgtgcactgg tatcagcaga agcctggaca ggctcctgtg 1380
ctggtggtgt acgacgacag cgatagacct agcggcatcc ccgagagatt cagcggcagc 1440
aattccggca ataccgccac actgaccatc agcagagtgg aagctggcga cgaggccgac 1500
tactactgcc aagtgtggga cagcagcagc gaccactggg ttttcggcgg aggcacaaag 1560
ctgacagtgc tg 1572
<210> 39
<211> 463
<212> PRT
<213> Artificial
<220>
<223> 抗ANG-2重链
<400> 39
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr
100 105 110
Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
115 120 125
Ser Ala Ser Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
130 135 140
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
145 150 155 160
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
165 170 175
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
180 185 190
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
195 200 205
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
210 215 220
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys Asp Lys Thr His
225 230 235 240
Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val
245 250 255
Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala Ser Arg Thr
260 265 270
Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu
275 280 285
Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
290 295 300
Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser
305 310 315 320
Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
325 330 335
Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu Lys Thr Ile
340 345 350
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Cys Thr Leu Pro
355 360 365
Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Ser Cys Ala
370 375 380
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
385 390 395 400
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
405 410 415
Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val Asp Lys Ser Arg
420 425 430
Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu
435 440 445
His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
450 455 460
<210> 40
<211> 1389
<212> DNA
<213> Artificial
<220>
<223> 抗ANG-2重链
<400> 40
caagtgcagc tggtgcaatc tggagccgag gtgaaaaagc ctggcgcctc tgtgaaggtg 60
tcctgcaagg ccagcggcta taccttcacc ggctactaca tgcactgggt gcggcaggcc 120
cctggccagg gcctggaatg gatgggatgg atcaacccca acagcggcgg caccaactac 180
gcccagaaat ttcagggcag agtgaccatg accagagata ccagcatcag caccgcctat 240
atggaactga gcagactgag atctgatgac accgccgtgt actactgcgc tagatcccct 300
aatccttact actacgacag cagcgggtac tattaccccg gagccttcga catctggggc 360
cagggcacca tggtgacagt gtcttctgcc agcgtggctg ctccaagcgt gttcatcttc 420
ccccccagcg atgagcagct gaagagcggc acagcctctg tggtgtgtct gctgaacaac 480
ttctacccac gcgaggccaa agtgcagtgg aaggtggaca acgccctgca gagcggcaat 540
tctcaggaga gcgtgaccga gcaggattct aaggatagca catacagcct gagctccact 600
ctaacactga gcaaggcaga ttacgagaag cacaaggtgt acgcttgtga agtgacacac 660
cagggcctga gcagccctgt gaccaagtcc tttaaccggg gagagtgcga caagacccac 720
acctgccctc catgtcctgc cccagaagcc gctggaggac ctagcgtgtt tctgttccct 780
cctaagccca aggacaccct gatggccagc cggacccctg aggtgacatg cgtggtggtc 840
gacgtgtccc acgaggaccc cgaggtcaag ttcaactggt acgtggacgg cgttgaggtc 900
cacaatgcca agacaaagcc tagagaggaa cagtacaact ctacatacag ggtggtgtcc 960
gtgctcaccg tgctggccca agactggctg aacggcaagg aatacaagtg caaggtgagt 1020
aacaaggccc tgggcgcccc tatcgagaaa acaattagca aggccaaggg ccaacctaga 1080
gagcctcagg tgtgcaccct gcctccgagc cgggacgagc tgacaaaaaa ccaggtgtct 1140
ctgtcttgtg ccgtgaaggg cttctacccc agcgacatcg ccgtagaatg ggaaagcaac 1200
ggccagcctg agaacaacta caagacaacc cctcccgtgc tggacagcga cggcagcttc 1260
ttcctggtct ccaaactgac cgtggataag agcagatggc agcagggcaa cgtgttcagc 1320
tgcagcgtga tgcatgaagc cctgcacaat gcttacaccc agaaaagcct gagcctgagc 1380
cccggcaag 1389
<210> 41
<211> 453
<212> PRT
<213> Artificial
<220>
<223> 抗VEGF-A重链
<400> 41
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Asp Phe Thr His Tyr
20 25 30
Gly Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Gly Trp Ile Asn Thr Tyr Thr Gly Glu Pro Thr Tyr Ala Ala Asp Phe
50 55 60
Lys Arg Arg Phe Thr Phe Ser Leu Asp Thr Ser Lys Ser Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Lys Tyr Pro Tyr Tyr Tyr Gly Thr Ser His Trp Tyr Phe Asp Val
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val
195 200 205
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys
210 215 220
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala
225 230 235 240
Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
245 250 255
Leu Met Ala Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
260 265 270
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
275 280 285
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
290 295 300
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu Ala Gln Asp Trp Leu
305 310 315 320
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Gly Ala
325 330 335
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
340 345 350
Gln Val Tyr Thr Leu Pro Pro Cys Arg Asp Glu Leu Thr Lys Asn Gln
355 360 365
Val Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
370 375 380
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385 390 395 400
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
405 410 415
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
420 425 430
Val Met His Glu Ala Leu His Asn Ala Tyr Thr Gln Lys Ser Leu Ser
435 440 445
Leu Ser Pro Gly Lys
450
<210> 42
<211> 1359
<212> DNA
<213> Artificial
<220>
<223> 抗VEGF-A重链
<400> 42
gaggtgcagc tggttgagag cggaggaggc ctggtgcagc ccggcggcag cctgagactg 60
agctgcgccg ctagtggcta cgactttaca cactacggca tgaactgggt taggcaggcc 120
cctggcaagg gcctggaatg ggtcggctgg atcaacacct acaccggcga gcctacatac 180
gccgccgact tcaagcggag attcacgttt tctctcgaca ccagcaagag cacagcatat 240
ctgcaaatga atagcctgcg ggccgaggat accgccgtgt actactgcgc caagtaccct 300
tactactacg gcaccagcca ctggtatttc gacgtgtggg gccaaggcac cctggtcaca 360
gtgtccagcg ccagcaccaa gggacctagc gtgttccctc tggctccttc ctccaagagc 420
acaagcggcg gaacagccgc tctgggatgt ctggtgaaag actacttccc cgagcccgtg 480
acagtgtcct ggaacagcgg agccctgact agcggcgtgc atacattccc cgccgtgctt 540
caaagcagcg gcctgtacag cctctcgagc gtggtgaccg ttccaagctc cagcctgggt 600
acacagacct acatctgcaa cgtgaaccac aagccgagca ataccaaggt ggacaaaaaa 660
gtggaaccca agtcttgcga caagacccac acctgccctc catgtcctgc tccagaagcc 720
gctggcggcc ctagcgtctt tctgttccct cctaaaccta aggacacact gatggcctct 780
agaacccctg aggtgacctg tgtggtcgtg gacgtgtccc acgaagatcc cgaagtgaag 840
ttcaactggt acgtggatgg cgtggaagtg cacaatgcca aaaccaagcc tagagaggaa 900
cagtacaaca gcacctacag agtggtatct gtgctgaccg tgctggccca ggactggctg 960
aacggcaaag agtacaagtg caaggtgtct aacaaggccc tgggcgctcc tatcgagaag 1020
accatcagca aggccaaggg ccagcctcgg gaaccccagg tgtacaccct gcctccctgt 1080
agagatgagc tgaccaagaa ccaggtgagc ctgtggtgcc tggtgaaggg cttctacccc 1140
tctgacatcg ccgtggagtg ggagagcaac ggccagcctg agaacaacta caaaaccacc 1200
cctccagtgc tggatagcga cggcagcttc ttcctgtata gcaagctgac agtggataag 1260
agcagatggc agcagggtaa tgtgttcagc tgcagcgtca tgcacgaggc cctgcacaac 1320
gcctacacac agaaaagcct gtctctgtct ccaggcaag 1359
<210> 43
<211> 214
<212> PRT
<213> Artificial
<220>
<223> 抗VEGF-A轻链
<400> 43
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Gln Asp Ile Ser Asn Tyr
20 25 30
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Val Leu Ile
35 40 45
Tyr Phe Thr Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Thr Val Pro Trp
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 44
<211> 642
<212> DNA
<213> Artificial
<220>
<223> 抗VEGF-A轻链
<400> 44
gacatccagc tgacccagag cccctctagc ctctctgcct ctgtgggcga tagagtgacc 60
attacatgca gcgctagcca agacatcagc aactacctga attggtacca gcagaaacct 120
ggcaaggccc ctaaggtgct gatctacttc accagcagcc tgcactctgg agtgcctagc 180
agattcagcg gcagcggctc tggcaccgac ttcaccctga ccatcagcag cctgcagcca 240
gaggactttg ccacctacta ctgccagcag tacagcaccg tgccatggac cttcggccag 300
ggcaccaaag tggaaatcaa aagaacagtg gccgctcctt ccgtgttcat cttccccccc 360
agcgacgagc agctgaagag cggaaccgcc agcgttgtgt gcctgctgaa caacttctac 420
cctcgggaag ccaaggtgca gtggaaggtg gacaacgccc tgcaaagcgg caatagccag 480
gagagcgtca cagagcagga cagcaaggac agcacatata gcctgtcctc tacactgaca 540
ctgtctaagg ccgattacga gaagcacaag gtgtacgcct gtgaagtgac acaccagggc 600
ctgtcctccc ctgtcaccaa gagctttaac cggggagagt gc 642
<210> 45
<211> 213
<212> PRT
<213> Artificial
<220>
<223> 抗ANG-2轻链
<400> 45
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Ser Ser Ala Ser
100 105 110
Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr
115 120 125
Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro
130 135 140
Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val
145 150 155 160
His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser
165 170 175
Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile
180 185 190
Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val
195 200 205
Glu Pro Lys Ser Cys
210
<210> 46
<211> 639
<212> DNA
<213> Artificial
<220>
<223> 抗ANG-2轻链
<400> 46
tcctacgtgc tcacacaacc tcctagcgtg tctgtggccc ctggacagac cgccagaatc 60
acctgcggcg gcaacaacat cggcagcaag tccgtgcatt ggtaccagca gaaacctggc 120
caggccccag tgctggtcgt gtacgacgat agcgatagac ctagcggcat ccccgagcgg 180
ttcagcggat ctaatagcgg caataccgct acactgacaa tcagtagagt ggaagccggc 240
gacgaggccg attattactg ccaggtgtgg gactcttcca gcgaccactg ggtctttggc 300
ggaggaacaa agctgaccgt gctgagcagc gccagcacca agggccctag cgtgttccct 360
ctggcccctt cttctaagtc tacaagcggc ggcacagctg ctctgggctg tctggtgaag 420
gactacttcc cagagcctgt gaccgtgtcc tggaacagcg gcgccctgac cagcggcgtg 480
cacaccttcc ccgccgtgct gcagagctcc ggcctgtaca gcctgagcag cgtggttacc 540
gtgcccagct ctagcctggg aacccagacc tacatctgca acgtgaacca caagcccagc 600
aacaccaagg tggacaagaa agtggaaccc aagagctgc 639
<210> 47
<211> 1400
<212> PRT
<213> Artificial
<220>
<223> 抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 47
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr
100 105 110
Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
115 120 125
Ser Ala Ser Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
130 135 140
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
145 150 155 160
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
165 170 175
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
180 185 190
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
195 200 205
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
210 215 220
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys Asp Lys Thr His
225 230 235 240
Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val
245 250 255
Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala Ser Arg Thr
260 265 270
Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu
275 280 285
Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
290 295 300
Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser
305 310 315 320
Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
325 330 335
Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu Lys Thr Ile
340 345 350
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Cys Thr Leu Pro
355 360 365
Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Ser Cys Ala
370 375 380
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
385 390 395 400
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
405 410 415
Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val Asp Lys Ser Arg
420 425 430
Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu
435 440 445
His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys Ala
450 455 460
Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro
465 470 475 480
Gly Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
485 490 495
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Tyr Asp Phe Thr
500 505 510
His Tyr Gly Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu
515 520 525
Trp Val Gly Trp Ile Asn Thr Tyr Thr Gly Glu Pro Thr Tyr Ala Ala
530 535 540
Asp Phe Lys Arg Arg Phe Thr Phe Ser Leu Asp Thr Ser Lys Ser Thr
545 550 555 560
Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
565 570 575
Tyr Cys Ala Lys Tyr Pro Tyr Tyr Tyr Gly Thr Ser His Trp Tyr Phe
580 585 590
Asp Val Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr
595 600 605
Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser
610 615 620
Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu
625 630 635 640
Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His
645 650 655
Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser
660 665 670
Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys
675 680 685
Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu
690 695 700
Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
705 710 715 720
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
725 730 735
Asp Thr Leu Met Ala Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
740 745 750
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
755 760 765
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
770 775 780
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu Ala Gln Asp
785 790 795 800
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
805 810 815
Gly Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
820 825 830
Glu Pro Gln Val Tyr Thr Leu Pro Pro Cys Arg Asp Glu Leu Thr Lys
835 840 845
Asn Gln Val Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
850 855 860
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
865 870 875 880
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
885 890 895
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
900 905 910
Cys Ser Val Met His Glu Ala Leu His Asn Ala Tyr Thr Gln Lys Ser
915 920 925
Leu Ser Leu Ser Pro Gly Lys Glu Gly Arg Gly Ser Leu Leu Thr Cys
930 935 940
Gly Asp Val Glu Glu Asn Pro Gly Pro Asp Ile Gln Leu Thr Gln Ser
945 950 955 960
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
965 970 975
Ser Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn Trp Tyr Gln Gln Lys
980 985 990
Pro Gly Lys Ala Pro Lys Val Leu Ile Tyr Phe Thr Ser Ser Leu His
995 1000 1005
Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
1010 1015 1020
Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr
1025 1030 1035
Tyr Tyr Cys Gln Gln Tyr Ser Thr Val Pro Trp Thr Phe Gly Gln
1040 1045 1050
Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro Ser Val
1055 1060 1065
Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala
1070 1075 1080
Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
1085 1090 1095
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
1100 1105 1110
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu
1115 1120 1125
Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys
1130 1135 1140
Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val
1145 1150 1155
Thr Lys Ser Phe Asn Arg Gly Glu Cys Gln Cys Thr Asn Tyr Ala
1160 1165 1170
Leu Leu Lys Leu Ala Gly Asp Val Glu Ser Asn Pro Gly Pro Ser
1175 1180 1185
Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1190 1195 1200
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser
1205 1210 1215
Val His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val
1220 1225 1230
Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe
1235 1240 1245
Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg
1250 1255 1260
Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp
1265 1270 1275
Ser Ser Ser Asp His Trp Val Phe Gly Gly Gly Thr Lys Leu Thr
1280 1285 1290
Val Leu Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu
1295 1300 1305
Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly
1310 1315 1320
Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
1325 1330 1335
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
1340 1345 1350
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
1355 1360 1365
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn
1370 1375 1380
His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys
1385 1390 1395
Ser Cys
1400
<210> 48
<211> 4200
<212> DNA
<213> Artificial
<220>
<223> 抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 48
caagtgcagc tggtgcaatc tggagccgag gtgaaaaagc ctggcgcctc tgtgaaggtg 60
tcctgcaagg ccagcggcta taccttcacc ggctactaca tgcactgggt gcggcaggcc 120
cctggccagg gcctggaatg gatgggatgg atcaacccca acagcggcgg caccaactac 180
gcccagaaat ttcagggcag agtgaccatg accagagata ccagcatcag caccgcctat 240
atggaactga gcagactgag atctgatgac accgccgtgt actactgcgc tagatcccct 300
aatccttact actacgacag cagcgggtac tattaccccg gagccttcga catctggggc 360
cagggcacca tggtgacagt gtcttctgcc agcgtggctg ctccaagcgt gttcatcttc 420
ccccccagcg atgagcagct gaagagcggc acagcctctg tggtgtgtct gctgaacaac 480
ttctacccac gcgaggccaa agtgcagtgg aaggtggaca acgccctgca gagcggcaat 540
tctcaggaga gcgtgaccga gcaggattct aaggatagca catacagcct gagctccact 600
ctaacactga gcaaggcaga ttacgagaag cacaaggtgt acgcttgtga agtgacacac 660
cagggcctga gcagccctgt gaccaagtcc tttaaccggg gagagtgcga caagacccac 720
acctgccctc catgtcctgc cccagaagcc gctggaggac ctagcgtgtt tctgttccct 780
cctaagccca aggacaccct gatggccagc cggacccctg aggtgacatg cgtggtggtc 840
gacgtgtccc acgaggaccc cgaggtcaag ttcaactggt acgtggacgg cgttgaggtc 900
cacaatgcca agacaaagcc tagagaggaa cagtacaact ctacatacag ggtggtgtcc 960
gtgctcaccg tgctggccca agactggctg aacggcaagg aatacaagtg caaggtgagt 1020
aacaaggccc tgggcgcccc tatcgagaaa acaattagca aggccaaggg ccaacctaga 1080
gagcctcagg tgtgcaccct gcctccgagc cgggacgagc tgacaaaaaa ccaggtgtct 1140
ctgtcttgtg ccgtgaaggg cttctacccc agcgacatcg ccgtagaatg ggaaagcaac 1200
ggccagcctg agaacaacta caagacaacc cctcccgtgc tggacagcga cggcagcttc 1260
ttcctggtct ccaaactgac cgtggataag agcagatggc agcagggcaa cgtgttcagc 1320
tgcagcgtga tgcatgaagc cctgcacaat gcttacaccc agaaaagcct gagcctgagc 1380
cccggcaagg ccacgaactt ctctctgtta aagcaagcag gagatgttga agaaaacccc 1440
gggcctgagg tgcagctggt tgagagcgga ggaggcctgg tgcagcccgg cggcagcctg 1500
agactgagct gcgccgctag tggctacgac tttacacact acggcatgaa ctgggttagg 1560
caggcccctg gcaagggcct ggaatgggtc ggctggatca acacctacac cggcgagcct 1620
acatacgccg ccgacttcaa gcggagattc acgttttctc tcgacaccag caagagcaca 1680
gcatatctgc aaatgaatag cctgcgggcc gaggataccg ccgtgtacta ctgcgccaag 1740
tacccttact actacggcac cagccactgg tatttcgacg tgtggggcca aggcaccctg 1800
gtcacagtgt ccagcgccag caccaaggga cctagcgtgt tccctctggc tccttcctcc 1860
aagagcacaa gcggcggaac agccgctctg ggatgtctgg tgaaagacta cttccccgag 1920
cccgtgacag tgtcctggaa cagcggagcc ctgactagcg gcgtgcatac attccccgcc 1980
gtgcttcaaa gcagcggcct gtacagcctc tcgagcgtgg tgaccgttcc aagctccagc 2040
ctgggtacac agacctacat ctgcaacgtg aaccacaagc cgagcaatac caaggtggac 2100
aaaaaagtgg aacccaagtc ttgcgacaag acccacacct gccctccatg tcctgctcca 2160
gaagccgctg gcggccctag cgtctttctg ttccctccta aacctaagga cacactgatg 2220
gcctctagaa cccctgaggt gacctgtgtg gtcgtggacg tgtcccacga agatcccgaa 2280
gtgaagttca actggtacgt ggatggcgtg gaagtgcaca atgccaaaac caagcctaga 2340
gaggaacagt acaacagcac ctacagagtg gtatctgtgc tgaccgtgct ggcccaggac 2400
tggctgaacg gcaaagagta caagtgcaag gtgtctaaca aggccctggg cgctcctatc 2460
gagaagacca tcagcaaggc caagggccag cctcgggaac cccaggtgta caccctgcct 2520
ccctgtagag atgagctgac caagaaccag gtgagcctgt ggtgcctggt gaagggcttc 2580
tacccctctg acatcgccgt ggagtgggag agcaacggcc agcctgagaa caactacaaa 2640
accacccctc cagtgctgga tagcgacggc agcttcttcc tgtatagcaa gctgacagtg 2700
gataagagca gatggcagca gggtaatgtg ttcagctgca gcgtcatgca cgaggccctg 2760
cacaacgcct acacacagaa aagcctgtct ctgtctccag gcaaggaggg caggggaagt 2820
cttctaacat gcggggacgt ggaggaaaat cccggcccag acatccagct gacccagagc 2880
ccctctagcc tctctgcctc tgtgggcgat agagtgacca ttacatgcag cgctagccaa 2940
gacatcagca actacctgaa ttggtaccag cagaaacctg gcaaggcccc taaggtgctg 3000
atctacttca ccagcagcct gcactctgga gtgcctagca gattcagcgg cagcggctct 3060
ggcaccgact tcaccctgac catcagcagc ctgcagccag aggactttgc cacctactac 3120
tgccagcagt acagcaccgt gccatggacc ttcggccagg gcaccaaagt ggaaatcaaa 3180
agaacagtgg ccgctccttc cgtgttcatc ttccccccca gcgacgagca gctgaagagc 3240
ggaaccgcca gcgttgtgtg cctgctgaac aacttctacc ctcgggaagc caaggtgcag 3300
tggaaggtgg acaacgccct gcaaagcggc aatagccagg agagcgtcac agagcaggac 3360
agcaaggaca gcacatatag cctgtcctct acactgacac tgtctaaggc cgattacgag 3420
aagcacaagg tgtacgcctg tgaagtgaca caccagggcc tgtcctcccc tgtcaccaag 3480
agctttaacc ggggagagtg ccagtgtact aattatgctc tcttgaaatt ggctggagat 3540
gttgagagca acccaggtcc ctcctacgtg ctcacacaac ctcctagcgt gtctgtggcc 3600
cctggacaga ccgccagaat cacctgcggc ggcaacaaca tcggcagcaa gtccgtgcat 3660
tggtaccagc agaaacctgg ccaggcccca gtgctggtcg tgtacgacga tagcgataga 3720
cctagcggca tccccgagcg gttcagcgga tctaatagcg gcaataccgc tacactgaca 3780
atcagtagag tggaagccgg cgacgaggcc gattattact gccaggtgtg ggactcttcc 3840
agcgaccact gggtctttgg cggaggaaca aagctgaccg tgctgagcag cgccagcacc 3900
aagggcccta gcgtgttccc tctggcccct tcttctaagt ctacaagcgg cggcacagct 3960
gctctgggct gtctggtgaa ggactacttc ccagagcctg tgaccgtgtc ctggaacagc 4020
ggcgccctga ccagcggcgt gcacaccttc cccgccgtgc tgcagagctc cggcctgtac 4080
agcctgagca gcgtggttac cgtgcccagc tctagcctgg gaacccagac ctacatctgc 4140
aacgtgaacc acaagcccag caacaccaag gtggacaaga aagtggaacc caagagctgc 4200
<210> 49
<211> 1409
<212> PRT
<213> Artificial
<220>
<223> HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 49
Tyr Pro Tyr Asp Val Pro Asp Tyr Ala Gln Val Gln Leu Val Gln Ser
1 5 10 15
Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys
20 25 30
Ala Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp Val Arg Gln
35 40 45
Ala Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser
50 55 60
Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr
65 70 75 80
Arg Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg
85 90 95
Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr
100 105 110
Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp
115 120 125
Gly Gln Gly Thr Met Val Thr Val Ser Ser Ala Ser Val Ala Ala Pro
130 135 140
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
145 150 155 160
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
165 170 175
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
180 185 190
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
195 200 205
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
210 215 220
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
225 230 235 240
Asn Arg Gly Glu Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala
245 250 255
Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro
260 265 270
Lys Asp Thr Leu Met Ala Ser Arg Thr Pro Glu Val Thr Cys Val Val
275 280 285
Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val
290 295 300
Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln
305 310 315 320
Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu Ala Gln
325 330 335
Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala
340 345 350
Leu Gly Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro
355 360 365
Arg Glu Pro Gln Val Cys Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr
370 375 380
Lys Asn Gln Val Ser Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro Ser
385 390 395 400
Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr
405 410 415
Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Val
420 425 430
Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe
435 440 445
Ser Cys Ser Val Met His Glu Ala Leu His Asn Ala Tyr Thr Gln Lys
450 455 460
Ser Leu Ser Leu Ser Pro Gly Lys Ala Thr Asn Phe Ser Leu Leu Lys
465 470 475 480
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Glu Val Gln Leu Val
485 490 495
Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser
500 505 510
Cys Ala Ala Ser Gly Tyr Asp Phe Thr His Tyr Gly Met Asn Trp Val
515 520 525
Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Gly Trp Ile Asn Thr
530 535 540
Tyr Thr Gly Glu Pro Thr Tyr Ala Ala Asp Phe Lys Arg Arg Phe Thr
545 550 555 560
Phe Ser Leu Asp Thr Ser Lys Ser Thr Ala Tyr Leu Gln Met Asn Ser
565 570 575
Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Lys Tyr Pro Tyr
580 585 590
Tyr Tyr Gly Thr Ser His Trp Tyr Phe Asp Val Trp Gly Gln Gly Thr
595 600 605
Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro
610 615 620
Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly
625 630 635 640
Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn
645 650 655
Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln
660 665 670
Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser
675 680 685
Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser
690 695 700
Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys Thr
705 710 715 720
His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser
725 730 735
Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala Ser Arg
740 745 750
Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro
755 760 765
Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala
770 775 780
Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val
785 790 795 800
Ser Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys Glu Tyr
805 810 815
Lys Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu Lys Thr
820 825 830
Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu
835 840 845
Pro Pro Cys Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Trp Cys
850 855 860
Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser
865 870 875 880
Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp
885 890 895
Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser
900 905 910
Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala
915 920 925
Leu His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
930 935 940
Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp Val Glu Glu Asn Pro
945 950 955 960
Gly Pro Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser
965 970 975
Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Gln Asp Ile Ser
980 985 990
Asn Tyr Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Val
995 1000 1005
Leu Ile Tyr Phe Thr Ser Ser Leu His Ser Gly Val Pro Ser Arg
1010 1015 1020
Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser
1025 1030 1035
Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr
1040 1045 1050
Ser Thr Val Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile
1055 1060 1065
Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser
1070 1075 1080
Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu
1085 1090 1095
Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp
1100 1105 1110
Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln
1115 1120 1125
Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu
1130 1135 1140
Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val
1145 1150 1155
Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe Asn Arg
1160 1165 1170
Gly Glu Cys Gln Cys Thr Asn Tyr Ala Leu Leu Lys Leu Ala Gly
1175 1180 1185
Asp Val Glu Ser Asn Pro Gly Pro Ser Tyr Val Leu Thr Gln Pro
1190 1195 1200
Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys
1205 1210 1215
Gly Gly Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln
1220 1225 1230
Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp
1235 1240 1245
Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly
1250 1255 1260
Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu
1265 1270 1275
Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His Trp
1280 1285 1290
Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Ser Ser Ala Ser
1295 1300 1305
Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser
1310 1315 1320
Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr
1325 1330 1335
Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr
1340 1345 1350
Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu
1355 1360 1365
Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly
1370 1375 1380
Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr
1385 1390 1395
Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys
1400 1405
<210> 50
<211> 4227
<212> DNA
<213> Artificial
<220>
<223> HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 50
tacccatacg atgttccaga ttacgctcaa gtgcagctgg tgcaatctgg agccgaggtg 60
aaaaagcctg gcgcctctgt gaaggtgtcc tgcaaggcca gcggctatac cttcaccggc 120
tactacatgc actgggtgcg gcaggcccct ggccagggcc tggaatggat gggatggatc 180
aaccccaaca gcggcggcac caactacgcc cagaaatttc agggcagagt gaccatgacc 240
agagatacca gcatcagcac cgcctatatg gaactgagca gactgagatc tgatgacacc 300
gccgtgtact actgcgctag atcccctaat ccttactact acgacagcag cgggtactat 360
taccccggag ccttcgacat ctggggccag ggcaccatgg tgacagtgtc ttctgccagc 420
gtggctgctc caagcgtgtt catcttcccc cccagcgatg agcagctgaa gagcggcaca 480
gcctctgtgg tgtgtctgct gaacaacttc tacccacgcg aggccaaagt gcagtggaag 540
gtggacaacg ccctgcagag cggcaattct caggagagcg tgaccgagca ggattctaag 600
gatagcacat acagcctgag ctccactcta acactgagca aggcagatta cgagaagcac 660
aaggtgtacg cttgtgaagt gacacaccag ggcctgagca gccctgtgac caagtccttt 720
aaccggggag agtgcgacaa gacccacacc tgccctccat gtcctgcccc agaagccgct 780
ggaggaccta gcgtgtttct gttccctcct aagcccaagg acaccctgat ggccagccgg 840
acccctgagg tgacatgcgt ggtggtcgac gtgtcccacg aggaccccga ggtcaagttc 900
aactggtacg tggacggcgt tgaggtccac aatgccaaga caaagcctag agaggaacag 960
tacaactcta catacagggt ggtgtccgtg ctcaccgtgc tggcccaaga ctggctgaac 1020
ggcaaggaat acaagtgcaa ggtgagtaac aaggccctgg gcgcccctat cgagaaaaca 1080
attagcaagg ccaagggcca acctagagag cctcaggtgt gcaccctgcc tccgagccgg 1140
gacgagctga caaaaaacca ggtgtctctg tcttgtgccg tgaagggctt ctaccccagc 1200
gacatcgccg tagaatggga aagcaacggc cagcctgaga acaactacaa gacaacccct 1260
cccgtgctgg acagcgacgg cagcttcttc ctggtctcca aactgaccgt ggataagagc 1320
agatggcagc agggcaacgt gttcagctgc agcgtgatgc atgaagccct gcacaatgct 1380
tacacccaga aaagcctgag cctgagcccc ggcaaggcca cgaacttctc tctgttaaag 1440
caagcaggag atgttgaaga aaaccccggg cctgaggtgc agctggttga gagcggagga 1500
ggcctggtgc agcccggcgg cagcctgaga ctgagctgcg ccgctagtgg ctacgacttt 1560
acacactacg gcatgaactg ggttaggcag gcccctggca agggcctgga atgggtcggc 1620
tggatcaaca cctacaccgg cgagcctaca tacgccgccg acttcaagcg gagattcacg 1680
ttttctctcg acaccagcaa gagcacagca tatctgcaaa tgaatagcct gcgggccgag 1740
gataccgccg tgtactactg cgccaagtac ccttactact acggcaccag ccactggtat 1800
ttcgacgtgt ggggccaagg caccctggtc acagtgtcca gcgccagcac caagggacct 1860
agcgtgttcc ctctggctcc ttcctccaag agcacaagcg gcggaacagc cgctctggga 1920
tgtctggtga aagactactt ccccgagccc gtgacagtgt cctggaacag cggagccctg 1980
actagcggcg tgcatacatt ccccgccgtg cttcaaagca gcggcctgta cagcctctcg 2040
agcgtggtga ccgttccaag ctccagcctg ggtacacaga cctacatctg caacgtgaac 2100
cacaagccga gcaataccaa ggtggacaaa aaagtggaac ccaagtcttg cgacaagacc 2160
cacacctgcc ctccatgtcc tgctccagaa gccgctggcg gccctagcgt ctttctgttc 2220
cctcctaaac ctaaggacac actgatggcc tctagaaccc ctgaggtgac ctgtgtggtc 2280
gtggacgtgt cccacgaaga tcccgaagtg aagttcaact ggtacgtgga tggcgtggaa 2340
gtgcacaatg ccaaaaccaa gcctagagag gaacagtaca acagcaccta cagagtggta 2400
tctgtgctga ccgtgctggc ccaggactgg ctgaacggca aagagtacaa gtgcaaggtg 2460
tctaacaagg ccctgggcgc tcctatcgag aagaccatca gcaaggccaa gggccagcct 2520
cgggaacccc aggtgtacac cctgcctccc tgtagagatg agctgaccaa gaaccaggtg 2580
agcctgtggt gcctggtgaa gggcttctac ccctctgaca tcgccgtgga gtgggagagc 2640
aacggccagc ctgagaacaa ctacaaaacc acccctccag tgctggatag cgacggcagc 2700
ttcttcctgt atagcaagct gacagtggat aagagcagat ggcagcaggg taatgtgttc 2760
agctgcagcg tcatgcacga ggccctgcac aacgcctaca cacagaaaag cctgtctctg 2820
tctccaggca aggagggcag gggaagtctt ctaacatgcg gggacgtgga ggaaaatccc 2880
ggcccagaca tccagctgac ccagagcccc tctagcctct ctgcctctgt gggcgataga 2940
gtgaccatta catgcagcgc tagccaagac atcagcaact acctgaattg gtaccagcag 3000
aaacctggca aggcccctaa ggtgctgatc tacttcacca gcagcctgca ctctggagtg 3060
cctagcagat tcagcggcag cggctctggc accgacttca ccctgaccat cagcagcctg 3120
cagccagagg actttgccac ctactactgc cagcagtaca gcaccgtgcc atggaccttc 3180
ggccagggca ccaaagtgga aatcaaaaga acagtggccg ctccttccgt gttcatcttc 3240
ccccccagcg acgagcagct gaagagcgga accgccagcg ttgtgtgcct gctgaacaac 3300
ttctaccctc gggaagccaa ggtgcagtgg aaggtggaca acgccctgca aagcggcaat 3360
agccaggaga gcgtcacaga gcaggacagc aaggacagca catatagcct gtcctctaca 3420
ctgacactgt ctaaggccga ttacgagaag cacaaggtgt acgcctgtga agtgacacac 3480
cagggcctgt cctcccctgt caccaagagc tttaaccggg gagagtgcca gtgtactaat 3540
tatgctctct tgaaattggc tggagatgtt gagagcaacc caggtccctc ctacgtgctc 3600
acacaacctc ctagcgtgtc tgtggcccct ggacagaccg ccagaatcac ctgcggcggc 3660
aacaacatcg gcagcaagtc cgtgcattgg taccagcaga aacctggcca ggccccagtg 3720
ctggtcgtgt acgacgatag cgatagacct agcggcatcc ccgagcggtt cagcggatct 3780
aatagcggca ataccgctac actgacaatc agtagagtgg aagccggcga cgaggccgat 3840
tattactgcc aggtgtggga ctcttccagc gaccactggg tctttggcgg aggaacaaag 3900
ctgaccgtgc tgagcagcgc cagcaccaag ggccctagcg tgttccctct ggccccttct 3960
tctaagtcta caagcggcgg cacagctgct ctgggctgtc tggtgaagga ctacttccca 4020
gagcctgtga ccgtgtcctg gaacagcggc gccctgacca gcggcgtgca caccttcccc 4080
gccgtgctgc agagctccgg cctgtacagc ctgagcagcg tggttaccgt gcccagctct 4140
agcctgggaa cccagaccta catctgcaac gtgaaccaca agcccagcaa caccaaggtg 4200
gacaagaaag tggaacccaa gagctgc 4227
<210> 51
<211> 450
<212> PRT
<213> Artificial
<220>
<223> 抗VEGF-A重链（G6-23）
<400> 51
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Cys Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu
355 360 365
Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210> 52
<211> 1350
<212> DNA
<213> Artificial
<220>
<223> 抗VEGF-A重链（G6-23）
<400> 52
gaggtgcagc tggtggagag cggaggagga ctggtgcagc caggaggctc cctgcggctg 60
tcttgcgccg ccagcggctt taccatctcc gactactgga ttcactgggt gagacaggca 120
cctggcaagg gactggagtg ggtggcagga atcaccccag caggaggcta cacatactat 180
gccgacagcg tgaagggccg gttcaccatc tccgccgata cctctaagaa cacagcctat 240
ctgcagatga actccctgcg ggccgaggac acagccgtgt actattgcgc cagattcgtg 300
ttcttcctgc catacgccat ggattattgg ggccagggca ccctggtgac agtgagctcc 360
gccagcacca agggaccatc cgtgttccca ctggcacctt ctagcaagtc cacctctgga 420
ggaacagccg ccctgggctg tctggtgaag gattactttc ctgagccagt gaccgtgagc 480
tggaactccg gcgccctgac cagcggagtg cacacattcc cagccgtgct gcagtcctct 540
ggcctgtact ccctgagctc cgtggtgacc gtgccttcta gctccctggg cacccagaca 600
tatatctgca acgtgaatca caagccaagc aatacaaagg tggacaagaa ggtggagccc 660
aagtcctgtg ataagaccca cacatgccct ccttgtcctg ctcctgaagc tgctggtggc 720
ccttccgtgt tcctgtttcc tccaaagcct aaggacaccc tgatggccag cagaacccct 780
gaagtgacct gtgtggtggt ggacgtgtcc cacgaagatc ccgaagtgaa gttcaattgg 840
tacgtggacg gcgtggaagt gcacaacgcc aagaccaagc ctagagagga acagtacaac 900
agcacctaca gagtggtgtc cgtgctgaca gtgctggccc aggattggct gaacggcaaa 960
gagtacaagt gcaaggtgtc caacaaggcc ctgggcgctc ccatcgagaa aaccatctct 1020
aaggccaagg gccagcctcg cgaaccccag gtttacacac ttcctccatg ccgggacgag 1080
ctgaccaaga atcaggtgtc cctgtggtgc ctggtcaagg gcttttaccc cagcgacatt 1140
gccgtggaat gggagagcaa tggccagcct gagaacaact acaagaccac acctcctgtg 1200
ctggacagcg acggctcatt cttcctgtac agcaagctga ccgtggacaa gagcagatgg 1260
cagcagggca acgtgttcag ctgcagcgtg atgcacgagg ccctgcacaa tgcctacaca 1320
cagaagtccc tgtctctgag ccctggcaag 1350
<210> 53
<211> 214
<212> PRT
<213> Artificial
<220>
<223> 抗VEGF-A轻链（G6-23）
<400> 53
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Lys Gln Gly Tyr Ala Asn Pro Trp
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 54
<211> 642
<212> DNA
<213> Artificial
<220>
<223> 抗VEGF-A轻链（G6-23）
<400> 54
gatattcaga tgacacagtc cccatctagc ctgtctgcca gcgtgggcga cagggtgacc 60
atcacatgta gagcaagcca ggacgtgagc accgcagtgg catggtacca gcagaagcct 120
ggcaaggccc caaagctgct gatctactcc gcctctttcc tgtattctgg cgtgccaagc 180
aggtttagcg ggtccggatc tggaaccgac ttcaccctga caatctcctc tctgcagcct 240
gaggattttg ccacatacta ttgcaagcag ggctatgcca atccatggac cttcggccag 300
ggcacaaagg tggagatcaa gaggaccgtg gcagcaccaa gcgtgttcat ctttccaccc 360
tccgacgagc agctgaagtc cggcacagcc tctgtggtgt gcctgctgaa caacttctac 420
cctagagagg ccaaggtgca gtggaaggtg gataacgccc tgcagtccgg caattctcag 480
gagagcgtga ccgagcagga ctccaaggat tctacatata gcctgagctc caccctgaca 540
ctgagcaagg ccgactacga gaagcacaag gtgtatgcct gcgaggtgac ccaccagggc 600
ctgtctagcc ctgtgacaaa gtccttcaat cgcggcgagt gt 642
<210> 55
<211> 1397
<212> PRT
<213> Artificial
<220>
<223> 抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 55
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr
100 105 110
Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
115 120 125
Ser Ala Ser Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
130 135 140
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
145 150 155 160
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
165 170 175
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
180 185 190
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
195 200 205
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
210 215 220
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys Asp Lys Thr His
225 230 235 240
Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val
245 250 255
Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala Ser Arg Thr
260 265 270
Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu
275 280 285
Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
290 295 300
Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser
305 310 315 320
Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
325 330 335
Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu Lys Thr Ile
340 345 350
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Cys Thr Leu Pro
355 360 365
Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Ser Cys Ala
370 375 380
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
385 390 395 400
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
405 410 415
Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val Asp Lys Ser Arg
420 425 430
Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu
435 440 445
His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys Ala
450 455 460
Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro
465 470 475 480
Gly Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
485 490 495
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser
500 505 510
Asp Tyr Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu
515 520 525
Trp Val Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp
530 535 540
Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr
545 550 555 560
Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
565 570 575
Tyr Cys Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp
580 585 590
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro
595 600 605
Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr
610 615 620
Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr
625 630 635 640
Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro
645 650 655
Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr
660 665 670
Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn
675 680 685
His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser
690 695 700
Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala
705 710 715 720
Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu
725 730 735
Met Ala Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
740 745 750
His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu
755 760 765
Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr
770 775 780
Tyr Arg Val Val Ser Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn
785 790 795 800
Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro
805 810 815
Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln
820 825 830
Val Tyr Thr Leu Pro Pro Cys Arg Asp Glu Leu Thr Lys Asn Gln Val
835 840 845
Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
850 855 860
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
865 870 875 880
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr
885 890 895
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
900 905 910
Met His Glu Ala Leu His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu
915 920 925
Ser Pro Gly Lys Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp Val
930 935 940
Glu Glu Asn Pro Gly Pro Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
945 950 955 960
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser
965 970 975
Gln Asp Val Ser Thr Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys
980 985 990
Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val
995 1000 1005
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu
1010 1015 1020
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys
1025 1030 1035
Lys Gln Gly Tyr Ala Asn Pro Trp Thr Phe Gly Gln Gly Thr Lys
1040 1045 1050
Val Glu Ile Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe
1055 1060 1065
Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val
1070 1075 1080
Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp
1085 1090 1095
Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser Val
1100 1105 1110
Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr
1115 1120 1125
Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
1130 1135 1140
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
1145 1150 1155
Phe Asn Arg Gly Glu Cys Gln Cys Thr Asn Tyr Ala Leu Leu Lys
1160 1165 1170
Leu Ala Gly Asp Val Glu Ser Asn Pro Gly Pro Ser Tyr Val Leu
1175 1180 1185
Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg
1190 1195 1200
Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val His Trp
1205 1210 1215
Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr Asp
1220 1225 1230
Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
1235 1240 1245
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala
1250 1255 1260
Gly Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser
1265 1270 1275
Asp His Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Ser
1280 1285 1290
Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser
1295 1300 1305
Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val
1310 1315 1320
Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly
1325 1330 1335
Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser
1340 1345 1350
Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser
1355 1360 1365
Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
1370 1375 1380
Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys
1385 1390 1395
<210> 56
<211> 4191
<212> DNA
<213> Artificial
<220>
<223> 抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 56
caagtgcagc tggtgcaatc tggagccgag gtgaaaaagc ctggcgcctc tgtgaaggtg 60
tcctgcaagg ccagcggcta taccttcacc ggctactaca tgcactgggt gcggcaggcc 120
cctggccagg gcctggaatg gatgggatgg atcaacccca acagcggcgg caccaactac 180
gcccagaaat ttcagggcag agtgaccatg accagagata ccagcatcag caccgcctat 240
atggaactga gcagactgag atctgatgac accgccgtgt actactgcgc tagatcccct 300
aatccttact actacgacag cagcgggtac tattaccccg gagccttcga catctggggc 360
cagggcacca tggtgacagt gtcttctgcc agcgtggctg ctccaagcgt gttcatcttc 420
ccccccagcg atgagcagct gaagagcggc acagcctctg tggtgtgtct gctgaacaac 480
ttctacccac gcgaggccaa agtgcagtgg aaggtggaca acgccctgca gagcggcaat 540
tctcaggaga gcgtgaccga gcaggattct aaggatagca catacagcct gagctccact 600
ctaacactga gcaaggcaga ttacgagaag cacaaggtgt acgcttgtga agtgacacac 660
cagggcctga gcagccctgt gaccaagtcc tttaaccggg gagagtgcga caagacccac 720
acctgccctc catgtcctgc cccagaagcc gctggaggac ctagcgtgtt tctgttccct 780
cctaagccca aggacaccct gatggccagc cggacccctg aggtgacatg cgtggtggtc 840
gacgtgtccc acgaggaccc cgaggtcaag ttcaactggt acgtggacgg cgttgaggtc 900
cacaatgcca agacaaagcc tagagaggaa cagtacaact ctacatacag ggtggtgtcc 960
gtgctcaccg tgctggccca agactggctg aacggcaagg aatacaagtg caaggtgagt 1020
aacaaggccc tgggcgcccc tatcgagaaa acaattagca aggccaaggg ccaacctaga 1080
gagcctcagg tgtgcaccct gcctccgagc cgggacgagc tgacaaaaaa ccaggtgtct 1140
ctgtcttgtg ccgtgaaggg cttctacccc agcgacatcg ccgtagaatg ggaaagcaac 1200
ggccagcctg agaacaacta caagacaacc cctcccgtgc tggacagcga cggcagcttc 1260
ttcctggtct ccaaactgac cgtggataag agcagatggc agcagggcaa cgtgttcagc 1320
tgcagcgtga tgcatgaagc cctgcacaat gcttacaccc agaaaagcct gagcctgagc 1380
cccggcaagg ccacgaactt ctctctgtta aagcaagcag gagatgttga agaaaacccc 1440
gggcctgagg tgcagctggt ggagagcgga ggaggactgg tgcagccagg aggctccctg 1500
cggctgtctt gcgccgccag cggctttacc atctccgact actggattca ctgggtgaga 1560
caggcacctg gcaagggact ggagtgggtg gcaggaatca ccccagcagg aggctacaca 1620
tactatgccg acagcgtgaa gggccggttc accatctccg ccgatacctc taagaacaca 1680
gcctatctgc agatgaactc cctgcgggcc gaggacacag ccgtgtacta ttgcgccaga 1740
ttcgtgttct tcctgccata cgccatggat tattggggcc agggcaccct ggtgacagtg 1800
agctccgcca gcaccaaggg accatccgtg ttcccactgg caccttctag caagtccacc 1860
tctggaggaa cagccgccct gggctgtctg gtgaaggatt actttcctga gccagtgacc 1920
gtgagctgga actccggcgc cctgaccagc ggagtgcaca cattcccagc cgtgctgcag 1980
tcctctggcc tgtactccct gagctccgtg gtgaccgtgc cttctagctc cctgggcacc 2040
cagacatata tctgcaacgt gaatcacaag ccaagcaata caaaggtgga caagaaggtg 2100
gagcccaagt cctgtgataa gacccacaca tgccctcctt gtcctgctcc tgaagctgct 2160
ggtggccctt ccgtgttcct gtttcctcca aagcctaagg acaccctgat ggccagcaga 2220
acccctgaag tgacctgtgt ggtggtggac gtgtcccacg aagatcccga agtgaagttc 2280
aattggtacg tggacggcgt ggaagtgcac aacgccaaga ccaagcctag agaggaacag 2340
tacaacagca cctacagagt ggtgtccgtg ctgacagtgc tggcccagga ttggctgaac 2400
ggcaaagagt acaagtgcaa ggtgtccaac aaggccctgg gcgctcccat cgagaaaacc 2460
atctctaagg ccaagggcca gcctcgcgaa ccccaggttt acacacttcc tccatgccgg 2520
gacgagctga ccaagaatca ggtgtccctg tggtgcctgg tcaagggctt ttaccccagc 2580
gacattgccg tggaatggga gagcaatggc cagcctgaga acaactacaa gaccacacct 2640
cctgtgctgg acagcgacgg ctcattcttc ctgtacagca agctgaccgt ggacaagagc 2700
agatggcagc agggcaacgt gttcagctgc agcgtgatgc acgaggccct gcacaatgcc 2760
tacacacaga agtccctgtc tctgagccct ggcaaggagg gcaggggaag tcttctaaca 2820
tgcggggacg tggaggaaaa tcccggccca gatattcaga tgacacagtc cccatctagc 2880
ctgtctgcca gcgtgggcga cagggtgacc atcacatgta gagcaagcca ggacgtgagc 2940
accgcagtgg catggtacca gcagaagcct ggcaaggccc caaagctgct gatctactcc 3000
gcctctttcc tgtattctgg cgtgccaagc aggtttagcg ggtccggatc tggaaccgac 3060
ttcaccctga caatctcctc tctgcagcct gaggattttg ccacatacta ttgcaagcag 3120
ggctatgcca atccatggac cttcggccag ggcacaaagg tggagatcaa gaggaccgtg 3180
gcagcaccaa gcgtgttcat ctttccaccc tccgacgagc agctgaagtc cggcacagcc 3240
tctgtggtgt gcctgctgaa caacttctac cctagagagg ccaaggtgca gtggaaggtg 3300
gataacgccc tgcagtccgg caattctcag gagagcgtga ccgagcagga ctccaaggat 3360
tctacatata gcctgagctc caccctgaca ctgagcaagg ccgactacga gaagcacaag 3420
gtgtatgcct gcgaggtgac ccaccagggc ctgtctagcc ctgtgacaaa gtccttcaat 3480
cgcggcgagt gtcagtgtac taattatgct ctcttgaaat tggctggaga tgttgagagc 3540
aacccaggtc cctcctacgt gctcacacaa cctcctagcg tgtctgtggc ccctggacag 3600
accgccagaa tcacctgcgg cggcaacaac atcggcagca agtccgtgca ttggtaccag 3660
cagaaacctg gccaggcccc agtgctggtc gtgtacgacg atagcgatag acctagcggc 3720
atccccgagc ggttcagcgg atctaatagc ggcaataccg ctacactgac aatcagtaga 3780
gtggaagccg gcgacgaggc cgattattac tgccaggtgt gggactcttc cagcgaccac 3840
tgggtctttg gcggaggaac aaagctgacc gtgctgagca gcgccagcac caagggccct 3900
agcgtgttcc ctctggcccc ttcttctaag tctacaagcg gcggcacagc tgctctgggc 3960
tgtctggtga aggactactt cccagagcct gtgaccgtgt cctggaacag cggcgccctg 4020
accagcggcg tgcacacctt ccccgccgtg ctgcagagct ccggcctgta cagcctgagc 4080
agcgtggtta ccgtgcccag ctctagcctg ggaacccaga cctacatctg caacgtgaac 4140
cacaagccca gcaacaccaa ggtggacaag aaagtggaac ccaagagctg c 4191
<210> 57
<211> 1406
<212> PRT
<213> Artificial
<220>
<223> HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 57
Tyr Pro Tyr Asp Val Pro Asp Tyr Ala Gln Val Gln Leu Val Gln Ser
1 5 10 15
Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys
20 25 30
Ala Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp Val Arg Gln
35 40 45
Ala Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser
50 55 60
Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr
65 70 75 80
Arg Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg
85 90 95
Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr
100 105 110
Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp
115 120 125
Gly Gln Gly Thr Met Val Thr Val Ser Ser Ala Ser Val Ala Ala Pro
130 135 140
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
145 150 155 160
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
165 170 175
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
180 185 190
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
195 200 205
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
210 215 220
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
225 230 235 240
Asn Arg Gly Glu Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala
245 250 255
Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro
260 265 270
Lys Asp Thr Leu Met Ala Ser Arg Thr Pro Glu Val Thr Cys Val Val
275 280 285
Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val
290 295 300
Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln
305 310 315 320
Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu Ala Gln
325 330 335
Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala
340 345 350
Leu Gly Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro
355 360 365
Arg Glu Pro Gln Val Cys Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr
370 375 380
Lys Asn Gln Val Ser Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro Ser
385 390 395 400
Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr
405 410 415
Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Val
420 425 430
Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe
435 440 445
Ser Cys Ser Val Met His Glu Ala Leu His Asn Ala Tyr Thr Gln Lys
450 455 460
Ser Leu Ser Leu Ser Pro Gly Lys Ala Thr Asn Phe Ser Leu Leu Lys
465 470 475 480
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Glu Val Gln Leu Val
485 490 495
Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser
500 505 510
Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr Trp Ile His Trp Val
515 520 525
Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Gly Ile Thr Pro
530 535 540
Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr
545 550 555 560
Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser
565 570 575
Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Phe Val Phe
580 585 590
Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr
595 600 605
Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro
610 615 620
Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val
625 630 635 640
Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala
645 650 655
Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly
660 665 670
Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly
675 680 685
Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys
690 695 700
Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys
705 710 715 720
Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu
725 730 735
Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala Ser Arg Thr Pro Glu
740 745 750
Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys
755 760 765
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys
770 775 780
Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu
785 790 795 800
Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys
805 810 815
Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu Lys Thr Ile Ser Lys
820 825 830
Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Cys
835 840 845
Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Trp Cys Leu Val Lys
850 855 860
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
865 870 875 880
Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly
885 890 895
Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln
900 905 910
Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn
915 920 925
Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys Glu Gly Arg
930 935 940
Gly Ser Leu Leu Thr Cys Gly Asp Val Glu Glu Asn Pro Gly Pro Asp
945 950 955 960
Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp
965 970 975
Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala Val
980 985 990
Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
995 1000 1005
Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
1010 1015 1020
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln
1025 1030 1035
Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Lys Gln Gly Tyr Ala Asn
1040 1045 1050
Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr
1055 1060 1065
Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
1070 1075 1080
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
1085 1090 1095
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
1100 1105 1110
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys
1115 1120 1125
Asp Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala
1130 1135 1140
Asp Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln
1145 1150 1155
Gly Leu Ser Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
1160 1165 1170
Gln Cys Thr Asn Tyr Ala Leu Leu Lys Leu Ala Gly Asp Val Glu
1175 1180 1185
Ser Asn Pro Gly Pro Ser Tyr Val Leu Thr Gln Pro Pro Ser Val
1190 1195 1200
Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly Asn
1205 1210 1215
Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly
1220 1225 1230
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser
1235 1240 1245
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala
1250 1255 1260
Thr Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr
1265 1270 1275
Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His Trp Val Phe Gly
1280 1285 1290
Gly Gly Thr Lys Leu Thr Val Leu Ser Ser Ala Ser Thr Lys Gly
1295 1300 1305
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly
1310 1315 1320
Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu
1325 1330 1335
Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val
1340 1345 1350
His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu
1355 1360 1365
Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr
1370 1375 1380
Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp
1385 1390 1395
Lys Lys Val Glu Pro Lys Ser Cys
1400 1405
<210> 58
<211> 4218
<212> DNA
<213> Artificial
<220>
<223> HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 58
tacccatacg atgttccaga ttacgctcaa gtgcagctgg tgcaatctgg agccgaggtg 60
aaaaagcctg gcgcctctgt gaaggtgtcc tgcaaggcca gcggctatac cttcaccggc 120
tactacatgc actgggtgcg gcaggcccct ggccagggcc tggaatggat gggatggatc 180
aaccccaaca gcggcggcac caactacgcc cagaaatttc agggcagagt gaccatgacc 240
agagatacca gcatcagcac cgcctatatg gaactgagca gactgagatc tgatgacacc 300
gccgtgtact actgcgctag atcccctaat ccttactact acgacagcag cgggtactat 360
taccccggag ccttcgacat ctggggccag ggcaccatgg tgacagtgtc ttctgccagc 420
gtggctgctc caagcgtgtt catcttcccc cccagcgatg agcagctgaa gagcggcaca 480
gcctctgtgg tgtgtctgct gaacaacttc tacccacgcg aggccaaagt gcagtggaag 540
gtggacaacg ccctgcagag cggcaattct caggagagcg tgaccgagca ggattctaag 600
gatagcacat acagcctgag ctccactcta acactgagca aggcagatta cgagaagcac 660
aaggtgtacg cttgtgaagt gacacaccag ggcctgagca gccctgtgac caagtccttt 720
aaccggggag agtgcgacaa gacccacacc tgccctccat gtcctgcccc agaagccgct 780
ggaggaccta gcgtgtttct gttccctcct aagcccaagg acaccctgat ggccagccgg 840
acccctgagg tgacatgcgt ggtggtcgac gtgtcccacg aggaccccga ggtcaagttc 900
aactggtacg tggacggcgt tgaggtccac aatgccaaga caaagcctag agaggaacag 960
tacaactcta catacagggt ggtgtccgtg ctcaccgtgc tggcccaaga ctggctgaac 1020
ggcaaggaat acaagtgcaa ggtgagtaac aaggccctgg gcgcccctat cgagaaaaca 1080
attagcaagg ccaagggcca acctagagag cctcaggtgt gcaccctgcc tccgagccgg 1140
gacgagctga caaaaaacca ggtgtctctg tcttgtgccg tgaagggctt ctaccccagc 1200
gacatcgccg tagaatggga aagcaacggc cagcctgaga acaactacaa gacaacccct 1260
cccgtgctgg acagcgacgg cagcttcttc ctggtctcca aactgaccgt ggataagagc 1320
agatggcagc agggcaacgt gttcagctgc agcgtgatgc atgaagccct gcacaatgct 1380
tacacccaga aaagcctgag cctgagcccc ggcaaggcca cgaacttctc tctgttaaag 1440
caagcaggag atgttgaaga aaaccccggg cctgaggtgc agctggtgga gagcggagga 1500
ggactggtgc agccaggagg ctccctgcgg ctgtcttgcg ccgccagcgg ctttaccatc 1560
tccgactact ggattcactg ggtgagacag gcacctggca agggactgga gtgggtggca 1620
ggaatcaccc cagcaggagg ctacacatac tatgccgaca gcgtgaaggg ccggttcacc 1680
atctccgccg atacctctaa gaacacagcc tatctgcaga tgaactccct gcgggccgag 1740
gacacagccg tgtactattg cgccagattc gtgttcttcc tgccatacgc catggattat 1800
tggggccagg gcaccctggt gacagtgagc tccgccagca ccaagggacc atccgtgttc 1860
ccactggcac cttctagcaa gtccacctct ggaggaacag ccgccctggg ctgtctggtg 1920
aaggattact ttcctgagcc agtgaccgtg agctggaact ccggcgccct gaccagcgga 1980
gtgcacacat tcccagccgt gctgcagtcc tctggcctgt actccctgag ctccgtggtg 2040
accgtgcctt ctagctccct gggcacccag acatatatct gcaacgtgaa tcacaagcca 2100
agcaatacaa aggtggacaa gaaggtggag cccaagtcct gtgataagac ccacacatgc 2160
cctccttgtc ctgctcctga agctgctggt ggcccttccg tgttcctgtt tcctccaaag 2220
cctaaggaca ccctgatggc cagcagaacc cctgaagtga cctgtgtggt ggtggacgtg 2280
tcccacgaag atcccgaagt gaagttcaat tggtacgtgg acggcgtgga agtgcacaac 2340
gccaagacca agcctagaga ggaacagtac aacagcacct acagagtggt gtccgtgctg 2400
acagtgctgg cccaggattg gctgaacggc aaagagtaca agtgcaaggt gtccaacaag 2460
gccctgggcg ctcccatcga gaaaaccatc tctaaggcca agggccagcc tcgcgaaccc 2520
caggtttaca cacttcctcc atgccgggac gagctgacca agaatcaggt gtccctgtgg 2580
tgcctggtca agggctttta ccccagcgac attgccgtgg aatgggagag caatggccag 2640
cctgagaaca actacaagac cacacctcct gtgctggaca gcgacggctc attcttcctg 2700
tacagcaagc tgaccgtgga caagagcaga tggcagcagg gcaacgtgtt cagctgcagc 2760
gtgatgcacg aggccctgca caatgcctac acacagaagt ccctgtctct gagccctggc 2820
aaggagggca ggggaagtct tctaacatgc ggggacgtgg aggaaaatcc cggcccagat 2880
attcagatga cacagtcccc atctagcctg tctgccagcg tgggcgacag ggtgaccatc 2940
acatgtagag caagccagga cgtgagcacc gcagtggcat ggtaccagca gaagcctggc 3000
aaggccccaa agctgctgat ctactccgcc tctttcctgt attctggcgt gccaagcagg 3060
tttagcgggt ccggatctgg aaccgacttc accctgacaa tctcctctct gcagcctgag 3120
gattttgcca catactattg caagcagggc tatgccaatc catggacctt cggccagggc 3180
acaaaggtgg agatcaagag gaccgtggca gcaccaagcg tgttcatctt tccaccctcc 3240
gacgagcagc tgaagtccgg cacagcctct gtggtgtgcc tgctgaacaa cttctaccct 3300
agagaggcca aggtgcagtg gaaggtggat aacgccctgc agtccggcaa ttctcaggag 3360
agcgtgaccg agcaggactc caaggattct acatatagcc tgagctccac cctgacactg 3420
agcaaggccg actacgagaa gcacaaggtg tatgcctgcg aggtgaccca ccagggcctg 3480
tctagccctg tgacaaagtc cttcaatcgc ggcgagtgtc agtgtactaa ttatgctctc 3540
ttgaaattgg ctggagatgt tgagagcaac ccaggtccct cctacgtgct cacacaacct 3600
cctagcgtgt ctgtggcccc tggacagacc gccagaatca cctgcggcgg caacaacatc 3660
ggcagcaagt ccgtgcattg gtaccagcag aaacctggcc aggccccagt gctggtcgtg 3720
tacgacgata gcgatagacc tagcggcatc cccgagcggt tcagcggatc taatagcggc 3780
aataccgcta cactgacaat cagtagagtg gaagccggcg acgaggccga ttattactgc 3840
caggtgtggg actcttccag cgaccactgg gtctttggcg gaggaacaaa gctgaccgtg 3900
ctgagcagcg ccagcaccaa gggccctagc gtgttccctc tggccccttc ttctaagtct 3960
acaagcggcg gcacagctgc tctgggctgt ctggtgaagg actacttccc agagcctgtg 4020
accgtgtcct ggaacagcgg cgccctgacc agcggcgtgc acaccttccc cgccgtgctg 4080
cagagctccg gcctgtacag cctgagcagc gtggttaccg tgcccagctc tagcctggga 4140
acccagacct acatctgcaa cgtgaaccac aagcccagca acaccaaggt ggacaagaaa 4200
gtggaaccca agagctgc 4218
<210> 59
<211> 450
<212> PRT
<213> Artificial
<220>
<223> 抗VEGF-A重链（G6-31）
<400> 59
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr
20 25 30
Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Cys Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu
355 360 365
Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210> 60
<211> 1350
<212> DNA
<213> Artificial
<220>
<223> 抗VEGF-A重链（G6-31）
<400> 60
gaggtgcagc tggtggagag cggaggagga ctggtgcagc caggaggctc cctgcggctg 60
tcttgcgccg ccagcggctt taccatctcc gactactgga ttcactgggt gagacaggca 120
cctggcaagg gactggagtg ggtggcagga atcaccccag caggaggcta cacatactat 180
gccgacagcg tgaagggccg gttcaccatc tccgccgata cctctaagaa cacagcctat 240
ctgcagatga actccctgcg ggccgaggac acagccgtgt actattgcgc cagattcgtg 300
ttcttcctgc catacgccat ggattattgg ggccagggca ccctggtgac agtgagctcc 360
gccagcacca agggaccatc cgtgttccca ctggcacctt ctagcaagtc cacctctgga 420
ggaacagccg ccctgggctg tctggtgaag gattactttc ctgagccagt gaccgtgagc 480
tggaactccg gcgccctgac cagcggagtg cacacattcc cagccgtgct gcagtcctct 540
ggcctgtact ccctgagctc cgtggtgacc gtgccttcta gctccctggg cacccagaca 600
tatatctgca acgtgaatca caagccaagc aatacaaagg tggacaagaa ggtggagccc 660
aagtcctgtg ataagaccca cacatgccct ccttgtcctg ctcctgaagc tgctggtggc 720
ccttccgtgt tcctgtttcc tccaaagcct aaggacaccc tgatggccag cagaacccct 780
gaagtgacct gtgtggtggt ggacgtgtcc cacgaagatc ccgaagtgaa gttcaattgg 840
tacgtggacg gcgtggaagt gcacaacgcc aagaccaagc ctagagagga acagtacaac 900
agcacctaca gagtggtgtc cgtgctgaca gtgctggccc aggattggct gaacggcaaa 960
gagtacaagt gcaaggtgtc caacaaggcc ctgggcgctc ccatcgagaa aaccatctct 1020
aaggccaagg gccagcctcg cgaaccccag gtttacacac ttcctccatg ccgggacgag 1080
ctgaccaaga atcaggtgtc cctgtggtgc ctggtcaagg gcttttaccc cagcgacatt 1140
gccgtggaat gggagagcaa tggccagcct gagaacaact acaagaccac acctcctgtg 1200
ctggacagcg acggctcatt cttcctgtac agcaagctga ccgtggacaa gagcagatgg 1260
cagcagggca acgtgttcag ctgcagcgtg atgcacgagg ccctgcacaa tgcctacaca 1320
cagaagtccc tgtctctgag ccctggcaag 1350
<210> 61
<211> 214
<212> PRT
<213> Artificial
<220>
<223> 抗VEGF-A轻链（G6-31）
<400> 61
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala
20 25 30
Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Gly Asn Pro Phe
85 90 95
Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 62
<211> 642
<212> DNA
<213> Artificial
<220>
<223> 抗VEGF-A轻链（G6-31）
<400> 62
gatattcaga tgacacagtc cccatctagc ctgtctgcca gcgtgggcga cagggtgacc 60
atcacatgta gagcaagcca ggacgtgagc accgcagtgg catggtacca gcagaagcct 120
ggcaaggccc caaagctgct gatctactcc gcctctttcc tgtattctgg cgtgccaagc 180
aggtttagcg ggtccggatc tggaaccgac ttcaccctga caatctcctc tctgcagcct 240
gaggattttg ccacatacta ttgccagcag ggctatggca atccattcac ctttggccag 300
ggcacaaagg tggagatcaa gaggaccgtg gcagcaccaa gcgtgttcat ctttccaccc 360
tccgacgagc agctgaagtc cggcacagcc tctgtggtgt gcctgctgaa caatttctac 420
cctagagagg ccaaggtgca gtggaaggtg gataacgccc tgcagtccgg caattctcag 480
gagagcgtga ccgagcagga ctccaaggat tctacatata gcctgagctc caccctgaca 540
ctgagcaagg ccgactacga gaagcacaag gtgtatgcct gcgaggtgac ccaccagggc 600
ctgtctagcc ctgtgacaaa gtccttcaat cgcggcgagt gt 642
<210> 63
<211> 1397
<212> PRT
<213> Artificial
<220>
<223> 抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 63
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Pro Asn Pro Tyr Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr
100 105 110
Pro Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
115 120 125
Ser Ala Ser Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
130 135 140
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
145 150 155 160
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
165 170 175
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
180 185 190
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
195 200 205
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
210 215 220
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys Asp Lys Thr His
225 230 235 240
Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val
245 250 255
Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala Ser Arg Thr
260 265 270
Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu
275 280 285
Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
290 295 300
Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser
305 310 315 320
Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
325 330 335
Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu Lys Thr Ile
340 345 350
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Cys Thr Leu Pro
355 360 365
Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Ser Cys Ala
370 375 380
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
385 390 395 400
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
405 410 415
Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val Asp Lys Ser Arg
420 425 430
Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu
435 440 445
His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys Ala
450 455 460
Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn Pro
465 470 475 480
Gly Pro Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro
485 490 495
Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Ile Ser
500 505 510
Asp Tyr Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu
515 520 525
Trp Val Ala Gly Ile Thr Pro Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp
530 535 540
Ser Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr
545 550 555 560
Ala Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr
565 570 575
Tyr Cys Ala Arg Phe Val Phe Phe Leu Pro Tyr Ala Met Asp Tyr Trp
580 585 590
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro
595 600 605
Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr
610 615 620
Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr
625 630 635 640
Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro
645 650 655
Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr
660 665 670
Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn
675 680 685
His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser
690 695 700
Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala
705 710 715 720
Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu
725 730 735
Met Ala Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
740 745 750
His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu
755 760 765
Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr
770 775 780
Tyr Arg Val Val Ser Val Leu Thr Val Leu Ala Gln Asp Trp Leu Asn
785 790 795 800
Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Gly Ala Pro
805 810 815
Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln
820 825 830
Val Tyr Thr Leu Pro Pro Cys Arg Asp Glu Leu Thr Lys Asn Gln Val
835 840 845
Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
850 855 860
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
865 870 875 880
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr
885 890 895
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
900 905 910
Met His Glu Ala Leu His Asn Ala Tyr Thr Gln Lys Ser Leu Ser Leu
915 920 925
Ser Pro Gly Lys Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp Val
930 935 940
Glu Glu Asn Pro Gly Pro Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
945 950 955 960
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser
965 970 975
Gln Asp Val Ser Thr Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys
980 985 990
Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val
995 1000 1005
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu
1010 1015 1020
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys
1025 1030 1035
Gln Gln Gly Tyr Gly Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys
1040 1045 1050
Val Glu Ile Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe
1055 1060 1065
Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val
1070 1075 1080
Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp
1085 1090 1095
Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser Val
1100 1105 1110
Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr
1115 1120 1125
Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
1130 1135 1140
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
1145 1150 1155
Phe Asn Arg Gly Glu Cys Gln Cys Thr Asn Tyr Ala Leu Leu Lys
1160 1165 1170
Leu Ala Gly Asp Val Glu Ser Asn Pro Gly Pro Ser Tyr Val Leu
1175 1180 1185
Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg
1190 1195 1200
Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val His Trp
1205 1210 1215
Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr Asp
1220 1225 1230
Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
1235 1240 1245
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala
1250 1255 1260
Gly Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser
1265 1270 1275
Asp His Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Ser
1280 1285 1290
Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser
1295 1300 1305
Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val
1310 1315 1320
Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly
1325 1330 1335
Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser
1340 1345 1350
Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser
1355 1360 1365
Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
1370 1375 1380
Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys
1385 1390 1395
<210> 64
<211> 4191
<212> DNA
<213> Artificial
<220>
<223> 抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 64
caagtgcagc tggtgcaatc tggagccgag gtgaaaaagc ctggcgcctc tgtgaaggtg 60
tcctgcaagg ccagcggcta taccttcacc ggctactaca tgcactgggt gcggcaggcc 120
cctggccagg gcctggaatg gatgggatgg atcaacccca acagcggcgg caccaactac 180
gcccagaaat ttcagggcag agtgaccatg accagagata ccagcatcag caccgcctat 240
atggaactga gcagactgag atctgatgac accgccgtgt actactgcgc tagatcccct 300
aatccttact actacgacag cagcgggtac tattaccccg gagccttcga catctggggc 360
cagggcacca tggtgacagt gtcttctgcc agcgtggctg ctccaagcgt gttcatcttc 420
ccccccagcg atgagcagct gaagagcggc acagcctctg tggtgtgtct gctgaacaac 480
ttctacccac gcgaggccaa agtgcagtgg aaggtggaca acgccctgca gagcggcaat 540
tctcaggaga gcgtgaccga gcaggattct aaggatagca catacagcct gagctccact 600
ctaacactga gcaaggcaga ttacgagaag cacaaggtgt acgcttgtga agtgacacac 660
cagggcctga gcagccctgt gaccaagtcc tttaaccggg gagagtgcga caagacccac 720
acctgccctc catgtcctgc cccagaagcc gctggaggac ctagcgtgtt tctgttccct 780
cctaagccca aggacaccct gatggccagc cggacccctg aggtgacatg cgtggtggtc 840
gacgtgtccc acgaggaccc cgaggtcaag ttcaactggt acgtggacgg cgttgaggtc 900
cacaatgcca agacaaagcc tagagaggaa cagtacaact ctacatacag ggtggtgtcc 960
gtgctcaccg tgctggccca agactggctg aacggcaagg aatacaagtg caaggtgagt 1020
aacaaggccc tgggcgcccc tatcgagaaa acaattagca aggccaaggg ccaacctaga 1080
gagcctcagg tgtgcaccct gcctccgagc cgggacgagc tgacaaaaaa ccaggtgtct 1140
ctgtcttgtg ccgtgaaggg cttctacccc agcgacatcg ccgtagaatg ggaaagcaac 1200
ggccagcctg agaacaacta caagacaacc cctcccgtgc tggacagcga cggcagcttc 1260
ttcctggtct ccaaactgac cgtggataag agcagatggc agcagggcaa cgtgttcagc 1320
tgcagcgtga tgcatgaagc cctgcacaat gcttacaccc agaaaagcct gagcctgagc 1380
cccggcaagg ccacgaactt ctctctgtta aagcaagcag gagatgttga agaaaacccc 1440
gggcctgagg tgcagctggt ggagagcgga ggaggactgg tgcagccagg aggctccctg 1500
cggctgtctt gcgccgccag cggctttacc atctccgact actggattca ctgggtgaga 1560
caggcacctg gcaagggact ggagtgggtg gcaggaatca ccccagcagg aggctacaca 1620
tactatgccg acagcgtgaa gggccggttc accatctccg ccgatacctc taagaacaca 1680
gcctatctgc agatgaactc cctgcgggcc gaggacacag ccgtgtacta ttgcgccaga 1740
ttcgtgttct tcctgccata cgccatggat tattggggcc agggcaccct ggtgacagtg 1800
agctccgcca gcaccaaggg accatccgtg ttcccactgg caccttctag caagtccacc 1860
tctggaggaa cagccgccct gggctgtctg gtgaaggatt actttcctga gccagtgacc 1920
gtgagctgga actccggcgc cctgaccagc ggagtgcaca cattcccagc cgtgctgcag 1980
tcctctggcc tgtactccct gagctccgtg gtgaccgtgc cttctagctc cctgggcacc 2040
cagacatata tctgcaacgt gaatcacaag ccaagcaata caaaggtgga caagaaggtg 2100
gagcccaagt cctgtgataa gacccacaca tgccctcctt gtcctgctcc tgaagctgct 2160
ggtggccctt ccgtgttcct gtttcctcca aagcctaagg acaccctgat ggccagcaga 2220
acccctgaag tgacctgtgt ggtggtggac gtgtcccacg aagatcccga agtgaagttc 2280
aattggtacg tggacggcgt ggaagtgcac aacgccaaga ccaagcctag agaggaacag 2340
tacaacagca cctacagagt ggtgtccgtg ctgacagtgc tggcccagga ttggctgaac 2400
ggcaaagagt acaagtgcaa ggtgtccaac aaggccctgg gcgctcccat cgagaaaacc 2460
atctctaagg ccaagggcca gcctcgcgaa ccccaggttt acacacttcc tccatgccgg 2520
gacgagctga ccaagaatca ggtgtccctg tggtgcctgg tcaagggctt ttaccccagc 2580
gacattgccg tggaatggga gagcaatggc cagcctgaga acaactacaa gaccacacct 2640
cctgtgctgg acagcgacgg ctcattcttc ctgtacagca agctgaccgt ggacaagagc 2700
agatggcagc agggcaacgt gttcagctgc agcgtgatgc acgaggccct gcacaatgcc 2760
tacacacaga agtccctgtc tctgagccct ggcaaggagg gcaggggaag tcttctaaca 2820
tgcggggacg tggaggaaaa tcccggccca gatattcaga tgacacagtc cccatctagc 2880
ctgtctgcca gcgtgggcga cagggtgacc atcacatgta gagcaagcca ggacgtgagc 2940
accgcagtgg catggtacca gcagaagcct ggcaaggccc caaagctgct gatctactcc 3000
gcctctttcc tgtattctgg cgtgccaagc aggtttagcg ggtccggatc tggaaccgac 3060
ttcaccctga caatctcctc tctgcagcct gaggattttg ccacatacta ttgccagcag 3120
ggctatggca atccattcac ctttggccag ggcacaaagg tggagatcaa gaggaccgtg 3180
gcagcaccaa gcgtgttcat ctttccaccc tccgacgagc agctgaagtc cggcacagcc 3240
tctgtggtgt gcctgctgaa caatttctac cctagagagg ccaaggtgca gtggaaggtg 3300
gataacgccc tgcagtccgg caattctcag gagagcgtga ccgagcagga ctccaaggat 3360
tctacatata gcctgagctc caccctgaca ctgagcaagg ccgactacga gaagcacaag 3420
gtgtatgcct gcgaggtgac ccaccagggc ctgtctagcc ctgtgacaaa gtccttcaat 3480
cgcggcgagt gtcagtgtac taattatgct ctcttgaaat tggctggaga tgttgagagc 3540
aacccaggtc cctcctacgt gctcacacaa cctcctagcg tgtctgtggc ccctggacag 3600
accgccagaa tcacctgcgg cggcaacaac atcggcagca agtccgtgca ttggtaccag 3660
cagaaacctg gccaggcccc agtgctggtc gtgtacgacg atagcgatag acctagcggc 3720
atccccgagc ggttcagcgg atctaatagc ggcaataccg ctacactgac aatcagtaga 3780
gtggaagccg gcgacgaggc cgattattac tgccaggtgt gggactcttc cagcgaccac 3840
tgggtctttg gcggaggaac aaagctgacc gtgctgagca gcgccagcac caagggccct 3900
agcgtgttcc ctctggcccc ttcttctaag tctacaagcg gcggcacagc tgctctgggc 3960
tgtctggtga aggactactt cccagagcct gtgaccgtgt cctggaacag cggcgccctg 4020
accagcggcg tgcacacctt ccccgccgtg ctgcagagct ccggcctgta cagcctgagc 4080
agcgtggtta ccgtgcccag ctctagcctg ggaacccaga cctacatctg caacgtgaac 4140
cacaagccca gcaacaccaa ggtggacaag aaagtggaac ccaagagctg c 4191
<210> 65
<211> 1406
<212> PRT
<213> Artificial
<220>
<223> HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 65
Tyr Pro Tyr Asp Val Pro Asp Tyr Ala Gln Val Gln Leu Val Gln Ser
1 5 10 15
Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys
20 25 30
Ala Ser Gly Tyr Thr Phe Thr Gly Tyr Tyr Met His Trp Val Arg Gln
35 40 45
Ala Pro Gly Gln Gly Leu Glu Trp Met Gly Trp Ile Asn Pro Asn Ser
50 55 60
Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln Gly Arg Val Thr Met Thr
65 70 75 80
Arg Asp Thr Ser Ile Ser Thr Ala Tyr Met Glu Leu Ser Arg Leu Arg
85 90 95
Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro Asn Pro Tyr
100 105 110
Tyr Tyr Asp Ser Ser Gly Tyr Tyr Tyr Pro Gly Ala Phe Asp Ile Trp
115 120 125
Gly Gln Gly Thr Met Val Thr Val Ser Ser Ala Ser Val Ala Ala Pro
130 135 140
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
145 150 155 160
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
165 170 175
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
180 185 190
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
195 200 205
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
210 215 220
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
225 230 235 240
Asn Arg Gly Glu Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala
245 250 255
Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro
260 265 270
Lys Asp Thr Leu Met Ala Ser Arg Thr Pro Glu Val Thr Cys Val Val
275 280 285
Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val
290 295 300
Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln
305 310 315 320
Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu Ala Gln
325 330 335
Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala
340 345 350
Leu Gly Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro
355 360 365
Arg Glu Pro Gln Val Cys Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr
370 375 380
Lys Asn Gln Val Ser Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro Ser
385 390 395 400
Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr
405 410 415
Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Val
420 425 430
Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe
435 440 445
Ser Cys Ser Val Met His Glu Ala Leu His Asn Ala Tyr Thr Gln Lys
450 455 460
Ser Leu Ser Leu Ser Pro Gly Lys Ala Thr Asn Phe Ser Leu Leu Lys
465 470 475 480
Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro Glu Val Gln Leu Val
485 490 495
Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser
500 505 510
Cys Ala Ala Ser Gly Phe Thr Ile Ser Asp Tyr Trp Ile His Trp Val
515 520 525
Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Gly Ile Thr Pro
530 535 540
Ala Gly Gly Tyr Thr Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr
545 550 555 560
Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser
565 570 575
Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Phe Val Phe
580 585 590
Phe Leu Pro Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr
595 600 605
Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro
610 615 620
Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val
625 630 635 640
Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala
645 650 655
Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly
660 665 670
Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly
675 680 685
Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys
690 695 700
Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys
705 710 715 720
Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu
725 730 735
Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ala Ser Arg Thr Pro Glu
740 745 750
Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys
755 760 765
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys
770 775 780
Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu
785 790 795 800
Thr Val Leu Ala Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys
805 810 815
Val Ser Asn Lys Ala Leu Gly Ala Pro Ile Glu Lys Thr Ile Ser Lys
820 825 830
Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Cys
835 840 845
Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Trp Cys Leu Val Lys
850 855 860
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
865 870 875 880
Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly
885 890 895
Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln
900 905 910
Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn
915 920 925
Ala Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys Glu Gly Arg
930 935 940
Gly Ser Leu Leu Thr Cys Gly Asp Val Glu Glu Asn Pro Gly Pro Asp
945 950 955 960
Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp
965 970 975
Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala Val
980 985 990
Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr
995 1000 1005
Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly
1010 1015 1020
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln
1025 1030 1035
Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Gly Tyr Gly Asn
1040 1045 1050
Pro Phe Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr
1055 1060 1065
Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
1070 1075 1080
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
1085 1090 1095
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
1100 1105 1110
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys
1115 1120 1125
Asp Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala
1130 1135 1140
Asp Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln
1145 1150 1155
Gly Leu Ser Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
1160 1165 1170
Gln Cys Thr Asn Tyr Ala Leu Leu Lys Leu Ala Gly Asp Val Glu
1175 1180 1185
Ser Asn Pro Gly Pro Ser Tyr Val Leu Thr Gln Pro Pro Ser Val
1190 1195 1200
Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly Asn
1205 1210 1215
Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly
1220 1225 1230
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser
1235 1240 1245
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala
1250 1255 1260
Thr Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr
1265 1270 1275
Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His Trp Val Phe Gly
1280 1285 1290
Gly Gly Thr Lys Leu Thr Val Leu Ser Ser Ala Ser Thr Lys Gly
1295 1300 1305
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly
1310 1315 1320
Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu
1325 1330 1335
Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val
1340 1345 1350
His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu
1355 1360 1365
Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr
1370 1375 1380
Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp
1385 1390 1395
Lys Lys Val Glu Pro Lys Ser Cys
1400 1405
<210> 66
<211> 4218
<212> DNA
<213> Artificial
<220>
<223> HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链
<400> 66
tacccatacg atgttccaga ttacgctcaa gtgcagctgg tgcaatctgg agccgaggtg 60
aaaaagcctg gcgcctctgt gaaggtgtcc tgcaaggcca gcggctatac cttcaccggc 120
tactacatgc actgggtgcg gcaggcccct ggccagggcc tggaatggat gggatggatc 180
aaccccaaca gcggcggcac caactacgcc cagaaatttc agggcagagt gaccatgacc 240
agagatacca gcatcagcac cgcctatatg gaactgagca gactgagatc tgatgacacc 300
gccgtgtact actgcgctag atcccctaat ccttactact acgacagcag cgggtactat 360
taccccggag ccttcgacat ctggggccag ggcaccatgg tgacagtgtc ttctgccagc 420
gtggctgctc caagcgtgtt catcttcccc cccagcgatg agcagctgaa gagcggcaca 480
gcctctgtgg tgtgtctgct gaacaacttc tacccacgcg aggccaaagt gcagtggaag 540
gtggacaacg ccctgcagag cggcaattct caggagagcg tgaccgagca ggattctaag 600
gatagcacat acagcctgag ctccactcta acactgagca aggcagatta cgagaagcac 660
aaggtgtacg cttgtgaagt gacacaccag ggcctgagca gccctgtgac caagtccttt 720
aaccggggag agtgcgacaa gacccacacc tgccctccat gtcctgcccc agaagccgct 780
ggaggaccta gcgtgtttct gttccctcct aagcccaagg acaccctgat ggccagccgg 840
acccctgagg tgacatgcgt ggtggtcgac gtgtcccacg aggaccccga ggtcaagttc 900
aactggtacg tggacggcgt tgaggtccac aatgccaaga caaagcctag agaggaacag 960
tacaactcta catacagggt ggtgtccgtg ctcaccgtgc tggcccaaga ctggctgaac 1020
ggcaaggaat acaagtgcaa ggtgagtaac aaggccctgg gcgcccctat cgagaaaaca 1080
attagcaagg ccaagggcca acctagagag cctcaggtgt gcaccctgcc tccgagccgg 1140
gacgagctga caaaaaacca ggtgtctctg tcttgtgccg tgaagggctt ctaccccagc 1200
gacatcgccg tagaatggga aagcaacggc cagcctgaga acaactacaa gacaacccct 1260
cccgtgctgg acagcgacgg cagcttcttc ctggtctcca aactgaccgt ggataagagc 1320
agatggcagc agggcaacgt gttcagctgc agcgtgatgc atgaagccct gcacaatgct 1380
tacacccaga aaagcctgag cctgagcccc ggcaaggcca cgaacttctc tctgttaaag 1440
caagcaggag atgttgaaga aaaccccggg cctgaggtgc agctggtgga gagcggagga 1500
ggactggtgc agccaggagg ctccctgcgg ctgtcttgcg ccgccagcgg ctttaccatc 1560
tccgactact ggattcactg ggtgagacag gcacctggca agggactgga gtgggtggca 1620
ggaatcaccc cagcaggagg ctacacatac tatgccgaca gcgtgaaggg ccggttcacc 1680
atctccgccg atacctctaa gaacacagcc tatctgcaga tgaactccct gcgggccgag 1740
gacacagccg tgtactattg cgccagattc gtgttcttcc tgccatacgc catggattat 1800
tggggccagg gcaccctggt gacagtgagc tccgccagca ccaagggacc atccgtgttc 1860
ccactggcac cttctagcaa gtccacctct ggaggaacag ccgccctggg ctgtctggtg 1920
aaggattact ttcctgagcc agtgaccgtg agctggaact ccggcgccct gaccagcgga 1980
gtgcacacat tcccagccgt gctgcagtcc tctggcctgt actccctgag ctccgtggtg 2040
accgtgcctt ctagctccct gggcacccag acatatatct gcaacgtgaa tcacaagcca 2100
agcaatacaa aggtggacaa gaaggtggag cccaagtcct gtgataagac ccacacatgc 2160
cctccttgtc ctgctcctga agctgctggt ggcccttccg tgttcctgtt tcctccaaag 2220
cctaaggaca ccctgatggc cagcagaacc cctgaagtga cctgtgtggt ggtggacgtg 2280
tcccacgaag atcccgaagt gaagttcaat tggtacgtgg acggcgtgga agtgcacaac 2340
gccaagacca agcctagaga ggaacagtac aacagcacct acagagtggt gtccgtgctg 2400
acagtgctgg cccaggattg gctgaacggc aaagagtaca agtgcaaggt gtccaacaag 2460
gccctgggcg ctcccatcga gaaaaccatc tctaaggcca agggccagcc tcgcgaaccc 2520
caggtttaca cacttcctcc atgccgggac gagctgacca agaatcaggt gtccctgtgg 2580
tgcctggtca agggctttta ccccagcgac attgccgtgg aatgggagag caatggccag 2640
cctgagaaca actacaagac cacacctcct gtgctggaca gcgacggctc attcttcctg 2700
tacagcaagc tgaccgtgga caagagcaga tggcagcagg gcaacgtgtt cagctgcagc 2760
gtgatgcacg aggccctgca caatgcctac acacagaagt ccctgtctct gagccctggc 2820
aaggagggca ggggaagtct tctaacatgc ggggacgtgg aggaaaatcc cggcccagat 2880
attcagatga cacagtcccc atctagcctg tctgccagcg tgggcgacag ggtgaccatc 2940
acatgtagag caagccagga cgtgagcacc gcagtggcat ggtaccagca gaagcctggc 3000
aaggccccaa agctgctgat ctactccgcc tctttcctgt attctggcgt gccaagcagg 3060
tttagcgggt ccggatctgg aaccgacttc accctgacaa tctcctctct gcagcctgag 3120
gattttgcca catactattg ccagcagggc tatggcaatc cattcacctt tggccagggc 3180
acaaaggtgg agatcaagag gaccgtggca gcaccaagcg tgttcatctt tccaccctcc 3240
gacgagcagc tgaagtccgg cacagcctct gtggtgtgcc tgctgaacaa tttctaccct 3300
agagaggcca aggtgcagtg gaaggtggat aacgccctgc agtccggcaa ttctcaggag 3360
agcgtgaccg agcaggactc caaggattct acatatagcc tgagctccac cctgacactg 3420
agcaaggccg actacgagaa gcacaaggtg tatgcctgcg aggtgaccca ccagggcctg 3480
tctagccctg tgacaaagtc cttcaatcgc ggcgagtgtc agtgtactaa ttatgctctc 3540
ttgaaattgg ctggagatgt tgagagcaac ccaggtccct cctacgtgct cacacaacct 3600
cctagcgtgt ctgtggcccc tggacagacc gccagaatca cctgcggcgg caacaacatc 3660
ggcagcaagt ccgtgcattg gtaccagcag aaacctggcc aggccccagt gctggtcgtg 3720
tacgacgata gcgatagacc tagcggcatc cccgagcggt tcagcggatc taatagcggc 3780
aataccgcta cactgacaat cagtagagtg gaagccggcg acgaggccga ttattactgc 3840
caggtgtggg actcttccag cgaccactgg gtctttggcg gaggaacaaa gctgaccgtg 3900
ctgagcagcg ccagcaccaa gggccctagc gtgttccctc tggccccttc ttctaagtct 3960
acaagcggcg gcacagctgc tctgggctgt ctggtgaagg actacttccc agagcctgtg 4020
accgtgtcct ggaacagcgg cgccctgacc agcggcgtgc acaccttccc cgccgtgctg 4080
cagagctccg gcctgtacag cctgagcagc gtggttaccg tgcccagctc tagcctggga 4140
acccagacct acatctgcaa cgtgaaccac aagcccagca acaccaaggt ggacaagaaa 4200
gtggaaccca agagctgc 4218
<210> 67
<211> 9
<212> PRT
<213> Artificial
<220>
<223> HA
<400> 67
Tyr Pro Tyr Asp Val Pro Asp Tyr Ala
1 5
<210> 68
<211> 27
<212> DNA
<213> Artificial
<220>
<223> HA
<400> 68
tacccatacg atgttccaga ttacgct 27
<210> 69
<211> 19
<212> PRT
<213> Artificial
<220>
<223> P2A
<400> 69
Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn
1 5 10 15
Pro Gly Pro
<210> 70
<211> 57
<212> DNA
<213> Artificial
<220>
<223> P2A
<400> 70
gccacgaact tctctctgtt aaagcaagca ggagatgttg aagaaaaccc cgggcct 57
<210> 71
<211> 18
<212> PRT
<213> Artificial
<220>
<223> T2A
<400> 71
Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp Val Glu Glu Asn Pro
1 5 10 15
Gly Pro
<210> 72
<211> 54
<212> DNA
<213> Artificial
<220>
<223> T2A
<400> 72
gagggcaggg gaagtcttct aacatgcggg gacgtggagg aaaatcccgg ccca 54
<210> 73
<211> 20
<212> PRT
<213> Artificial
<220>
<223> E2A
<400> 73
Gln Cys Thr Asn Tyr Ala Leu Leu Lys Leu Ala Gly Asp Val Glu Ser
1 5 10 15
Asn Pro Gly Pro
20
<210> 74
<211> 60
<212> DNA
<213> Artificial
<220>
<223> E2A
<400> 74
cagtgtacta attatgctct cttgaaattg gctggagatg ttgagagcaa cccaggtccc 60
Claims (21)
1.一种AAV病毒载体，包括编码双特异性抗体构建体的序列，其中所述双特异性抗体构建体包含特异于VEGF-A和ANG-2的结合结构域，所述双特异性抗体构建体中重链可变区(VH)和轻链可变区(VL)从N-末端到C-末端按照如下顺序排列：
1)VH抗VEGF-A-VL抗VEGF-A-VH抗ANG-2-VL抗ANG-2；
2)VL抗ANG-2-VH抗VEGF-A-VL抗VEGF-A-VH抗ANG-2；或
3)VL抗VEGF-A-VH抗ANG-2-VL抗ANG-2-VH抗VEGF-A。
2.如权利要求1所述的AAV病毒载体，其中所述重链可变区(VH)和轻链可变区(VL)之间由(G4S)n链接，其中n＝1至4间任意整数。
3.如权利要求1所述的AAV病毒载体，其中所述双特异性抗体构建体的N-末端包含信号肽序列或标签序列，优选所述信号肽序列为如SEQ ID NO：21所示的CD5-sp信号肽，优选标签序列为HA标签。
4.如权利要求1所述的AAV病毒载体，进一步包括：5’ITR和3’ITR、启动子、polyA序列。
5.如权利要求1所述的AAV病毒载体，其中所述VH抗VEGF-A包含如SEQ ID NO:1所示的氨基酸序列，所述VL抗VEGF-A包含如SEQ ID NO:3所示的氨基酸序列，所述VH抗ANG-2包含如SEQ IDNO:5所示的氨基酸序列，所述VL抗ANG-2包含如SEQ ID NO:7所示的氨基酸序列。
6.如权利要求6所述的AAV病毒载体，其中所述双特异性抗体构建体的结构选自
VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:9所示；
VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2，如SEQ ID NO:13所示；
VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S-VH抗VEGF-A；如SEQ ID NO:17所示；
CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:11所示；
CD5-sp-VL抗ANG-2-G4S-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2，如SEQ ID NO:15所示；或
CD5-sp-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2-G4S-VH抗VEGF-A；如SEQ ID NO:19所示。
7.如权利要求1所述的AAV病毒载体，其中所述VH抗VEGF-A包含如SEQ ID NO:23所示的氨基酸序列，所述VL抗VEGF-A包含如SEQ ID NO:25所示的氨基酸序列；所述VH抗ANG-2包含如SEQ IDNO:5所示的氨基酸序列，所述VL抗ANG-2包含如SEQ ID NO:7所示的氨基酸序列。
8.如权利要求7所述的AAV病毒载体，其中所述双特异性抗体构建体的结构选自
VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:27所示；或
CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:29所示。
9.如权利要求1所述的AAV病毒载体，其中所述VH抗VEGF-A包含如SEQ ID NO:31所示的氨基酸序列，所述VL抗VEGF-A包含如SEQ ID NO:33所示的氨基酸序列；所述VH抗ANG-2包含如SEQ IDNO:5所示的氨基酸序列，所述VL抗ANG-2包含如SEQ ID NO:7所示的氨基酸序列。
10.如权利要求9所述的AAV病毒载体，其中所述双特异性抗体构建体的结构选自
VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:35所示；或
CD5-sp-VH抗VEGF-A-(G4S)3-VL抗VEGF-A-G4S-VH抗ANG-2-(G4S)3-VL抗ANG-2，如SEQ ID NO:37所示。
11.一种AAV病毒载体，包括编码双特异性抗体构建体的序列，其中所述双特异性抗体构建体包含特异于VEGF-A和ANG-2的结合结构域，所述双特异性抗体构建体结构按照如下顺序排列：
抗ANG-2重链Fab段-P2A-抗VEGF-A重链Fab段-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链；
抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链；
HA-抗ANG-2重链Fab段-P2A-抗VEGF-A重链Fab段-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链；或
HA-抗ANG-2重链-P2A-抗VEGF-A重链-T2A-抗VEGF-A轻链-E2A-抗ANG-2轻链；
其中抗ANG-2重链中恒定区CH1被CL替换，抗ANG-2轻链中CL被恒定区CH1替换。
12.如权利要求9所述的AAV病毒载体，其中所述抗ANG-2重链Fab段包含SEQ ID NO:39,所述抗ANG-2轻链包含SEQ ID NO:45，所述抗VEGF-A重链Fab段包含SEQ ID NO:41、51或59，所述抗VEGF-A轻链包含SEQ ID NO:43、53或61。
13.如权利要求9所述的AAV病毒载体，其中所述双特异性抗体构建体的序列包含选自SEQ ID NO:47、49、55、57、63、或65。
14.如权利要求9所述的AAV病毒载体，其中所述双特异性抗体构建体的N-末端包含信号肽序列或标签序列，优选所述信号肽序列为如SEQ ID NO：21所示的CD5-sp信号肽，优选标签序列为HA标签。
15.如权利要求9所述的AAV病毒载体，进一步包括：5’ITR和3’ITR、启动子、polyA序列。
16.一种AAV病毒颗粒，包括如权利要求1-15任一项所述的AAV病毒载体和衣壳蛋白。
17.如权利要求16所述的AAV病毒颗粒，其中所述衣壳蛋白的血清型为AAV1、AAV2、AAV4、AAV5、AAV6、AAV7、AAV8、或AAV9。
18.一种药物组合物，包括如权利要求1-15任一项所述的AAV病毒载体或如权利要求16或17所述的AAV病毒颗粒，以及药学上可接受的载体。
19.如权利要求1-15任一项所述的AAV病毒载体、如权利要求16或17所述的AAV病毒颗粒、或如权利要求18所述的药物组合物在制备用于治疗或预防癌症、眼内新生血管综合征、类风湿性关节炎、银屑病、增殖性视网膜病变、年龄相关的黄斑变性或糖尿病性黄斑水肿的药物中的用途。
20.如权利要求19所述的用途，所述年龄相关的黄斑变性为湿性年龄相关黄斑变性。
21.如权利要求19或20所述的用途，其中所述药物通过玻璃体腔或视网膜下腔注射施用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111048202.XA CN115772544B (zh) | 2021-09-06 | 抗vegf-a和ang-2的aav载体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111048202.XA CN115772544B (zh) | 2021-09-06 | 抗vegf-a和ang-2的aav载体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115772544A true CN115772544A (zh) | 2023-03-10 |
| CN115772544B CN115772544B (zh) | 2024-04-26 |
Family
ID=
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107001456A (zh) * | 2014-11-10 | 2017-08-01 | 豪夫迈·罗氏有限公司 | 抗ang2 抗体及使用方法 |
| CN109415435A (zh) * | 2016-07-04 | 2019-03-01 | 豪夫迈·罗氏有限公司 | 新型抗体形式 |
| CN111727201A (zh) * | 2017-10-18 | 2020-09-29 | 再生生物股份有限公司 | 完全人源翻译后修饰的抗体治疗剂 |
| CN113185613A (zh) * | 2021-04-13 | 2021-07-30 | 武汉大学 | 新型冠状病毒s蛋白及其亚单位疫苗 |
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107001456A (zh) * | 2014-11-10 | 2017-08-01 | 豪夫迈·罗氏有限公司 | 抗ang2 抗体及使用方法 |
| CN109415435A (zh) * | 2016-07-04 | 2019-03-01 | 豪夫迈·罗氏有限公司 | 新型抗体形式 |
| CN111727201A (zh) * | 2017-10-18 | 2020-09-29 | 再生生物股份有限公司 | 完全人源翻译后修饰的抗体治疗剂 |
| CN113185613A (zh) * | 2021-04-13 | 2021-07-30 | 武汉大学 | 新型冠状病毒s蛋白及其亚单位疫苗 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021063330A1 (zh) | 靶向cd3的抗体、双特异性抗体及其用途 | |
| WO2020043184A1 (zh) | 抗pd-1-抗vegfa的双功能抗体、其药物组合物及其用途 | |
| CN111788225A (zh) | 抗cd38抗体及与抗cd3和抗cd28抗体的组合 | |
| CN106939050B (zh) | 抗pd1和cd19双特异性抗体及其应用 | |
| KR20210050547A (ko) | 항-클라우딘18.2 항체 및 이의 용도 | |
| CN109476732A (zh) | 三特异性和/或三价结合蛋白 | |
| IL257062B (en) | New anti-pd-1 antibodies | |
| KR20140019385A (ko) | 이중특이성 및 단일특이성, 비대칭성 항체 및 이의 제조방법 | |
| KR20140032992A (ko) | Ｃｓｆ－1ｒ에 대한 항체 | |
| JP2023503180A (ja) | 抗ヒトクローディン１８．２抗体及びその適用 | |
| KR20210142638A (ko) | Cd3 항원 결합 단편 및 이의 응용 | |
| CN114349865B (zh) | 一种pd-1/lag-3四价双特异性抗体、其制备方法和用途 | |
| BR112020020637A2 (pt) | anticorpo anti-pd-l1, fragmento de ligação ao antígeno ou variante do mesmo, anticorpo biespecífico, composição farmacêutica e uso dos mesmos para aliviar ou tratar tumores | |
| CN110972463A (zh) | 抗序列相似家族19成员a5抗体在治疗青光眼中的用途 | |
| CN113164777A (zh) | Csf1r/ccr2多特异性抗体 | |
| CN114634566B (zh) | 一种抗Claudin18_2的抗原结合片段、抗体及其应用 | |
| CN113683697B (zh) | 抗b7-h3抗体、其制备方法及用途 | |
| CN115772544B (zh) | 抗vegf-a和ang-2的aav载体 | |
| KR20230104256A (ko) | 증가된 선택성의 다중표적화 이중특이적 항원 결합 분자 | |
| KR20220167331A (ko) | 항-flt3 항체 및 조성물 | |
| CN115772544A (zh) | 抗vegf-a和ang-2的aav载体 | |
| WO2023016554A1 (zh) | 靶向cd22的抗原结合蛋白及其用途 | |
| CN115521379B (zh) | Pd-1抗体及其用途 | |
| RU2812910C2 (ru) | Антитела к cd38 и комбинации с антителами к cd3 и cd28 | |
| WO2023179716A1 (zh) | 一种抗cd3抗体、其制备方法及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |